A Comparative Study of the Effects of Sesbania Drummondii on the Hepatic Cytochrome P-450 Monooxygenase Systems of Chickens and Rats. by Banton, Marcy Iva
Louisiana State University
LSU Digital Commons
LSU Historical Dissertations and Theses Graduate School
1990
A Comparative Study of the Effects of Sesbania
Drummondii on the Hepatic Cytochrome P-450
Monooxygenase Systems of Chickens and Rats.
Marcy Iva Banton
Louisiana State University and Agricultural & Mechanical College
Follow this and additional works at: https://digitalcommons.lsu.edu/gradschool_disstheses
This Dissertation is brought to you for free and open access by the Graduate School at LSU Digital Commons. It has been accepted for inclusion in
LSU Historical Dissertations and Theses by an authorized administrator of LSU Digital Commons. For more information, please contact
gradetd@lsu.edu.
Recommended Citation
Banton, Marcy Iva, "A Comparative Study of the Effects of Sesbania Drummondii on the Hepatic Cytochrome P-450 Monooxygenase
Systems of Chickens and Rats." (1990). LSU Historical Dissertations and Theses. 4970.
https://digitalcommons.lsu.edu/gradschool_disstheses/4970
INFORMATION TO USERS
The most advanced technology has been used to photograph and 
reproduce this manuscript from the microfilm master. UMI films the 
text directly from the original or copy submitted. Thus, some thesis and 
dissertation copies are in typewriter face, while others may be from any 
type of computer printer.
The quality of this reproduction is dependent upon the quality of the 
copy submitted. Broken or indistinct print, colored or poor quality 
illustrations and photographs, print bleedthrough, substandard margins, 
and improper alignment can adversely affect reproduction.
In the unlikely event that the author did not send UMI a complete 
manuscript and there are missing pages, these will be noted. Also, if 
unauthorized copyright material had to be removed, a note will indicate 
the deletion.
Oversize materials (e.g., maps, drawings, charts) are reproduced by 
sectioning the original, beginning at the upper left-hand corner and 
continuing from left to right in equal sections with small overlaps. Each 
original is also photographed in one exposure and is included in 
reduced form at the back of the book.
Photographs included in the original manuscript have been reproduced 
xerographically in this copy. Higher quality 6" x 9" black and white 
photographic prints are available for any photographs or illustrations 
appearing in this copy for an additional charge. Contact UMI directly 
to order.
University Microfilms International 
A Bell & Howell Information C om pany  
300  North Z e e b  R oad . Ann Arbor, Ml 48106-1346 USA 
313 /761-4700  800 /521-0600
Order Num ber 9112217
A com parative  s tu d y  of th e  effects o f Sesbania drummondii on th e  
hepatic  cy tochrom e P-450 m onooxygenase system s o f chickens 
a n d  ra ts
Banton, Marcy Iva, Ph.D.
The Louisiana State University and Agricultural and Mechanical Col., 1990
UMI
300 N. Zeeb Rd.
Ann Arbor, MI 48106
A COMPARATIVE STUDY OP THE EFFECTS OF SE8BANIA PRUMMOMPII 
OH THE HEPATIC CYTOCHROME P-450 MONOOXYGENASE SYSTEMS
OF CHICKENS AMD RATS
A Dissertation
Submitted to the Graduate Faculty of the 
Louisiana State University and 
Agricultural and Mechanical College 
in partial fulfillment of the requirements for the degree of
Doctor of Philosophy
in
The Interdepartmental Program in Veterinary Medical Sciences
(Toxicology Option)
by Marcy I. Banton 
D.V.M., Louisiana State University, 1981 
August 1990
AgKHfiWIiBBgMHT6
I would like to acknowledge the contributions of the following 
individuals. My sincere appreciation is extended to my major 
advisor, Dr. W. Flory, for his advice, support, and guidance 
throughout this course of study. I am especially grateful to 
Dr. C.R. Short, for taking on the position of co-chairman of 
my committee in the absence of Dr. W. Flory and for his 
support and counsel in the preparation of this manuscript. I 
am most appreciative to Dr. G.w. Winston, for his commitment 
to the planning, execution, and analysis of this study. I also 
am grateful to the other members of my advisory committee, Dr. 
S.S. Nicholson, Dr. K.M. Kleinow and Dr. R.M. Grodner for 
their constructive criticisms and thoughtful analysis of this 
study.
I am thankful for the financial support received from: 
Louisiana State University in the form of an assistantship for 
3 years; Dr. J.J. England for graciously providing monies for 
supplies; and Dr. W. Springer for furnishing the White Leghorn 
chickens and their housing.
Superior technical help was received from: Dr. P.L.H. Jowett 
for aldrin epoxidase method development; Dr. P. Bounds for gel 
electrophoresis and western blotting techniques; Dr. S. 
Narayan for cytochrome P-450-mediated activities; Dr. M.J.J.
Ronis for providing cytochrome P-450 antibodies and western 
blots; and finally J. Pawlusiow and T. McManus for animal 
assistance.
I am grateful to Dr. M.A. Freeman for statistical analyses of 
the data and much help with the preparation of this 
manuscript.
I would also like to thank Dr. L.P. Ruhr for serving as my 
mentor during the first years of my graduate study.
Finally, I thank my husband, Michael, and my children, 
Rebecca, Amelia, and James for their love, understanding, 
patience, and sacrifice during the time of this study.
TABLE -QF-CflMTEWTP
PAGE
TITLE PAGE i
ACKNOWLEDGEMENTS ii
TABLE OF CONTENTS iv
LIST OF TABLES vii
LIST OF FIGURES X
ABSTRACT xi
CHAPTER 1 - INTRODUCTION 1
CHAPTER 2 - LITERATURE REVIEW 4
A. Sesbania drummondii 4
1. Botany of Sesbania 4
2. Sesbania in agriculture 7
3. Sesbania in medicine 9
4. Sesbania toxicosis 10
B. Hepatic cytochrome P-450 monooxygenase 18
system
1. Structure of the cytochrome P-450
monooxygenase system 19
2. Function of the cytochrome P-450
monooxygenase system 20
3. Regulation of the cytochrome
P-450 monooxygenase system 24
4. Avian hepatic cytochrome P-450
monooxygenase system 28
CHAPTER 3 - EXPERIMENTAL GOALS AND DESIGN 37
CHAPTER 4 
A.
B.
C.
D.
CHAPTER 5
- SPECIFIC OBJECTIVES, MATERIALS AND 
METHODS, RESULTS AND DISCUSSION 42
Phase I - Preliminary investigations of 
the effects of an extract of Sesbania 
dnimiBondi i on the hepatic cytochrome P-450 
monooxygenase systems of chickens and rats.42
Experiment 1 - Initial characterization 
studies of the effects of an extract of 
Sesbania drummondii on hepatic cytochrome 
P-450 monooxygenase systems of chickens 
and rats. 42
Experiment 2 - Evaluation of the effects 
of the bicarbonate-azide extraction 
buffer/vehicle on the hepatic cytochrome 
P-450 monooxygenase systems of chickens 
and rats. 70
Experiment 3 - Comparison of the effects 
of an extract of Sesbania drummondii on 
the hepatic cytochrome P-450 monooxygenase 
systems of male versus female rats. 75
Experiment 4 - Evaluation of the effects
of an extract of Sesbania drummondii on 
microsomal membrane stability. 82
Phase II - Characterization of Sesbania 
drummondii effects on the catalytic 
properties of the hepatic cytochrome 
P-450 monooxygenase systems. Comparison 
with effects caused by phenobarbital 
and B-naphthoflavone. 91
Phase III - Effects of Sesbania drummondii 
on hepatic NADPH-dependent cytochrome P-450 
reductase. Comparison with effects caused 
by phenobarbital and B-naphthoflavone. 147
Phase IV - Induction of microsomal enzymes 
by Sesbania drummondii as determined by 
SDS-PAGE and Western blots with anti­
cytochrome P-450 antibodies. Comparison 
with effects caused by phenobarbital and 
B-naphthoflavone. 188
- SUMMARY AND CONCLUSIONS 208
v
BIBLIOGRAPHY 225
APPENDICES 253
VITA 292
Vi
List of Tables
Pag*
Table l. Effect of Sesbania drummondi i-treatment on 
body and liver weights in chickens and r a t s ...........  57
Table 2. Effect of Sesbania drummondi i-treatment on 
hepatic microsomal monooxygenase cytochromes and 
reductases in chickens and rats ........................  58
Table 3. Effect of Sesbania druromond i i-treatment on
selected hepatic microsomal monooxygenase activities .. 60
Table 4. The effect of bicarbonate-azide buffer (BBN) 
vehicle on cytochrome P-450 content and hepatic 
microsomal monooxygenase activities in chickens and 
rats......................................................  73
Table 5. Cytochrome P-450 content of Sesbania 
drummondii-treated male and female rats ...............  78
Table 6. Glucose-6-phosphatase activity of Sesbania 
drummondii-treated chickens and rats....................  88
Table 7. Optimized conditions for the assay of
aminopyrine N-demethylase activity in hepatic
microsomes from control chickens and rats.............  97
Table 8. Optimized conditions for the assay of aldrin 
epoxidase activity in hepatic microsomes from control 
chickens and rats........................................  99
Table 9. Optimized conditions for the assay of 
methoxyphenoxazone O-dealkylase activity in hepatic 
microsomes from control chickens and r a t s .............  103
Table 10. Optimized conditions for the assay of 
ethoxyphenoxazone O-dealkylase activity in hepatic 
microsomes from control chickens and rats...............  104
Table 11. Optimized conditions for the assay of 
pentoxyphenoxazone O-dealkylase activity in hepatic 
microsomes from control chickens and rats...............  105
Table 12. Optimized conditions for the assay of 
benzyloxyphenoxazone O-dealkylase activity in hepatic 
microsomes from control chickens and rats............... 106
Table 13. The effect of g.esfranja drummondii. 
phenobarbital, and B-naphthoflavone on chicken and rat 
hepatic cytochrome P-450 specific content and 
absorbance maxima.......................   109
vii
Table 14. The effect of Sesbania drummondii. 
phenobarbital, and 6-naphthoflavone on aminopyrine N- 
demethylase activity in chicken and rat hepatic 
microsomes................................................. 112
Table 15. The effect of Sesbania drummondii. 
phenobarbital, and B-naphthoflavone on aldrin epoxidase 
activity in chicken and rat hepatic microsomes.......... 114
Table 16. Methoxyphenoxazone O-dealkylase activity of 
Sesbania drummondii. phenobarbital, and B-naphthoflavone 
treated chickens and rats................................. 117
Table 17. Ethoxyphenoxazone O-dealkylase activity of 
Sesbania drummondii. phenobarbital, and B-naphthoflavone 
treated chickens and rats................................. 119
Table 18. Pentoxyphenoxazone O-dealkylase activity of 
Sesbania drummondii. phenobarbital, and B-naphthoflavone 
treated chickens and rats................................. 122
Table 19. Benzyloxyphenoxazone O-dealkylase activity of 
Sesbania drummondii. phenobarbital, and B-naphthoflavone 
treated chickens and rats................................. 125
Table 20. Optimized conditions for the assay of cumene 
hydroperoxide-mediated aminopyrine N-demethylase 
activity in hepatic microsomes from control chickens 
and rats ....................     152
Table 21. Optimized conditions for the assay of t-butyl 
hydroperoxide-mediated aminopyrine N-demethylase 
activity in hepatic microsomes from control chickens 
and rats................ .................................. 154
Table 22. Optimized conditions for the assay of cumene 
hydroperoxide-mediated aldrin epoxidase activity in 
hepatic microsomes from control chickens and rats....... 156
Table 23. Optimized conditions for the assay of t-butyl 
hydroperoxide-mediated aldrin epoxidase activity 
in hepatic microsomes from control chickens and rats....158
Table 24. The effect of Sesbania drummondii f 
phenobarbital, and B-naphthof lavone on chicken and rat 
hepatic NADH-and NADPH-cytochrome c reductase 
activities................................................. 161
Table 25. The effect of Sesbania drummondii. 
phenobarbital, and B-naphthoflavone on cumene 
hydroperoxide-mediated aminopyrine N-demethylase 
activity in hepatic microsomes from chickens and rats...163
viii
Table 26. The effect of Sesbania dr.uromoraUi, 
phenobarbital, and 6-naphthoflavone on t-butyl 
hydroperoxide-mediated aminopyrine N-demethylase 
activity in hepatic microsomes from chickens and rats...166
Table 27. The effect of Sesbania drummondii. 
phenobarbital, and B-naphthoflavone on cumene 
hydroperoxide-mediated aldrin epoxidase activity in 
hepatic microsomes from chickens and rats................169
Table 28. The effect of Sesbania druminondii . 
phenobarbital, and B-naphthoflavone on t-butyl 
hydroperoxide-mediated aldrin epoxidase activity in 
hepatic microsomes from chickens and rats................172
Table 29. Cross-reactivity detected in hepatic 
microsomes from control, Sesbania drummondii-. 
phenobarbital, and B-naphthoflavone-treated chickens 
and rats using polyclonal antibodies prepared against 
members of rat cytochrome P-450 isozymes...............  201
List of Figures
Page
Figure l. Line drawing of Sesbania drummondii ........ 6
Figure 2. Catalytic cycle of the cytochrome P-450- 
dependent monooxygenase ................................  22
Figure 3. The cytochrome P-450 monooxygenase-catalyzed 
N-demethylation of aminopyrine .........................  96
Figure 4. Cytochrome P-450 monooxygenase-mediated 
epoxidation of aldrin ..................................  98
Figure 5. Cytochrome P-450 monooxygenase-mediated 
O-dealkylation of the alkoxyphenoxazones ..............  101
Figure 6. Degree of induction of cytochrome P-450- 
mediated activities of hepatic microsomes from chickens 
treated with Sesbania drummondii. phenobarbital, and 
B-naphthof lavone.........................................  128
Figure 7. Degree of induction of cytochrome P-450- 
mediated activities of hepatic microsomes from rats 
treated with Sesbania drummondii. phenobarbital, and 
fl-naphthof lavone............................    129
Figure 8. Chemical structures of the organic 
hydroperoxides ..........................................  151
Figure 9. SDS-polyacrylamide gel electrophoresis 
separations of control, g.epfrania drummondii. 
phenobarbital, and B-naphthoflavone-stimulated 
microsomal proteins of chickens.........................  197
Figure 10. SDS-polyacrylamide gel electrophoresis 
separations of control, Sesbania drummondii. 
phenobarbital, and fi-naphthoflavone-stimulated 
microsomal proteins of rats.............................  198
Figure 11. Western blot showing cross-reactivity 
between antibodies to rat P-450IA1 with liver microsome 
from rats induced by B-naphthoflavone and with liver 
microsomes from control, Sesbania d r u m m o n d i i. and 
B-naphthoflavone-induced chickens....................... 200
x
ABSTRACT
The effect of an extract of Sesbania drummondii on the hepatic 
cytochrome P-450 monooxygenase system was evaluated in two 
experimental models, the White Leghorn chicken and the 
Sprague-Dawley rat. The cytochrome P-450 monooxygenase 
systems were compared using studies of catalytic activities 
and two major enzyme components, cytochrome P-450 and NADPH- 
cytochrome P-450 reductase. Two "classical" cytochrome P-450 
inducers, phenobarbital and B-naphthoflavone, were used to 
probe induction mechanisms.
£. drummondii induced opposite effects on the hepatic 
cytochrome P-450 component of chickens versus rats. 
Cytochrome P-450 specific content was increased 2-fold in 
chickens but decreased 2-fold in rats. Qualitative differences 
in microsomal proteins were found using SOS-gel 
electrophoresis. The protein profile of £. drummondii- t r e a t e d  
chickens was induced differently from phenobarbital or B- 
naphthoflavone. In the rat, the microsomal protein profile 
was similar to controls but of lower protein band staining 
intensity. Western blots revealed two £. drummondi i-i 
microsomal proteins of chickens that cross-reacted with 
antibody against rat P-450IA1. One of these proteins 
corresponded to the B-naphthoflavone-induced chicken protein. 
The other appeared unique to £. drummondii treatment.
xi
Neither protein was detected by this antibody in the £. 
drvirorcpndii -treated rat.
Sesbania drummondii induced different responses in chicken 
versus rat cytochrome P-450 catalytic activities. Chickens 
showed increases of 2-fold in aminopyrine N-demethylase and 4- 
fold in aldrin epoxidase; no change in ethoxyphenoxazone and 
benzyloxyphenoxazone O-dealkylases; and a 2-fold decrease in 
pentoxyphenoxazone O-dealkylase. Similar activities were 
induced by phenobarbital. In contrast, S. drummondii-treated 
rats had 2 to 3-fold decreases in all activities, except 
ethoxyphenoxazone O-dealkylase, which was unchanged.
Species differences were also observed in the effect of 
drummondii on the NADPH-cytochrome P-450 reductase component.
S. drummondii-treatment induced a 2-fold increase in NADPH- 
cytochrome c reductase activity in chickens but no change in 
treated rats. Use of cumene hydroperoxide indicated that the 
induced effects on the reductase contribute to aminopyrine but 
not aldrin metabolism in the chicken, and neither substrate's 
metabolism in the rat.
These findings suggest that Sesbania drummondii can induce 
changes in hepatic cytochrome P-450 monooxygenase systems and 
these changes are species-dependent.
xii
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INTRODUCTION
Sesbania drummondii is a perennial herbaceous shrub or small 
tree inhabiting the sandy soils and marshes throughout the 
southeastern United States. This poisonous plant, also called 
rattlebrush or coffeebean, is sporadically ingested by 
livestock and usually results in fatalities (Kingsbury, 1964). 
Poisonings have been reported in cattle, sheep, and goats, 
usually in the fall or winter after other forage has become 
scarce (Marsh, 1920). The toxic principle of §. drummondi i 
has not yet been identified, but appears to be concentrated in 
mature seed-containing pods (Terblanche e£ al., 1966).
Chickens and rats have been proven to be highly sensitive to 
extracts of f>. drummondii seeds and pods and are, therefore, 
useful avian and mammalian experimental models for studying 
toxic effects of the plant (Flory and Hebert, 1984; Marceau- 
Day, 1988). Clinical signs, blood chemistry values, and 
tissue lesions have previously been described in poisoned 
chickens by Flory and Hebert (1984). Typically the clinical 
signs include weakness, depression, anorexia, diarrhea, 
ruffled feathers, cold feet, and rapid loss of body weight. 
An interesting clinical feature observed in chickens is a 
severe decrease in the concentration of total plasma proteins 
(Flory and Hebert, 1984). At necropsy, gross changes are
1
2evident in body fat, muscle mass, liver, kidney, spleen, crop, 
intestines, and the heart (Flory and Hebert, 1984). Similar 
clinical signs and pathologic changes are observed in £5. 
drummondii-poisoned rats (Marceau-Day, 1988).
Some of the changes in poisoned birds, as well as in rats, can 
be explained by inhibition of smooth muscle function. 
Venugopalan gt gl. (1984) reported significant decreases in 
the responsiveness of ileum and lung isolated from chickens 
poisoned with §. drummondii to two common smooth muscle 
agonists, histamine and carbachol. However, other changes in 
both species may be caused by toxic effects of £>. drummondii 
on the liver. Earlier studies have focused on the liver to 
determine the cause of depleted circulating serum plasma 
concentration (Marceau-Day, 1988). These results indicate 
that S. drummondii inhibits protein synthesis and export 
protein release from the liver (Marceau-Day, 1988). Further 
investigations revealed that £. drummondii also alters a 
number of liver enzymes, including microsomal glutathione-S- 
transferase isozymes (Marceau-Day, 1988).
In addition to these toxic effects on the liver, there is the 
potential for £. drummondii to affect the major hepatic 
biotransformation system, the hepatic cytochrome P-450 
monooxygenase system. Altering a major drug metabolizing 
system by consumption of S. drummondii could be important in
any species exposed to this toxic plant.
3
A related Sesbania species, sesbania exaltata. is a major weed 
problem in soybean fields of the southeastern United States 
(Lunsford et &!•, 1976). There exists the potential for S. 
exaltata. S. drummondii. and other Sesbania species to 
contaminate harvested soybeans. The seeds from these plants 
could thereby be unintentionally and chronically consumed in 
soybean-containing products by both animals and humans.
Acute or chronic exposures to the Sesbania species, as with 
numerous xenobiotic compounds, could induce a host of 
undesirable consequences arising from effects on the 
microsomal cytochrome P-45O-dependent mixed function 
monooxygenase system. Less toxic agents could become more 
toxic, producing acute intoxications on exposure. Alterations 
of this system could also change the pharmacokinetics and thus 
the efficacy of therapeutic agents given at the time of £. 
drummondii exposure. Additionally, S. drummondii induced 
changes in the cytochrome P-450 monooxygenase system could 
modify metabolism of endogenous substances resulting in 
reproductive and endocrine problems.
In order to lay groundwork to answer these questions, the 
effects of an extract of £. drummondii on the hepatic 
microsomal cytochrome P-450 monooxygenase system were studied.
gram s z
LITERATURE REVIEW
A. Sesbania tinwfmpnflii 
1. Botany of Sesbania:
Sesbania is a diverse group of plants that occur in both 
annual and perennial forms in tropical and subtropical regions 
and are adaptable to a wide variety of soil conditions. 
Sesbania drummondii is a perennial herbaceous shrub or small 
tree that inhabits the gulf coast plain of the southeastern 
United States south into Mexico (Lasseigne, 1973). The plant 
is locally very abundant from June to October and prefers 
soils that are the edges of low woods, banks of bayous, 
marshes, roadsides, margins of ponds, edges of ditches, 
railroad embankments, prairies, and sandy beaches (Lasseigne, 
1973) . drummondii is a common weed of south Louisiana
pastureland and is also sometimes found around the periphery 
of soybean fields (Nicholson, 1989).
The genus Sesbania is taxonomically classified in the kingdom, 
Plantae; phylum, Spermatophyta; class, Angiospermae; subclass, 
Dicotyledonae; order, Rosales; family, Leguminosae; subfamily, 
Papilionoideae; and the tribe Robinieae (Kingsbury, 1964; 
Evans and Rotar, 1987). At least four subgenera, consisting of 
approximately 50 species, comprise the genus Sesbania and
4
5include Sesbania. Aaati. Glottidiuin. and Daubentonia (Evans 
and Rotar, 1987). Sesbania drummondii (Rydb.) Cory is placed 
in the subgenera Daubentonia.
Several latin and common names have been used by various 
authors to identify this species. drummondii is the same as 
Daubentonia longifolia. Daubentonia drummondii. and Sesbania 
cavanillesii (Kingsbury, 1964; Marsh and Clawson, 1920). 
Common names for this plant include rattlebrush, rattlebox, 
coffee bean, senna-bean, and poison bean (Ellis, 1975; Correll 
and Johnston, 1970).
Morphology among the Sesbania species is somewhat variable 
with similarities in the leaves, flowers, and seedpods. The 
S_g, drummondii shrub grows to a maximum height of approximately 
6 meters (Ellis, 1975). The branches often die back during 
the winter with only the lowest part of the plant remaining 
alive and becoming woody (Correll and Johnston, 1970). The 
anatomical features of S j . drummondii are presented in Figure
1. The leaves are pinnate, approximately 13 to 20
centimeters long, and are made up of 20 to 50 small green 
leaflets that are 15 to 35 millimeters long and 4 to 7 
millimeters broad (Ellis, 1975; Correll and Johnston, 1970). 
The flowers are yellow, 13 to 16 millimeters long, and are 
formed in loose racemes (Ellis, 1975; Correll and Johnston, 
1970). The seedpod is four-sided with four wings running the
Figure
D r u m m o n d  R a t t l e b o x  
Sesbania drum m ondii (Rydb.) Cory'
L. Line drawing of Seebania drummondii (Vines, 1960;
reproduced with permission of University of Texas Press).
7length of the pod and often reaches 5 to 6 centimeters in 
length (Ellis, 1975; Correll and Johnston, 1970). The seedpod 
changes color as it matures from green, to yellow, and finally 
to dark brown (Ellis, 1975). Four to seven small, hard seeds 
separated by transverse partitions are contained in the pod 
(Kingsbury, 1964; Ellis, 1975). The seeds are loose in the 
mature pods and rattle when the bush is in motion; hence the 
name "rattlebush" (Correll and Johnston, 1970).
2. Sesbania in agriculture;
The Sesbania species have both beneficial and harmful 
agricultural roles. Among the most important beneficial uses 
of the plants are in nitrogen fixation (green manures) and 
soil reclamation (Evans and Rotar, 1987). Because Sesbania 
species are well tolerant to soil salinity and alkalinity, 
flooding, and waterlogging, they are often used as green 
manures for rice and other crops in south and southeast Asia 
(Evans and Rotar, 1987). These tolerances also enable the 
Sesbania species to colonize problem soil sites and help in 
stabilizing and reclaiming these lands.
Several minor agricultural uses of the different species 
include pulp fiber resources, fuel wood, animal fodder, gum 
sources, and windbreaks (Evans and Rotar, 1987). Sesbania 
frjgpjnpgflf £Ls. sesban. and £L. arandiflora are the species of 
principal interest as commercial pulp fiber crops (Evans and
8Rotar, 1987). Gums which have potential value in food 
processing and other industrial purposes are produced by many 
species of Sesbania. Sesbania arandiflora. forroosa. and S.
sesban are noted for their gum bark and bispinosa and S.
sesban for their seed gums (Evans and Rotar, 1987).
Some of the Sesbania species have limited use as animal and 
human food (Evans and Rotar, 1987). The Sesbania species 
considered as potential sources of animal feed include S. 
faispjposa, EL_ sesban. and S_^  grandiflora.
The benefits of Sesbania in agriculture have been appreciated 
mostly outside of the United States. The predominant impact 
of the Sesbania species in American agriculture is negative.
The Sesbania species as weeds compete with crops for light, 
moisture, and nutrients. Sesbania seeds may contaminate 
harvest grain and reduce its value (Evans and Rotar,1987). 
The Sesbania species with the worst weed reputation is s. 
exaltata. This plant is a widespread weed of crops in the 
southern United States, especially in soybean fields (Lunsford 
St al.. 1976).
While the majority of the species of Sesbania are considered 
to be nontoxic, a few species are considered to be potentially 
toxic plants for grazing farm animals (Williams, 1983).
9Toxicoses have been reported with Sj_ vesicaria. S. punicear 
and Sj. dgyffmondjj, of the subgenera Daubentonia and Glottidium 
(Evans and Rotar, 1987).
3. Sesbania in medicine:
The Sesbania species have been medically useful to native 
healers and may become important in modern medical treatment 
as well. The herbal medicinal powers of the Sesbania species 
have been utilized by Asian cultures to treat a variety of 
disorders (Evans and Rotar, 1987). Extracts, mostly from S. 
grandiflora. S. sesban. and g*. bispinosa. have been used as 
astringents, antipyretics, laxatives, anthelmintics, 
antifertility agents, and abortifacients (Evans and Rotar, 
1987).
Some of the Sesbania species show potential for use in modern 
treatment regimens for cancer. Seed extracts of Sesbania 
vgsigarla > ounicea. and &>. drummondii exhibit antitumor 
activity against lymphocytic leukemia P-388 (PS) in vivo 
(Powell et al.. 1976). Efforts to isolate the antitumor agent 
in £ 1. drummondii resulted in the identification of two 
inactive compounds, sesbanine and drummondol (Powell e£ al.. 
1979; Powell and Smith, 1981) and finally the active compound 
sesbanimide (Powell, 1983; Mayberry, 1983). Sesbanimide is a 
structurally unusual compound consisting of 3 rings linked by 
single bonds (Powell, 1983). The structure partly resembles
10
that of the antibiotics cycloheximide, streptimidone, and 
streptovitacin (Mayberry, 1983). This resemblance of 
sesbanimide to some antibiotics produced by soil bacteria 
raises a question as to its true source, the Sesbania plant or 
its associated microflora (Mayberry, 1983). Sesbanimide has 
demonstrated potent antitumor activity at very low doses in 
mice with leukemia and human carcinoma cells growing .in vitro 
(Mayberry, 1983). A major obstacle to continued studies of 
sesbanimide is the very small concentration of the material in 
the seeds. Recent efforts are directed toward synthetic 
production of sesbanimide (Tomioka and Koga, 1984).
4. Sesbania toxicosis:
Toxicosis from vesicaria. S. punicea. and S_s. drummondii 
have been recognized in a variety of domestic animals since 
the early 1900's. Poisoning by these species generally occurs 
when animals are introduced onto new pastures and graze 
indiscriminately or during the winter months when other forage 
is scarce (Evans and Rotar, 1987). The Sesbania species pods 
remain on the plant during the winter months and present a 
hazard for hungry livestock.
Natural poisoning from vesicaria (Glottidium vesicarium) 
has been observed in sheep and cattle (Broughton and Hardy, 
1939; Simpson and West, 1953; Newberne, 1953). Experimental 
studies in a number of animals have confirmed the ability of
1 1
this plant to produce illness and death. Emmel (1935) 
reported that 200 seeds of Gj. vesicarium fed to adult White 
Leghorn hens were fatal. Duncan et al. (1955) observed that 
seeds but not leaves of vesicaria were toxic to chickens. 
Similarly, Broughton and Hardy (1939) found the minimum lethal 
dose of seeds in sheep to be 0.0625% of body weight. 
Featherly gt al. (1943) produced illness with vesicarium 
seeds in a cow, a rabbit, and in White Leghorn hens. 
Experimental observations of vesicarium-ooisoned cattle
were made by Emmel (1935) and Simpson and West (1953). 
Simpson and West (1953) observed dose related acute vs chronic 
effects from fib. vesicarium seeds in steers.
Poisoning from £L_ punicea (Daubentonia punicea) has been 
reported in several domestic animals and poultry. Duncan et 
al. (1955) observed illness and death in chickens fed green or 
mature seeds of IL. punicea. Shealy and Thomas (1928) found 
that as few as nine Daubentonia seeds were fatal to poultry. 
Terblance al. (1966) observed experimentally induced S. 
punicea toxicosis in cattle, sheep, horses, pigs, dogs, 
rabbits, guinea pigs, chickens, pigeons and turkeys. 
Toxicosis, however, could not be produced in either young or 
adult ducks. The resistance in the duck was hypothesized to 
be related to the speed at which the seeds passed whole 
through the gastrointestinal tract.
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Widespread losses in sheep and goat herds have been reported 
from indiscriminate grazing on St drummondii (Harsh, 1920; 
Marsh and Clawson, 1920; Robey, 1925). Robey (1925) reported 
as many as 200 to 250 sheep and goats died after grazing the 
plant that was growing along the road down which they were 
driven. Harsh and Clawson (1920) experimentally examined the 
effects of fii lonqifolia seeds, pods and leaves in sheep. They 
found the seed and pods to be more toxic than the leaves and 
that as little as 30 grams of seeds were capable of poisoning 
and 60 grams killing sheep. Flory and Hebert (1984) evaluated 
the clinical and pathologic changes with extracts of S. 
drummondii on the chicken and found doses of 1.0 % of body 
weight to be uniformly lethal. Marceau-Day (1988) further 
characterized the clinical effects of S*. drummondii extract 
in both the chicken and the rat. One human fatality of a 
small boy occurred following the ingestion of S^ . drummondii 
seeds (Ellis, 1975).
The clinical signs and necropsy changes in poisoned animals 
are indistinguishable between St vesicaria. S. punicea and S. 
drummondii. Clinical changes in the gastrointestinal, 
nervous, cardiovascular and respiratory systems are 
consistently observed in Sesbania-poisoned animals. 
Typically, with acute poisoning the animal exhibits 
depression, weakness, anorexia, diarrhea, an irregular pulse, 
and decreased respiration. Coma usually precedes death (Ellis,
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1975). Additionally, ruffled feathers (Flory and Hebert, 
1984; Shealy and Thomas, 1928; Terblanche e£ al.. 1966) and 
cold feet (Flory and Hebert, 1984) have been observed in 
poisoned chickens, with chronic low level exposures, poisoned 
animals are emaciated, sluggish, and have roughened hair or 
ruffled feathers and diarrhea. Natural recoveries are rare 
with acute or chronic exposures to Sesbania.
Postmortem examination of Sesbania-poisoned animals reveal 
changes of the cardiovascular, gastrointestinal, 
musculoskeletal, and urinary systems. Typical macroscopic 
lesions observed are muscle mass reduction, large prominent 
superficial blood vessels, organ congestion, flaccid heart in 
diastole and gastroenteritis of varying degrees of severity 
(Shealy and Thomas, 1928; Simpson and West, 1953; Emmel, 1935; 
Emmel, 1944) . £_*_ drummondii-poisoned chickens also have crops
engorged with clear fluid, gizzards full of food, and empty 
gas-filled intestines (Flory and Hebert, 1984). Full crops 
and gizzards were also observed by Emmel (1935) in G. 
vesicarium-poisoned chickens. Less frequently observed 
lesions have included hemorrhagic lymph nodes in Sj_ vesicaria- 
poisoned sheep (Broughton and Hardy, 1939), conjunctival 
exudation and eyelid edema in 1L. punicea-poisoned rats 
(Terblanche e£ al.. 1966), and hyperemia around the edges of 
the eyelids in rabbits treated with S*. punicea (Terblanche et 
al.. 1966).
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Microscopic descriptions of Sesbania-induced lesions are few 
in the literature and mostly confirm the gross findings. 
Differences, however, are noted in the microscopic lesions of 
the gastrointestinal tract between the toxic Sesbania species. 
Severe gastrointestinal changes are normally present with s. 
vesicaria and Sj. nunicea. Emmel (1935) observed inflammation 
and necrosis from the crop to the proximal small intestine in 
G. vesicarium-treated chickens. Congestion and inflammation 
in the abomasum and duodenum of a ^  vesicarium-poisoned cow 
was also reported by Emmel (1944). Terblanche gt al. (1966) 
observed species differences in the presence and severity of 
the gastrointestinal lesions with S*. punicea. Marked 
hyperemia, hemorrhages, and in some cases necrosis were
present in sheep, rabbits, chickens, turkeys, pigeons, and 
pigs. Most Sj. punicea-treated rats, however, were devoid of 
any gastrointestinal lesions. The absence of gastrointestinal 
lesions was also observed by Flory and Hebert (1984) with S. 
drummondii treatment of chickens. Marceau-Day (1988) observed 
only moderate hyperemia of the lower gastrointestinal tract in 
chickens and rats dosed with |L±. drummondii.
Several researchers noted microscopic changes in the kidney. 
Flory and Hebert (1984) observed glomerular contraction from 
the distended parietal layer of the glomerular capsule
(Bowman's capsule) and the presence of protein in the
convoluted tubules of S^ _ drummondii-poisoned chickens.
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Simpson and West (1953) reported that the pelvis of the kidney 
of a cow poisoned with ves icar ium contained an albumin-like 
substance. Emmel (1944) reported that two cows administered 
G. vesicarium seeds had kidneys with generalized, well- 
advanced albuminous degeneration which was more marked in the 
convoluted rather than the straight tubules.
The clinical pathological features of Sesbania species 
poisoning have been documented only with JL. punicea and S. 
drummondii. Terblanche et al. (1966) observed increases in 
blood glucose, blood urea nitrogen and creatinine in S. 
punicea treated sheep, cattle, and horses. Flory and Hebert 
(1984) reported increases in creatine kinase and plasma 
cholinesterase, marked decreases in total plasma protein 
concentrations, and no changes in packed cell volumes and 
plasma glucose concentrations in chickens administered S. 
drummondii. Marceau-Day (1988) more completely characterized 
the clinical pathological changes in SL. drummondii-poisoned 
chickens and rats. She observed decreases in serum proteins, 
plasma cholinesterase, lactate dehydrogenase, gamma glutamyl 
transpeptidase, and alkaline phosphatase in both chickens and 
rats. Affected chickens, but not rats, also had decreases in 
packed cell volumes and serum potassium concentrations. Liver 
microsomal glutathione peroxidase activity was reduced in 
Sesbania-treated chickens whereas cytosolic glutathione 
peroxidase was increased in both treated chickens and rats.
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Several glutathione-S-transferase isozymes were increased in 
the microsomal and cytosolic fractions of drummondii -
treated chickens.
The pathophysiology and causative toxins of Sesbania-induced 
toxicosis are uncertain. Venugopalan et al. (1984) observed 
decreased responsiveness of intestinal and lung parenchymal 
strips to histamine and carbachol in S_i_ druramondii-treated 
chickens indicating the likelihood of smooth muscle 
involvement as a cause of toxicosis. Additional studies by 
Venugopalan et al. (1987) revealed £L_ drummondii inhibition of 
vascular smooth muscle which may be the cause of the 
frequently observed postmortem finding of engorged blood 
vessels.
Several 1L. drummondii-induced toxic effects may contribute to 
the marked drop in total plasma protein concentration. Flory 
and Hebert (1984) suggested that toxic glomerular damage with 
leakage was partly responsible for the protein decrease. 
Marceau-Day (1988) demonstrated that the plasma protein 
depression in £*. drummondii -noi sonfid chickens was influenced 
by decreases in protein synthesis and export protein release 
from the liver.
Attempts at isolating the toxic principle of Sesbania species 
have led to the discovery of a number of new compounds. Robey
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(1925) described a sapotoxin from extracts of fi*. lonaifolia. 
Powell ££ al. (1976) isolated three compounds: sesbanine,
drummondol, and sesbanimide. Whether any, all, or none of 
these compounds contribute to Sesbania-induced toxicosis is 
not presently known. However, the many documentations of 
pharmacological and toxicological responsiveness to ingestions 
of this plant suggest that classical phase 1 and/or phase II 
metabolic processes are involved in the manifestation of 
clinical signs.
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B. Hepatic cytochrome P-450 monooxvgenase system
Many foreign compounds, or xenobiotics, to which organisms are 
exposed in their environment are lipid soluble and readily 
gain entrance through biological membranes. These lipophilic 
compounds would tend to accumulate in the living organism and 
disrupt cellular processes if there was not a mechanism to 
convert them to more water soluble and readily excretable 
metabolites. The biotransformation enzymes are primarily 
responsible for this function (Sipes and Gandolfi, 1986).
The biotransformation enzymes have been divided into two types 
(Williams, 1959): Phase I and Phase II. The Phase I reactions 
are the predominate biotransformation pathway and involve 
oxidation, reduction, and hydrolysis. Phase I reactions 
result in functionalization which is the addition or 
uncovering of specific functional groups (deBethizy and Hayes, 
1989). Phase II reactions are biosynthetic reactions where 
the foreign compound or Phase I-derived metabolite is 
covalently linked to an endogenous molecule, producing a 
conjugate (Sipes and Gandolfi, 1986).
The cytochrome P-450 monooxygenase system is the most 
important enzyme system involved in Phase I biotransformation. 
This system is a unique and versatile catalyst capable of 
metabolizing both lipophilic xenobiotics as well as a variety
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of endobiotics such as steroids, prostaglandins, leukotrienes, 
and fatty acids (Gelboin, 1988).
The first description of cytochrome P-450 came in independent 
studies of microsomes from rat liver by Klingenberg (1958) and 
pig liver by Garfinkel (1958). Several years later, Omura and 
Sato (1962,1964a, 1964b) showed that the pigment was a b-type 
of hemocytochrome and named it "P-450” because it exhibited a 
spectral Soret peak at 450nm when the cytochrome was reduced 
and bound to carbon monoxide. Cytochrome P-450 has been shown 
to be present in mammals, birds, reptiles, amphibians, 
insects, bacteria, yeasts, and higher plants (Nebert et al.. 
1989a).
1. Structure of the cytochrome P-4 50 monooxvgenase system: 
In mammals, the cytochrome P-450 system is most abundant in 
the liver but is also present in nearly all tissues except 
striated muscle and erythrocytes (Guengerich, 1988). Within 
the cell, these enzymes are membrane bound and are 
concentrated in the endoplasmic reticulum, the nuclear 
envelope, and the mitochondria (Guengerich, 1988) . In 
general, the cytochrome P-450 system involved in xenobiotic 
biotransformation is located in the endoplasmic reticulum 
(microsomal), whereas those involved in steroid metabolism are 
in the mitochondria.
2 0
The major components of the microsomal cytochrome P-450 
monooxygenase system are two enzymes: cytochrome P-450 and 
NADPH cytochrome P-450 reductase. Other components which may 
also be involved with metabolism of specific xenobiotics are 
cytochrome b5 and cytochrome b5 reductase (deBethizy and 
Hayes, 1989).
Cytochrome P-450 is not a single enzyme but a family of 
multiple forms or isozymes (Gibson, 1989). More than 60 
different forms of cytochrome P-450 have been isolated from 
various sources (Guengerich, 1988). The rat liver alone 
contains 20 different forms which have been purified and 
characterized (Ortiz de Montellano, 1986). The availability 
of cDNA and some protein sequences has permitted the 
categorization of these cytochrome P-450 enzymes into gene 
families (Guengerich, 1988) . The cytochrome P-450 enzymes are 
coded for by a "supergene" family, which contains 78 genes 
divided into 14 families (Nebert et al., 1989b).
2. Function, of the cytochrome P-450 monooxvgenase system: 
The cytochrome P-450 monooxygenase system functions mostly in 
the oxidation and to a lesser degree the reduction of 
chemically diverse endogenous and exogenous substrates. The 
microsomal cytochrome P-450 oxidation of xenobiotics is 
concerned primarily with detoxication through the formation of 
more polar, biologically-inactive, readily excretable
2 1
metabolites (Ioannides and Parke, 1987). However, this system 
is also capable of the bioactivation of compounds to reactive 
intermediates which may interact with vital cellular 
macromolecules resulting in DNA damage, mutations, malignancy 
and other pathologic processes (Ioannides and Parke, 1987).
The overall oxidation reaction catalyzed by the microsomal 
cytochrome P-450 monooxygenase system and stoichiometry are 
illustrated by the following equation (deBethizy and Hayes, 
1989):
RH + 02 + NADPH + H+ --->  ROH + H20 + NADP+
where RH = substrate
NADPH = required cosubstrate
The generally accepted sequence of reactions involved in the 
oxidation of substrates is shown as a catalytic cycle in 
Figure 2. The initial step of the cycle is the binding of 
substrate to the oxidized form of cytochrome P-450 (Fe+3) to 
form a substrate-cytochrome P-450 complex. The complex is 
reduced by a single electron to form a ferrous (Fe+2) P-450 
substrate complex. This electron is provided by NADPH via the 
flavoprotein, NADPH-cytochrome P-450 reductase. The reduced 
substrate P-450 complex binds to oxygen to form a ternary 
complex. The next stage of the catalytic cycle is not 
completely understood. The ternary complex accepts a second 
electron from either NADH or NADPH resulting in the activation
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of the oxygen molecule. The activated oxygen is then inserted 
into the substrate forming an oxidized substrate with the 
release of water and regeneration of oxidized ferric 
cytochrome P-450 (deBethizy and Hayes, 1989).
A number of different types of oxidation reactions are 
catalyzed by the cytochrome P-450 monooxygenase system. These 
include aliphatic and aromatic hydroxylation, epoxidation, 
N-,0-and S-dealkylation, deamination, desulfuration, 
sulfoxidation, N-hydroxylation, and oxidative dehalogenation 
(Sipes and Gandolfi, 1986).
In addition to their physical differences, the cytochrome P- 
450 isozymes exhibit variable substrate and product 
specificity (Gelboin, 1988). The individual proteins exhibit 
overlapping substrate and oxygenation mechanism specificity, 
as well as varying degrees of selectivity for certain 
substrates and reactions catalyzed (Ioannides and Parke, 
1987). Differences in substrate specificity,
regiospecificity, and stereospecificity of various cytochrome 
P-450 isozymes play an important role in regulating the 
balance between bioactivation and detoxication pathways of a 
given xenobiotic (Lu, 1979). Thus the relative proportions of 
various forms of cytochrome P-450s in a given tissue and their 
regulation are important factors in determining the outcome of 
chemical biotransformation.
3. Regulation of the cytochrome P-450 monooxvgenase system: 
The distribution pattern of the various cytochrome P-450 
isozymes is genetically determined by the predominance, or 
relative absence of certain isozymes (Ioannides e£ ail., 1984). 
These differences contribute to the observed differences in 
how species metabolize xenobiotics. The isozymal distribution 
pattern can also be modified by factors such as age, nutrition 
and diet, and selective induction of cytochrome P-450 isozymes 
following previous exposure to chemicals (Ioannides al.. 
1984).
The magnitude, onset and duration of induction of cytochrome 
P-450 isozymes are influenced by factors related to the 
inducing agent as well as to the host. The chemical nature of 
the inducing agent, its dose, and the duration of exposure all 
contribute to the enzyme induction. A number of different 
chemical agents have been found to induce the cytochrome P-450 
monooxygenases.
The early literature described three types of inducers: 
phenobarbital (PB), 3-methylcholanthrene (3-MC), and mixed 
(Goldstein, 1980). These are considered the "classical" types 
of cytochrome P-450 monooxygenase inducers. Now, there are 
four other distinct major inducer categories and the list is 
likely to grow. These others are considered the "non- 
classical" inducers and include ethanol, steroids, hormones
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and perioxsome proliferators (Guengerich, 1990). There are 
also P-450 inducers that do not fit into any of the above 
categories (Okey, 1990).
Much of the cytochrome P-450 induction study has been limited 
to the classical inducers. Phenobarbital induces the 
cytochrome P-450 isozyme family and 3-MC induces the 
cytochrome P-448 isozyme family. Consequently, the cytochrome 
P-450 isozyme family is referred to as the PB inducible form 
and the cytochrome P-448 isozyme family is referred to as the 
3-MC inducible forms (Lewis e£ al., 1986). Other chemical 
inducers are classified as PB-like or 3-MC-like if their 
pattern of isozymal induction is similar to these two 
chemicals. Some chemicals are considered to be mixed-type 
inducers if characteristics of both PB and 3-MC are observed.
Several classes of cytochrome P-450 isozymes and their gene 
families have been related and classified according to their 
chemical inducing agent. In the rat, the major PB-inducible 
isozyme is referred to as cytochrome P-450b (P-450IIB1) and 
the major 3-MC-inducible isozyme is cytochrome P-450c (P-
450IA1) (Nebert al*, 1989b). However, not all P-450
isozymes are inducible by xenobiotic chemicals. Rat liver P- 
450f and P-450g are relatively refractory to induction by all 
common classes of P-450 inducers (Bandiera si al*, 1986). The 
steroid-metabolizing P-450's are resistant to xenobiotic
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chemical induction; but instead their regulation often 
involves induction by endogenous substances (Okey, 1990).
Marked physiologic and anatomic changes are observed in liver 
cells following pretreatment with PB and 3-MC. Varying 
degrees of liver enlargement and smooth endoplasmic reticulum 
proliferation are observed as well as changes in concentration 
of the cytochrome P-450 enzyme components and the levels of 
certain cytochrome P-450-mediated enzyme activities (Sipes and 
Gandolfi, 1986).
Some of the cytochrome P-450 mediated enzyme activities show 
varying degrees of specificity for the cytochrome P-450 
isozyme families and therefore have been used to indirectly 
measure the major types and degrees of induction. In the rat, 
the enzyme activity arylhydrocarbon hydroxylase has been 
associated with induction of cytochrome P-448 (McCormack fit 
al., 1979) and aminopyrine N-demethylase has been associated 
with induced cytochrome P-450 (Kato and Onado, 1970). 
Unfortunately, many of these activities have not been found to 
clearly distinguish between the cytochrome P-450 isozyme 
families. Recently, however, cytochrome P-450 mediated enzyme 
activities that show a high degree of isozyme specificity have 
been reported. In the rat, the 0-dealkylation of various 
substituted alkoxyresorufin analogues have provided a simple 
routine test for distinguishing between several inducible
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isozymes of cytochrome P-450 (Burke and Mayer, 1983; Burke 
al., 1985).
The most common mechanism for cytochrome P-450 monooxygenase 
induction involves transcriptional activation of the gene 
(Nebert et al., 1989a) . This appears to be the case with PB,
3-MC, and most other inducing chemicals. However, ethanol, 
pyrazole, imidazole, and acetone induction, have been shown to 
involve post-transcriptional and post-translational gene 
regulation (Nebert at al., 1989a).
Not only can cytochrome P-450 monooxygenase activity be 
increased through chemical interaction, it can be decreased as 
well. Inhibition of cytochrome P-450 mediated xenobiotic 
biotransforroation can result from a number of general and 
specific inhibitory mechanisms. The general or non-specific 
inhibitors affect cytochrome P-450 as well as the majority of 
biotransformation reactions. These include agents that affect 
protein synthesis, compete for active sites or cofactors of 
the enzymes, cause allosteric changes in enzyme conformation, 
interfere with transport components in multienzymic systems 
and cause loss of functional tissue (Sipes and Gandolfi, 
1986). A number of chemicals have more specific inhibitory 
effects on the cytochrome P-450 system. Ethylisocyanide and 
carbon monoxide compete with molecular oxygen by interacting 
with the reduced heme moiety of cytochrome P-450. Metyrapone,
SKF-525A, piperonyl butoxide, and others compete for the 
substrate binding site of cytochrome P-450. Some of these 
inhibitors are selective for certain of the cytochrome P-450 
isozyme families. These chemicals can produce either a 
competitive or a noncompetitive inhibition of cytochrome P- 
450. Another group of chemicals act as suicide inhibitors. 
These chemicals are activated by cytochrome P-450 to reactive 
metabolites which then covalently bond to the heme moiety 
resulting in destruction of the heme and loss of cytochrome P- 
450 activity (Sipes and Gandolfi, 1986).
Clearly, the presence of chemical inducers and inhibitors can 
profoundly alter the biotransformation capabilities of the 
cytochrome P-4 50 monooxygenase system.
4. Avian hepatic cytochrome P-450 monooxvgenase system:
The avian hepatic cytochrome P-450 monooxygenase system has 
many similarities to the mammalian system with regard to 
structure, function, and regulation. However, very specific 
differences between the two classes have been noted in 
cytochrome P-450 content, cytochrome P-450 mediated enzyme 
activities, and response to inducers (Ronis and Walker, 1989). 
In addition, qualitative and quantitative differences are also 
evident among the avian species (Pan and Fouts, 1978).
The physiological and toxicological significance of the 
cytochrome P-450 monooxygenase system of birds has been
recognized only recently. Studies have linked the decline of 
predators such as the peregrine (Falco oerearinus) and 
sparrowhavk fAccioter nisus) in Great Britain and the bald
eagle (Haliaetus leucocephalus) in North America to the
bioaccumulation of organochlorine insecticides, the likely 
consequence of slow metabolism (Walker and Stanley, 1987; 
Walker, 1981). Certain of the avian cytochrome P-450 isozymes 
have been shown to be readily inducible by environmental 
chemicals, thus these may be useful as biological monitors for 
exposures in the field (Ronis and Walker, 1989). Knowledge of 
the role of the monooxygenases in the food producing birds, 
chickens, ducks, turkeys, and geese, is important for
understanding the safe and effective use of xenobiotics in 
these species (Ronis and Walker, 1989; Dalvi et al., 1987).
The concentration of cytochrome P-450 in liver microsomes of 
birds is, on average, four-fold less than mammals (Ronis and 
Walker, 1989; Dalvi al., 1987). The Passeriformes and
Galliformes have the highest of the avian cytochrome P-450 
contents, whereas the Palecaniformes and Charadriformes. fish 
eating birds, have the lowest content (Ronis and Walker, 
1989). Among the food producing avian species, turkeys have 
the highest cytochrome P-450 content followed by geese, 
chickens, ducks, and quail (Dalvi al., 1987). Riviere
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al. (1985) observed that the cytochrome P-450 content in
duodenal microsomes in the grey partridge and chicken were
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very similar in concentration to those in liver. The Japanese 
quail and pheasant, however, had extremely low duodenal 
cytochrome P-450 contents (Riviere al., 1985).
The activity of the hepatic cytochrome P-450 monooxygenases in 
birds has been measured using a variety of lipophilic 
substrates (Ronis and Walker, 1989). The relative activity in 
the avian species can be compared to the activity in male rats 
by adjusting for liver to body weight ratios (Walker, 1978 and 
1980). Differences in these activities appear to be a 
function of the substrate used. The cytochrome P-450 mediated 
metabolism of aldrin, aminopyrine, and HCE (an analogue of 
dieldrin) are relatively low in birds compared to the male rat 
(Walker and Ronis, 1989). Alternatively, the relative 
activity for aniline metabolism is similar and that for 7- 
ethoxyresorufin greater for birds than the rat (Walker and 
Ronis, 1989). A comparison of the relative activities for 
many substrates, with the exclusion of ethoxyresorufin, 
against the body weights in mammals and birds show that most 
birds have activities substantially below those of mammals of 
similar body weights (Ronis and Walker, 1989). These data 
also show a distinct difference between predator bird species 
and non-predator birds. Predator birds show lower relative 
activities than non-predators (Ronis and Walker, 1989). As is
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true for the cytochrome P-450 content, the Passeriformes and 
Galliformes show high relative activities compared to other 
bird orders (Ronis and Walker, 1989). The more chemically 
complex diet of these herbivorous and omnivorous birds may 
contribute to this finding (Ronis and Walker, 1989).
The hepatic cytochrome P-450 monooxygenases of birds, like 
those of mammals, are inducible but with a number of 
significant differences. The 3-MC-type of cytochrome P-450 
inducer has been shown to produce increases in all the avian 
species tested. These include chickens, Japanese quail, and 
pigeons treated with either 3-MC, 6-naphthoflavone (BNF), or 
2,3,7,8- tetrachlorodibenzo-p-dioxin (TCDD) (Ronis and Walker, 
1989). Buynitzky et al. (1978) administered 3-MC to White 
Leghorn chickens and observed a 4-fold increase in cytochrome 
P-450 content, 1.7-fold in ethylmorphine N-demethylase, 2.5- 
fold in aniline hydroxylase, and 20-fold in arylhydrocarbon 
hydroxylase. Ehrich al* (1984) observed increased
detoxication of the organophosphate malathion in livers of 
chickens given BNF and 3-MC. Ehrich and Larsen (1983) 
detected increases in cytochrome P-450 content, p-nitroanisole 
O-demethylase, and aniline hydroxylase in BNF and 3-MC treated 
adult White Leghorn hens.
Consistent findings observed with 3-MC induction in both birds 
and mammals are increases in cytochrome P-450 content,
arylhydrocarbon hydroxylase activity, and the characteristic 
blue shift in the reduced cytochrome P-450-CO difference 
spectrum from 450 nm to 448 nm. Some features that are 
different between the two classes, however, include: more 
marked increases in overall cytochrome P-450 content in birds 
than in mammals; earlier development of inducibility in the 
avian embryo than the mammalian embryo; and increases in the 
enzyme activities aminopyrine N-demethylase, ethylmorphine N- 
demethylase, and biphenyl-2-hydroxylase in birds but not in 
mammals (Ronis and Walker, 1989). In addition, the Ah
receptor observed in 3-MC induced mammals has not been 
identified in birds which may indicate that 3-MC induction is 
mediated differently between the two species (Sawyer et al.. 
1986) .
Phenobarbital-type induction has produced variable responses 
in birds (Walker and Ronis, 1989). Chickens, as do mammals, 
show good response whereas the Japanese quail and the
cormorant show little or no response to PB induction (Walker
and Ronis, 1989). Strittmatter and Umberger (1969)
administered PB to several age groups of chickens and in all 
stages of development observed increases of cytochrome P-450 
content and meberal N-demethylase activity. Powis e£ al. 
(1976) observed three- to four-fold increases in cytochrome P- 
450 content with increases in aminopyrine N-demethylase and 
aniline hydroxylase in 7-day old chickens treated with PB.
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Pilch and Combs (1981) studied the relationship of dietary 
vitamin E and selenium on PB induction in young male and 
female chickens. They found maximal induction was impaired in 
male but not female chicks by combined vitamin E/selenium 
deficiency. Lorr and Bloom (1987) examined the ontogeny of 
the chicken cytochrome P-450 enzyme system from 7 days of 
incubation to 36 days post hatching. They observed increases 
in cytochrome P-450 content and aminopyrine N-demethylase 
activity as early as 7 days of incubation. The early response 
seen by several investigators in birds to PB induction has not 
been observed in mammals (Ronis and Walker, 1989).
Immunochemical identification of avian cytochromes P-450 using 
monoclonal antibodies raised against PB isoforms of rat 
cytochrome P-450 give additional evidence of difference among 
bird species. A cytochrome P-450 was purified from PB-treated 
chick embryos and shown to cross react with antibodies raised 
to rat cytochrome P-450b (P-450IIB1) (Brooker fit al*/ 1983). 
However, cormorants dosed with PB did not have a cytochrome P- 
450 that cross reacted with rat cytochrome P-450b (P-450IIB1) 
(Ronis and Walker, 1989).
Another difference between birds and mammals is the number of 
phenobarbital inducible genes present in the genome. 
Mattschoss fit al* (1986) reported the presence of two 
independent PB inducible P-450 genes in the chicken genome.
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Hobbs al. (1986) used the chicken cytochrome P-450 protein 
sequence to propose that the ancestral genes of mammals should 
have at least four distantly related PB-inducible gene 
subfamilies.
Mixed-type induction occurs in birds as in mammals with 
exposure to a number of complex organic compounds including 
polychlorinated biphenyls, polybrominated biphenyls, 
hexachlorobenzene, and 2-acetylaminofluorene (AAF)(Ronis and 
Walker, 1989). These studies have mostly been limited to the 
chicken and quail. Cecil et al. (1978) reported that Aroclor 
1254 and 1268 but not 1242 were potent inducers of hepatic 
enzyme activity in White Leghorn cockerels. Ehrich and Larsen 
(1983) observed that Aroclor 1254 was a selective inducer of 
aniline hydroxylase activity in hens. Differences in 
induction between chicks and young barn owls treated with 
Aroclor 1254 were observed by Rinzky and Perry (1983). Darby 
et al. (1985) examined AAF treatment in chick embryos and
found induction similarities to both PB and 3-MC.
A number of other classes of compounds produce induction 
responses in birds that are not characteristic of either 
PB-,3-MC- or mixed-type of inducers. One interesting class of 
compounds is the ergosterol biosynthesis inhibitors, 
prochloraz, imazalil and ketaconazole. Prochloraz is a potent 
inducer of cytochrome P-450 in birds but only a weak inducer
in rats (Riviere, 1983; Rivere e£ al., 1985). In the red- 
legged partridge, prochloraz induces a ten-fold increase in 
cytochrome P-450 content, a substantial increase in 
ethoxyresorufin O-deethylase and aldrin epoxidase activities, 
and a shift in the cytochrome P-450-CO-difference spectrum to 
a peak at 453 nm (Johnston at al., 1989). Immunochemical 
studies of the partridge show that the cytochrome P-450 form 
induced by prochloraz cross reacts with antibodies against 
cytochrome P-450c of the rat (Johnston gt al* t 1989). These 
changes give strong indications of 3-MC-type of induction as 
well as another new type of induction (Johnston e£ al*» 1989). 
Riviere e£ al* (1983) studied the effect of pyrethroids on 
mixed function oxidase activity in Japanese quail. Small 
increases in P-450 specific content and ethoxyresorufin 0- 
deethylase activity were observed in the duodenum, however 
there were no significant changes in the liver.
The glucocorticoids also appear to be inducers of hepatic 
mixed function oxidase activity in the chick embryo. Leakey 
e£ al* (1979) observed increases in cytochrome P-450 specific 
content and aminopyrine N-demethylase activity in chick 
embryos administered corticosterone.
The response of the avian cytochrome P-450 monooxygenase 
system to inhibitors has not been thoroughly investigated. 
However, it is likely that the avian cytochrome P-450 system
responds similarly to the general and specific inhibitors of 
the mammalian cytochrome P-450 system. Two insecticides have 
been found to inhibit avian cytochrome P-450. Malathion 
treatment resulted in significant inhibition of aniline 
hydroxylase and the demethylation of p-chloro N-methyl aniline 
in White Leghorn cockerels (Varshneya g£ al., 1986). DDT 
caused decreased aniline hydroxylase activity in Japanese 
quail and chickens (Sell gt al., 1971 and 1972; Sifri e£ al.. 
1975) and inhibition of aminopyrine N-demethylase activity in 
quail (Sifri gt al., 1975). However, ducklings given DDT did 
not show suppressed microsomal monooxygenase activities (Sifri 
gt al., 1975). This demonstrates that there are differences 
between avian species in the response to inhibitors as well as 
to inducers of the cytochrome p-450 monooxygenase system.
CHAPTER 3 
EXPERIMENTAL GOALS AND DESIGN
The primary objective of this study was to determine the 
effects of treatment with an extract of Sesbania drummondii on 
the major biotransformation system, the hepatic cytochrome P- 
450 monooxygenase system. Comparisons were sought between the 
avian experimental model for Sesbania drummondii toxicosis, 
the chicken, and the mammalian experimental model, the rat. 
This study included 4 experimental phases.
A. Phase I - Preliminary investigations of the effects of 
an extract of Sesbania drummondii on hepatic cytochrome 
P_^450_monooxygenase systems of chickens and rats.
The preliminary investigations were designed to determine 
fundamental effects of an extract of Sesbania drummondii on 
the hepatic cytochrome P-450 monooxygenase systems of chickens 
and rats. This was accomplished with 4 experiments.
The purpose of experiment 1 was to characterize and compare 
the effects of Sesbania drummondii-treatment on components of 
the hepatic cytochrome P-450 monooxygenase system in treated 
chickens and rats vs. untreated controls. Evaluations were 
made of liver to body weight ratio, cytochrome P-450 and b5 
content, NADH- and NADPH-cytochrome c reductase activity and
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six selected cytochrome P-450 mediated enzyme activities.
Experiment 2 was designed to evaluate the effects of the 
Sesbania drummondii-extraction buffer on the cytochrome P-450 
monooxygenase system. Assurances were needed that changes 
observed were due to Sesbania drummondii alone and not the 
extraction solution. These were obtained by determining the 
extraction solution effects on the cytochrome P-450 content 
and two cytochrome P-450-mediated enzyme activities in 
chickens and rats treated with the extraction buffer vs. 
untreated chicken and rat controls.
Experiment 3 determined whether the Sesbania drummondii- 
induced effects on the hepatic cytochrome P-450 system in rats 
were sex-dependent. This information was necessary for the 
design of subsequent studies. A comparison between the 
cytochrome P-450 content of Sesbania drummondii-treated male 
and female rats was used to satisfy this goal.
Experiment 4 evaluated the contribution of changes in 
microsomal membrane stability to the Sesbania drummondii- 
induced effects of the hepatic cytochrome P-450 monooxygenase 
system. This was accomplished by measurements of a microsomal 
membrane marker enzyme, glucose-6-phosphatase.
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B. Phase II - Characterization of Sesbania drummondii
effects on catalytic properties of_the hepatic
cytochrome P-450 monooxygenase systems. CpfflP.arjg.9n
with effects caused bv phenobarbital and 
B-naphthoflavone.
The goal of the catalytic study was to characterize the 
effects of an extract of Sesbania drummondii on cytochrome P- 
450-mediated enzyme activities of treated chickens and rats 
and to compare these changes with those induced by the 2 major 
classes of cytochrome P-450 inducing agents, phenobarbital and 
B-naphthoflavone. This was achieved by characterizing 
cytochrome P-450 mediated enzyme activities of both low and 
high degrees of specificity for cytochrome P-450 isozyme 
families. The enzyme activities studied were aminopyrine N- 
demethylase, aldrin epoxidase, and the alkoxyphenoxazone 0- 
dealkylases. Aminopyrine N-demethylase activity has been 
associated with the phenobarbital-inducible cytochrome P-450 
isozyme subfamily (P-450IIB1), although the specificity of 
this activity is low (Lubet e£ &1., 1985). The aldrin
epoxidase activity has also been associated with 
phenobarbital-inducible cytochrome P-450 but with greater 
specificity (Lubet , 1985). Presently, the O-
dealkylation of various alkoxyphenoxazone derivatives are the 
most specific of the cytochrome P-450-mediated enzyme 
activities for distinguishing between the inducible cytochrome
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P-450 isozymes in rat hepatic microsomes. Increases in the 0- 
dealkylation of pentoxy- and benzyloxyphenoxazone are 
associated with induced rat cytochrome P-450IIB1 and an 
increase in the 0-dealkylation of ethoxyphenoxazone is 
associated with induction of cytochrome P-450IA1 (Burke and 
Mayer, 1983; Burke al., 1985).
C. Phase III - Effects of Sesbania drummondii on
NADPH-deoendent cytochrome P-450 reductase. Comparison
With effects saiisefl fey Phenobarbital and fl-
naphthoflavone.
The purpose of the reductase study was to determine whether 
the Sesbania drummondii-induced changes in the cytochrome P- 
450 monooxygenase system were enzymic in nature or were the 
result of altered efficiency of electron transfer. This was 
accomplished by characterizing the effects of Sesbania 
drummondfi on the NADPH-dependent cytochrome P-450 reductase 
of the cytochrome P-450 monooxygenase system and to compare 
these changes to those induced by phenobarbital and &- 
naphthoflavone. NADPH-dependent cytochrome P-450 reductase 
was characterized by measuring the reductase activities and by 
determining the relative contribution of the reductase 
component to the overall changes induced in the cytochrome P- 
450 system. The reductase activity was determined by 
measuring the rates of reduction of cytochrome c. The
relative contribution of the reductase component to the 
overall changes induced in the cytochrome P-450 system was 
determined by comparing reductase-dependent, NADPH-mediated 
metabolism to reductase-independent, organic hydroperoxide- 
mediated metabolism i.e., the peroxygenase activity of 
cytochrome P-450. Two cytochrome P-450-mediated activities, 
aminopyrine N-demethylase and aldrin epoxidase were measured 
via the peroxygenase activity using two organic 
hydroperoxides, cumene hydroperoxide and t-butyl hydroperoxide 
as oxygen donors. These activities were characterized in both 
treated chickens and rats.
D. Phase IV - Induction of microsomal enzymes bv
Sesbania drummondii as determined bv SDS-PAGE and
western blots with anti-cvtochrome P-450
antibodies. Comparison__with effects caused by
phenobarbital and B-naphthoflavone.
Electrophoretic and immunochemical characterization of 
cytochrome P-450-induced changes provides for definitive 
classifications as to cytochrome P-450 isozyme family. 
Therefore, the final study was designed to compare the
Sesbania drummondii-induced changes to those of phenobarbital 
and B-naphthof lavone using SDS gel electrophoresis and Western 
blotting techniques.
CHAPTER 4
SPECIFIC OBJECTIVES, MATERIALS AMD METHODS, 
RESULTS AMD DISCUSSION
A. PHASE I ~ PRELIMINARY INVESTIGATIONS OF THE EFFECTS OF 
AN EXTRACT OF SESBANIA DRUMMONDII ON THE HEPATIC 
CYTOCHROME P-450 MONOOXYGENASE SYSTEMS OF CHICKENS AND 
RATS.
EXPERIMENT 1 - Initial characterization studies of the effects
of an extract of Sesbania drummondii on hepatic cytochrome P-
450 monooxygenase systems of chickens and rats.
OBJECTIVES:
1. To determine the effect of treatment with S. drummondii 
on body and liver weight in chickens and rats.
2. To determine the effect of S. drummondii-treatment on 
hepatic microsomal cytochrome P-450 and cytochrome b5 
specific content in chickens and rats.
3. To determine the effect of £. drummondi i-treatment on 
hepatic microsomal NADH-and NADPH-dependent cytochrome c 
reductase activity in chickens and rats.
4. To determine the effect of S. drummondii-treatment on 
selected hepatic microsomal cytochrome P-450 mediated- 
activities.
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MATERIALS AND METHODS;
Many of the materials and methods described below will be used 
in subsequent studies throughout this project.
A. Chemicals;
4-Aminophenol (99% pure), aniline (99% pure), benzo(a)pyrene 
(98% pure), 4-dimethylaminoantipyrene (98% pure), 7-
ethoxycoumarin (99% pure), and umbelliferone (98% pure) were 
purchased from Sigma Chemical Co. (St. Louis, MO). 7-
Ethoxyresorufin (98% pure) was purchased from Molecular 
Probes, Inc. (Eugene, OR). Resorufin (75% dye content) was 
obtained from Aldrich Chemical Co., Inc. (Milwaukee, WI). 
Aldrin (99.4% pure) and dieldrin (99.8% pure) were obtained 
from the EPA (Research Triangle Park, NC) . 3-
Hydroxybenzo(a)pyrene (99% pure) was purchased from the 
Chemical Repository of the National Cancer Institute 
(Bethesda, MD). All other chemicals and biochemicals were of 
analytical grade or better and were obtained from various 
commercial sources.
B. Animals:
Twenty-four male and female 300-to 500-g White Leghorn
chickens were obtained from the Department of Veterinary 
Science, Louisiana State University, Baton Rouge, LA. 
Eighteen male Sprague-Dawley 200-to 300-g rats were obtained 
from Hilltop Lab Animals, Inc. (Scottsdale, PA). The chickens
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were group housed in commercial brooders and the rats were 
maintained 3 per cage on a 12-hr light/dark cycle in a 
temperature (21-24 C) and humidity (40-60 %) controlled
environment. Chickens and rats were given feed (Purina chick 
Startena and Purina rat chow) and water ad libitum. Both 
species were acclimated for 1 week. Experiments using 
chickens were performed with 3 groups of 8 animals, 4 treated 
and 4 control in each group. Experiments using rats were 
performed with 3 groups of 6 animals, 3 treated and 3 control 
in each group.
C. Treatments;
Extracts of S. drummondii were prepared from dry ground seeds 
and pods gathered locally. Ground seeds and pods have 
virtually the same toxicity as whole ground seeds (Marceau- 
Day, 1988). The ground seeds and pods were soaked overnight 
in a 25 mM sodium bicarbonate buffer (pH 7.4) containing 0.02% 
sodium azide in a ratio of l part ground seeds to 5 parts 
buffer. Sodium azide was added to inhibit bacterial growth in 
the extract. The extract was recovered by vacuum filtration 
through 6 layers of cheese cloth. The concentration of the 
extract was calculated from the volume of filtrate per gram of 
seeds/pods. Animals were weighed daily for 3 days and then 
given either freshly prepared extracts of s. drummondii by 
gavage, or they received no treatment. Control animals were 
not given the extracts. No differences in the growth and
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health of chickens and rats treated with bicarbonate-azide 
buffer versus those not dosed with the buffer have been 
observed in our laboratory. The volume of extract given was 
calculated by multiplying the body weight of the animal, the 
dose as percentage of body weight, and the concentration of 
extract. Treated chickens received daily doses equal to 0.8% 
of body weight and rats received 0.4% of body weight. These 
doses have been found to induce similar clinical signs and 
lesions observable at necropsy in the two species over a 3-day 
period (Marceau-Day, 1988).
D. Preparation of hepatic microsomes;
On the fourth day, the animals were weighed, sacrificed by 
guillotine, and examined for gross lesions. Livers were 
carefully removed, weighed, and placed on ice in 0.125 M KC1. 
Microsomes were prepared from the pooled livers of the group, 
treated or control. The livers were minced, rinsed, and 
homogenized in 4 volumes of ice cold buffer solution (10 mM 
tris, 0.25 M sucrose, and 1.0 mM disodium EDTA; pH 7.4). A 
microsomal pellet was prepared by stepwise differential 
centrifugation of the homogenate and its supernatant (Lake, 
1987) at 600, 8000, and 14500 x g, and subsequent
centrifugation of the supernatant at 105,000 x g. The
resulting pellet was washed once with 0.125 M KC1 and
recentrifuged at 105,000 x g for 1 hr. All centrifugation
steps were conducted at 4 C. The final microsomal pellet was
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resuspended in 0.125 M KCL in 20% glycerol and frozen (-70 C) 
until used. Microsomes were used within two weeks of 
isolation.
E. Protein determination;
The concentration of microsomal protein was determined 
according to the method of Lowry et al. (1951). Microsomal 
suspensions (duplicates) were diluted 1:100 and 1:200 in 0.1 
N NaOH. Protein standards (0, 30, 50, 100, and 200 /ig/mL) 
were prepared from stock bovine serum albumin (Sigma fraction 
V, 10 mg/mL) in 0.1 N NaOH. To both sample and standard 
solutions (ImL) was added 5 mL of copper reagent (2% Na2C03,
0.4% NaOH, 0.025% Na2CuEDTA) at 30 sec intervals followed by 
vortexing. Exactly 10 min later, 0.5 mL of freshly prepared 
Folin Ciocalteu reagent (diluted 1:1 in triply distilled 
water) was added and the solution was again vortexed. 
Following a 30 min incubation at room temperature, the 
absorbances were measured at 500 nm on a Bausch & Lomb 
Spectronic 2000 UV-visible spectrophotometer (Bausch & Lomb, 
Rochester, New York). The concentration of protein in the 
samples was determined from a standard curve constructed from 
the standards. A typical standard curve used in the protein 
determinations is shown in Appendix 1.
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F. Cytochrome P-450:
The cytochrome P-450 content of the microsomes was determined 
by the method of Omura and Sato (1964b). Microsomes were
diluted (1:10 for chickens and 1:20 for rats) in 0.1 M
potassium phosphate buffer (pH 7.4). A few grains (approx.
0.1 g) of sodium dithionite was added, the solutions were 
mixed by inversion, and 1.0 mL aliquots were placed into two 
plastic cuvettes (10 mm path length). The cuvettes, reference 
and sample, were placed into the spectrophotometer and a 
baseline of zero absorbance between the two cuvettes was run 
from 300 to 500 nm and stored. The sample cuvette was then 
saturated with carbon monoxide (CO) by exposure to a stream of
small bubbles for 30 sec. It was then returned to the
spectrophotometer, and a difference spectrum was recorded 
between 350-500 nm. Depending upon the source of microsomes 
and the pretreatments the absorbance maximum were observed 
between 447-452 nm. The cytochrome P-450 content of the 
microsomes was determined from the difference in absorbance of 
the carbon monoxide complex of dithionite-reduced cytochrome 
P-450 and that of the non-liganded reduced cytochrome P-450. 
The change in absorbance at 450 nm relative to 490 nm was then 
converted to the specific content of cytochrome P-450 using an 
extinction coefficient of 91 cm'1mM'1 (Omura and Sato, 1964b). 
The final concentration was expressed as nmole cytochrome P- 
450 per mg of microsomal protein.
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G. Cytochrome b5:
The concentration of cytochrome b5 in the microsomal 
suspensions was determined by the method of Omura and Sato 
(1964b). Microsomes were diluted (1:10 for chickens and 1:20 
for rats) in 0.1 M potassium phosphate buffer (Ph 7.4) and 1.0 
Ml aliquots were placed into two plastic cuvettes. The 
cuvettes, reference and sample,, were placed into the 
spectrophotometer and a baseline of zero absorbance was run 
between the sample and reference cuvettes in the range of 300- 
500 nm and stored. The cuvettes were removed and 5 jjL of a 
freshly prepared NADH solution (30 Mm) was added to the sample 
cuvette and 5/iL of water was added to the reference cuvette. 
The cuvettes were inverted to mix, returned to the 
spectrophotometer, and scanned from 350-490 nm.
The addition of NADH to the contents of the sample cuvette 
resulted in the rapid reduction of cytochrome b5 as 
characterized by an increase in absorbance at about 556 nm and 
426 nm and a loss of absorbance at about 409 nm. The 
microsomal concentration of cytochrome b5 was determined by 
applying the millimolar difference extinction coefficient of 
185 mM^cm'1 for the difference in absorbance between 426 and 
409 nm. The cytochrome b5 content was expressed an nmoles 
cytochrome bs per mg of microsomal protein.
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H. NADH- and NADPH-dependent cytochrome c reductase; 
NADH- and NADPH-dependent cytochrome c reductase activities 
were assayed by use of the method of Phillips and Langdon 
(1962) as modified by Yasukochi and Masters (1976). 
Microsomal suspensions were diluted 1:10 in 0.125 M KCL. A 
working stock solution of cytochrome c was prepared by 
solubilizing 62 mg of cytochrome c (Type III, from horse 
heart) in 10 mL of water and 34 mL potassium phosphate buffer 
(1 M, pH 7.7) and then diluting to 100 mL with triply 
distilled water. Sample and reference solutions were prepared 
by pipetting 2.5 mL of cytochrome c solution (room 
temperature) followed by 5 fxL of the microsomal dilution into 
two l cm plastic cuvettes. The spectrophotometer was balanced 
between the two cuvettes and the parameters were set for 
absorbance measurements every 30 sec for 180 sec at 550 nm 
using the built-in kinetic program. The reaction was 
initiated by the addition of 10 n L of freshly prepared NADH 
(lOmM) or NADPH (lOmM) to the sample cuvette. The sample 
cuvette was inverted to mix and returned to the sample 
chamber. The reductase activities were quantified using an 
extinction coefficient of 29.5 mM'^cm'1 for reduced cytochrome 
c. The final NADH- and NADPH-cytochrome c reductase 
activities were expressed as nmol of cytochrome c reduced per 
min per mg of microsomal protein.
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I. Hepatic microsomal monooxygenase activities:
1. Aminopyrine N-demethvlase:
The microsoma 1-mediated metabolism of aminopyrine was measured 
by determination of the product, formaldehyde. The reaction 
mixture consisted of 1.5 mg of microsomal protein, 0.3 mM 
NADP+, 10 mM glucose 6-phosphate, 7 units glucose 6-phosphate 
dehydrogenase, 10 mM MgCl2, 100 mM potassium phosphate buffer 
(pH 7.4), and 10 mM aminopyrine in a final volume of 3.0 mL. 
The reaction was started by the addition of the NADPH- 
generating system (glucose 6-phosphate and glucose 6-phosphate 
dehydrogenase) , incubated at 37 C for 15 min, and stopped by 
the addition of 1 mL 70% trichloroacetic acid. Aminopyrine N- 
demethylase (APND) was quantified by measuring the amount of 
formaldehyde formed according to the method of Nash (1953) as 
compared with a standard curve prepared in the reaction 
matrix. A typical standard curve used in the determination of 
activity is shown in Appendix 2. Aminopyrine N-demethylase 
activity was expressed as nmoles of formaldehyde formed per 
min per mg microsomal protein and nmoles of formaldehyde 
formed per min per nmole cytochrome P-450.
2. Aniline hydroxylase:
Aniline hydroxylase activity (ANH) was measured by following 
the formation of p-aminophenol from aniline according to the 
method of Lake (1987) with modifications. The 2 mL reaction 
mixture contained 1 mg of microsomal protein, 50 mM Tris-HCL
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buffer (pH 7.8), 5 mM MgS04, 0.5 mM NADP+, 5 mM glucose 6- 
phosphate, 1.5 units of glucose 6-phosphate dehydrogenase, and 
5 mM aniline-HCl. The reaction was started by the addition of 
the NADPH-generating system (glucose 6-phosphate and glucose 
6-phosphate dehydrogenase) and was incubated in a 37 C water 
bath for 10 min. The reaction was terminated by adding 2 mL 
of 10% trichloroacetic acid. After centrifugation, a 2 mL 
aliquot of the supernatant was added to 1 mL of 10% Na2C03 
followed by the addition of 2 mL of 1% phenol in 0.1 N NaOH. 
The resulting optical density was measured at 620 nm after 30 
min and compared with a p-aminophenol standard. A typical p- 
aminophenol standard curve is shown in Appendix 3. Aniline 
hydroxylase activity was expressed as nmoles of p-aminophenol 
formed per min per mg of microsomal protein and nmoles of p- 
aminophenol formed per min per nmole of cytochrome P-450.
3. Aldrin epoxidase:
Aldrin epoxidase activity (AE) was determined from the amount 
of dieldrin produced as described by Riviere et al. (1985) 
with modifications. The incubation system contained 50 mM 
potassium phosphate buffer (pH 6.8); 0.25 mM NADP+; 2.5 mM 
glucose-6-phosphate; 1 unit glucose-6-phosphate dehydrogenase;
0.2 mg of microsomal protein; and 50 /M  aldrin in a final 
volume of 1.0 mL. Incubation was performed aerobically in a 
constant temperature shaker at 37 c for 15 min. The reaction 
was initiated by the addition of aldrin and stopped by the
addition of 0.2 mL of acetone. Hexane (5 mL) was added and 
the tubes were capped and vortexed for 45 sec. This resulted 
in extraction of dieldrin from the incubation mixture (bottom 
layer) into the hexane layer (top layer). Dieldrin was 
assayed by use of a Hewlett Packard 5880A gas chromatograph 
(Hewlett Packard, Avondale, PA) equipped with an electron- 
capture detector (nickel-63) and a capillary column (15 m x,
0.53 mm ID, phase 007-17 Quadrex Corp., New Haven, CT). The 
column, detector, and injector temperatures were 220-240 C (10 
C per min), 300 C, and 180 C, respectively. The injection of 
samples was made in the splitless mode using a direct flash 
injection liner. The carrier gas was 5% methane in argon at 
a flow rate of 11 mL per minute. Carrier gas was also used 
for detector make-up to a total flow of ca. 30 mL per minute. 
The amount of dieldrin in the extract was quantified by peak 
height from a standard curve. A typical standard curve used 
in the determination of aldrin epoxidase activity is shown in 
Appendix 4. The aldrin epoxidase activity was expressed as 
nmoles of dieldrin produced per min per mg of microsomal 
protein and nmoles of dieldrin produced per min per nmole of 
cytochrome P-450.
4. Ethoxvcoumar in O-deethvlase:
The O-dealkylation of 7-ethoxycoumarin was measured 
fluorometrically using a spectrophotofluorometer (Farrand 
Optical Col, Valhalla, NY) by the method of Lake (1987). The
ethoxycoumarin O-deethylase (ECOD) assay was run aerobically 
at 37 C for 10 min and contained a standard reaction mixture 
of 50 mM Tris-HCl buffer (pH 7.8); 5 mM MgS04; 0.5 mM NADP+; 
5 mM glucose-6-phosphate; 3 units of glucose-6-phosphate 
dehydrogenase; 0.5 mM 7-ethoxycoumarin and 1.0 mg of 
microsomal protein in a final volume of 2.0 mL. The reaction 
was started with the addition of substrate and terminated by 
the addition of 1.0 mL of zinc sulfate solution (5% w/v) 
followed by 1.0 mL of saturated barium hydroxide to all tubes. 
After centrifugation, 1.5 mL of supernatant was removed and 
added to 3.0 mL of 0.5 M glycine-sodium hydroxide buffer (pH 
10.5). The ECOD assay was measured using 380 nm excitation and 
452 nm emission wavelengths and was compared with an 7- 
hydroxycoumarin (umbelliferone) standard. A typical 7- 
hydroxycoumarin standard curve is shown in Appendix 5. The 
ECOD activity was expressed as nmoles 7-hydroxycoumarin formed 
per min per mg of microsomal protein and nmoles 7- 
hydroxycoumarin formed per min per nmole of cytochrome P-450.
5. Ethoxvresorufin o-deethvlase activity;
The O-dealkylation of 7-ethoxyresorufin was also measured 
fluorometrically by the method of Lake (1987). The 7- 
ethoxyresorufin O-deethylase (EROD) assay was nearly identical 
to the ECOD assay. The EROD assay was also performed 
aerobically at 37 C for 10 min and contained the components of 
the ECOD reaction mixture with the exception that 5 iM  7-
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ethoxyresoruf in was used for the substrate and the microsomal 
protein concentration was 0.1 mg per mL. The pH of the
glycine-sodium hydroxide buffer that was added to the
supernatant following centrifugation was raised to 8.5 for 
EROD. The 7-ethoxyresorufin O-deethylase activity was 
measured using 535 nm excitation and 582 nm emission 
wavelengths and quantitated with resorufin as a standard. A 
typical resorufin standard curve is shown in Appendix 6. The
EROD activity was expressed both as pmoles of resorufin formed
per min per mg of microsomal protein and pmoles of resorufin 
formed per min per nmole of cytochrome P-450.
6. Arvl hydrocarbon hydroxylase:
Aryl hydrocarbon hydroxylase activity was measured by the 
method described by Guengerich (1982). The components of a 
1.0 mL reaction mixture included: 50 mM potassium phosphate 
buffer (pH 7.4), 5.0 mM MgCl2, 1.0 mM NADP+, 10.0 mM glucose 
6-phosphate, 3 units glucose 6-phosphate dehydrogenase, 80 /xM 
benzo(a)pyrene, and 0.1 mg of microsomal protein. The 
reaction was started with the NADPH-generating system (glucose 
6-phosphate and glucose 6-phosphate dehydrogenase). 
Incubations were performed aerobically at 37 c for 10 min and 
were terminated with 1.0 mL of cold acetone (4 C). The 
products were extracted with 3.25 mL hexane followed by the 
addition of 1 N NaOH. Fluorescence of the aqueous layer was 
read using an excitation wavelength of 396 nm and an emission
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wavelength of 522 nm. Aryl hydrocarbon hydroxylase activity 
was quantitated using a 3-OH benzo(a)pyrene standard. A 
typical 3-OH benzo(a)pyrene standard curve is shown in 
Appendix 7. Activities were expressed as pmoles of 3-OH 
benzo(a)pyrene formed per min per mg of microsomal protein and 
the pmoles of 3-OH benzo(a)pyrene formed per min per nmole of 
cytochrome P-450.
J. Statistical analysis:
The significance of difference between nontreated controls and 
treated groups was determined using an unpaired Student's t 
test. The acceptable level of significance for this study was 
established at p < 0.05.
RESVLTS:
Body weights and livers weights:
Decreases in body weights in chickens were detected in the S. 
drummondii-treated groups, compared with controls. These 
weight losses developed despite the finding of large 
quantities of food material in the crops of treated chickens 
at necropsy. The treated rats had slight, but not 
significant, decreases in gains in body weight relative to 
controls. Liver weight changes paralleled those of body 
weight in the treated animals, resulting in liver to body 
weight ratios similar to those of the control animals (Table 
1).
Hepatic microsomal cytochromes and reductases;
Marked differences in content of microsomal cytochrome P-450 
of S. drummondii-treated vs control animals were detected 
(Table 2). An approximate 2-fold increase in chickens' and a 
2-fold decrease in rats' cytochrome P-450 specific content 
were consistently observed for the treated groups. 
Significant differences were not observed in the cytochrome b5 
content of microsomes from S. drummondii-treated chickens or 
rats.
The effect of S. drummondii treatment on NADPH- and NADH- 
cytochrome c reductase activities followed a pattern similar 
to that described for the cytochromes. A 2.5-fold increase
Table 1. Effect of Sesbania drummondii treatment on body and liver weights in chickens and rats
Chickens Rats
Control Treated Control Treated
Body weight {% change)*
Relative liver/body weight 
(% body weight)*
+7.2+2.3 
+2.0+0.1
-8.1+3.Of 
+2.0+0.1
+5.6+3.4 
+3.9+0.3
+1.8+6.8 
+3.8+0.3
Data are expressed as group means (+_ SEM), n = 3).
The results were calculated according to this formula: Final weight - First day weight
First day weight
t The results were calculated according to this formula: Pooled liver weight
Pooled body weight
f Significantly different (Student's _t test) from control data (P<0.01).
X 100
X 100
Table 2. Effect of Sesbania drummondii treatment on hepatic microsomal monooxygenase cytochromes and
reductases in chickens and rats
Chickens Rats
Control Treated Control Treated
Cytochrome P-450 0.17£0.04 
(nmol/mg protein)
0.36+0.02t 0.71+0.06 0.43+0.09*
Cytochrome bs 0.11+0.04 0.18+0.06 0.21+0.04 0.22+0.07
(nmol/mg protein)
NADH cytochrome £  reductase 160+35 178+26 607+16 525+102
(nmol reduced/min/mg protein)
NADPH cytochrome c reductase 64+16 156+12t 99+28 66+29
(nmol reduce(T/min/mg protein)
Data are expressed as group means (_+ SEM), n = 3. Significantly different (Student's £  test) from 
control data (* PC0.05, tP<0-01)-
inco
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in the chickens and slight, but not significant, decrease in 
the rats were observed for NADPH-cytochrome c reductase 
activity. Significant differences were not observed for NADH- 
cytochrome c reductase activity in either species treated with
S. drummondii.
Hepatic microsomal monooxygenase activities:
The effects of S. drummondii-treatment on six selected hepatic 
microsomal monooxygenase enzyme activities were compared in 
terms of mg of microsomal protein (specific activity) and 
nmoles of cytochrome P-450 (molar activity or turnover number; 
Table 3).
When expressed per mg of microsomal protein, increases in all 
six activities were evident with the treated chickens. Two­
fold increases were detected for aminopyrine N-demethylase, 
aniline hydroxylase, ethoxycoumarin O-deethylase, and 
arylhydrocarbon hydroxylase activities. Aldrin epoxidase 
activity was increased 4-fold in treated birds. The most 
pronounced change was observed for ethoxyresorufin 0- 
deethylase activity, with a 15-fold increase in treated birds, 
compared with controls.
Significant decreases in three activities, expressed per mg of 
microsomal protein, were observed in the treated rats. A 40% 
reduction in aminopyrine N-demethylase, aniline
IT a b le  3 .  E f f e c t  o f  S e s b a n i a  d r u t m o n d i i  t r e a t m e n t  o n  s e l e c t e d  h e p a t i c  m ic r o s o m a l  m o n o o x y g e n a s e  a c t i v i t i e s .
C h i c k e n s R a t s
C o n t r o l T r e a t e d C o n t r o l T r e a t e d
A m in o p y r i  n e - N - d e m e t h y l a s e
( n m o le s  H C K O /m in/m g p r o t e i n )  
( n m o le s  H C H O /m in /n m o le  P - 4 5 0 )
3 . 0 9 + 1 .0 5
1 8 .0 0 + 3 .4 8
6 .1 9 + 1 .5 2 *
1 7 .4 6 + 4 .9 0
3 . 3 8 + 0 . 1 8
4 . 7 8 + 0 . 6 1
2 . 1 0 + 0 . 2 0 t
5 . 0 4 + 1 . 5 6
A n i l i n e  h y d r o x y l a s e
( n m o le s  p - a m in o p h e n o l /m i n / m g  p r o t e i n )  
( n m o le s  p - a m i n o p h e n o l / m i n / n m o l e  P - 4 5 0 )
2 . 3 8 + 0 . 5 5
1 4 .0 1 + 1 .3 2
5 . 6 8 + 1 .2 6 *
1 6 .0 9 + 4 .2 8
1 . 9 6 + 0 .0 7
2 . 7 6 + 0 . 3 5
l . l l + 0 . 0 5 t
2 . 6 6 + 0 . 6 4
A l d r i n  e p o x i d a s e
( n m o le s  d i e l d r i n / m i n / m g  p r o t e i n )  
( n m o le s  d i e l d r i n / m i n / n m o l e  P - 4 5 0 )
0 . 6 1 + 0 . 1 5
3 . 6 3 + 0 .9 9
2 . 6 5 + 0 . 4 8 t
7 .4 9 + 1 .7 2 *
1 .5 6 + 0 .5 6
2 . 2 4 + 0 . 9 9
0 .9 2 + 0 .2 1
2 . 1 4 + 0 .3 3
7 - E t h o x y c o u m a r i n - O - d e e t h y l a s e
( n m o le s  7-O H  c o u n a r i n / m i n / m g  p r o t e i n )  
( n m o le s  7-O H  c o u n a r i n / m i n / n m o l e  P - 4 5 0 )
3 . 8 9 + 0 .4 5
2 3 .1 9 + 2 . 2 7
7 . 6 8 + 0 . 9 9 t
2 1 .6 2 + 3 .4 2
3 .9 9 + 0 . 1 8
5 . 6 4 + 0 . 7 6
2 . 3 9 + 0 . 1 2 t
5 .7 0 + 1 .3 7
7 - E t h o x y r e s o r u f i n - O - d e e t h y l a s e
( p m o le s  r e s o r u f i n / m i n / m g  p r o t e i n )  
( p m o le s  r e s o r u f i n / m i n / n m o l e  P - 4 5 0 )
8+1
4 9 + 1 4
1 2 3 + 1 8 t  
3 4 4 + 5  I t
2 7 9 + 1 0 2
4 0 1 + 1 8 1
8 9 + 6
2 1 0 + 3 1
A r y l  h y d r o c a r b o n  h y d r o x y l a s e
( p m o le  3-O H  b e n z o (  ) p y r e n e / m i n / m g  p r o t e i n  
( p m o le  3-O H  b e n z o (  ) p y r e n e / m i n / n m o l e  P - 4 5 0 )
1 7 5 + 4 8
1 0 2 4 + 7 0
4 2 3 + 1 7 t  
1 1 8 7 + 6 0 *
2 1 4 + 4 0
3 0 5 + 8 0
12 8+ 8
3 0 8 + 8 6
D a ta  a r e  e x p r e s s e d  a s  g r o u p  m e a n s  ( +  S E N ) , n 
t P O .O l )
= 3 .  S i g n i f i c a n t l y  d i f f e r e n t  ( S t u d e n t ' s  t  t e s t )  f r o m  c o n t r o l  d a t a  ( * P < 0 .0 5 ,
ONo
I
hydroxylase, and ethoxycoumarin O-deethylase activities 
developed in the treated rats. Statistically insignificant 
decreases in aldrin epoxidase, arylhydrocarbon hydroxylase, 
and ethoxyresorufin O-deethylase were observed in treated 
rats.
More specific changes in enzyme activities were evident for 
activities expressed as the turnover number for the 
cytochrome(s) P-450 (units per nmole of P-450). Only 
arylhydrocarbon hydroxylase, aldrin epoxidase, and 
ethoxyresorufin O-deethylase activities were increased in the 
treated chickens approximately l.2-fold, two-fold, and seven­
fold, respectively. Significant decreases in enzyme 
activities were not detected in rats.
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DISCUSSION:
This study indicates that extracts of Sesbania drurnnondii 
markedly affect the hepatic microsomal monooxygenase systems 
of chickens and rats. In White Leghorn chickens, S. 
drummondii treatment resulted in induction of the hepatic 
microsomal monooxygenase system. This finding was shown by 
the increases in cytochrome P-450 content, NADPH-cytochrome c 
reductase activity, and the activities of six cytochrome P-450 
mediated enzyme activities.
The consequence of induction of the cytochrome P-450 
monooxygenase system in the chicken by Sesbania drummondii on 
the outcome of chemical biotransformation of both endogenous 
and exogenous substrates is related to the changes induced in 
the relative proportions of the various cytochrome P-450 
isozyme families. Individual cytochrome P-450 isozymes 
exhibit variable substrate and reaction specificity. 
Therefore, changes in the proportions of various forms of 
cytochrome P-450 isozymes may determine which reactions 
predominate and whether detoxication or bioactivation will 
result.
Specific changes in the cytochrome P-450 isozymal distribution 
pattern have been related to exposure to particular chemicals. 
Goldstein (1980) described a classification scheme for 
chemical inducers consisting of three types: phenobarbital, 3-
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methylcholanthrene, and mixed. Much work has been performed 
in mammals to characterize the effects of phenobarbital, 3- 
methylcholanthrene, and mixed- types of induction on the 
cytochrome P-450 monooxygenase system and on xenobiotic 
biotransformation. Therefore, it is convenient to compare the 
effects of new chemicals on the components of the cytochrome 
P-450 monooxygenase system with the effects induced by the 
three classical chemical inducers.
The cytochrome P-450 content of chicken hepatic microsomes is 
increased by all three classical chemical inducers. 
Phenobarbital increased the cytochrome P-450 content by 3 to 
4-fold in White Leghorn chickens (Strittmatter and Umberger, 
1969; Powis at al., 1976; Darby et al* # 1985; Lorr and Bloom, 
1987). Inductions of cytochrome P-450 specific content from 3 
to 6-fold have been reported with the 3-methylcholanthrene- 
type inducers; 3-methylcholanthrene, B-naphthoflavone, and 
2,3,7,8 tetrachlorodibenzo-p-dioxin (Buckpitt and Boyd, 1982; 
Ehrich and Larsen, 1983; Sawyer et al*» 1986; Darby et al.. 
1985). Arochlor 1254, a mixed-type of inducer, increased 
cytochrome P-450 specific content 6-fold in White Leghorn 
chicks (Rinzky and Perry, 1983). Additionally, a number of 
other compounds (non-classical) have been reported to increase 
chicken cytochrome P-450 content. Variable increases (2 to 4- 
fold) were reported with prochloraz (Riviere at al*» 1985),
S,S,S-tri-jj-butyl phosphorotrithioate (Lapadula et al*, 1984),
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2-acetylaminofluorene (Darby al., 1985) and DDT (Sell 
al.# 1971).
Sesbania drymmondij treatment of White Leghorn chickens 
increased cytochrome P-450 specific content by 2-fold. The 
magnitude of this increase was lower than reported with 
phenobarbital, 3-methylcholanthrene, and mixed induction of 
chickens. By comparison, similar (2-fold) increases were 
observed with treatment of non-classical inducers.
Increased NADPH-cytochroroe c reductase activity in mammals is 
associated with phenobarbita1-type of induction (Snyder and 
Remmer, 1979). In chickens, slight to moderate increases in 
NADPH-cytochrome c reductase activity have been observed with 
phenobarbital, mixed, and non-classical inducers. Pilch and 
Combs (1981) reported a moderate increase (approx. 2-fold) in 
reductase activity in 12-day old cockerels given phenobarbital 
and fed diets supplemented with vitamin E and selenium. This 
increase was less pronounced without vitamin E and selenium 
supplements in male chicks and in female chicks with or 
without the supplements. Arochlor 1254 slightly elevated 
(1.5-fold) NADPH-cytochrome c reductase activity in White 
Leghorn chickens (Rinzky and Perry, 1983). Sonali pearl 
chicks treated with caffeine for 5 days also had slight 
increases (l.5-fold) in NADPH-cytochrome c reductase activity 
(Govindwar e£ al., 1984). No change in NADPH-cytochrome c
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reductase activity were reported with 3-methylcholanthrene 
(Buynitzky gt al*, 1978), phenolic compounds (Klasing et al.. 
1985), estradiol implants (Takahashi and Jensen, 1984) or 
dietary changes (Brenes a£ al*» 1985).
The effect of Sesbania drummondii treatment on NADPH- 
cytochrome c reductase activity resembled the increases 
observed with phenobarbital, Arochlor 1254, and caffeine. 
However, the magnitude of the increase (nearly 2.5-fold) was 
greatest with Sesbania drummondii. It is interesting to note 
that in Sprague-Dawley rats a similar increase (2.8-fold) in 
NADPH-cytochrome c reductase activity was reported with 
pregnenolone-16a-carbonitrile (Gorski et al., 1985).
Changes in cytochrome P-450-mediated enzyme activities in the 
chicken are dependent on the chemical inducer as well as the 
specific enzyme activity. Increases in aminopyrine N- 
demethylase activity in chicken hepatic microsomes are 
reported with phenobarbital and mixed-type of inducers. 
Moderate (2-fold) increases in this activity in chickens were 
reported with phenobarbital (Pilch and Combs, 1981; Darby e£ 
al., 1985; Lorr and Bloom, 1987) and polychlorinated biphenyls 
(Rinzky and Perry, 1983; Cecil at al* * 1978; Rifkind al.. 
1984).
Aldrin epoxidase activity of chicken hepatic microsomes was
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increased 4-fold with Arochlor (Rinzky and Perry, 1983) and
2.5-fold with prochloraz (Riviere at al* # 1985), but was
decreased 2-fold with 2,3,7,8-tetrachlorodibenzo-p-dioxin 
(Sawyer at al* , 1986). To the best of our knowledge, the 
effect of phenobarbital induction on aldrin epoxidase activity 
in chickens has not been reported.
Aniline hydroxylase activity was increased in chickens treated 
with phenobarbital, 3-methylcholanthrene, mixed, and other 
chemical inducers. Aniline hydroxylase activities increased 
2-fold with phenobarbital (Pilch and Combs, 1981), 3-
methylcholanthrene (Buynitzky at al* , 1978) and Arochlor
(Cecil at al* , 1978) . Larger increases of 4-fold were induced 
by prochloraz (Riviere at al* * 1985) and S,S,S-tri-ja-butyl 
phosphorotrithioate (Lapadula et al*, 1984).
The effect of the classical chemical inducers on 
ethoxycoumarin O-deethylase activity in chickens has been 
limited to the mixed-type. A 2-fold increase in activity was 
reported in chicken embryo livers with 4 polychlorinated 
biphenyl congeners (Rifkind at al*» 1984). No change in
ethyoxycoumarin O-deethylase activity was observed with 
phenobarbital-type (Rifkind at al* # 1982) or 3-
methylcholanthrene-type (Darby at al* , 1986) inducers in
chickens.
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Induction of ethoxyresorufin o-deethylase in chickens has been 
reported with 3-methylcholanthrene, mixed, and non-classical 
chemical inducers. Marked increases of 40-fold with 2,3,7,8- 
tetrachlorodibenzo-p-dioxin (Sawyer e£ al., 1986) and 50-fold 
with polychlorinated biphenyl congeners (Rifkind e£ al* • 1984) 
were observed in ethoxyresorufin O-deethylase activity. A 
much smaller increase of 3-fold was detected with prochloraz 
treatment of chickens (Riviere et al., 1985).
Arylhydrocarbon hydroxylase activity was induced in chickens 
treated with all 3 classical and other non-classical inducers. 
Darby et al* (1985) reported small increases of 1.5-fold with 
phenobarbital and 2-fold with 2-acetylaminofluorene in chicken 
hepatic microsomal arylhydrocarbon hydroxylase activity. 
Larger increases of 8 to 20-fold of arylhydrocarbon 
hydroxylase were reported with treatments of polychlorinated 
biphenyl congeners (Rifkind at al-, 1984) and 3-
methylcholanthrene (Buynitzky at al*» 1978).
The Sesbania dEjy^enail-induced changes in the chicken hepatic 
microsomal cytochrome P-450-mediated enzyme activities did not 
parallel any of the three classical inducers through all six 
of the enzyme activities. With some of the activities, 
Sesbania drummondii treatment resembled phenobarbital 
induction, but with other activities it resembled 3- 
methylcholanthrene or mixed induction. Sesbania drummondii
treatment induced essentially 2-fold increases in aminopyrine 
N-demethylase, aniline hydroxylase, arylhydrocarbon 
hydroxylase, and ethoxycoumarin O-deethylase. Similar 
increases in these activities in chickens were induced with 
phenobarbital and polychlorinated biphenyls. The 4-fold 
induction of aldrin epoxidation with Sesbania drummondii 
treatment was of a similar magnitude as reported with Arochlor 
1254. Sesbania drummondii induced ethoxyresorufin 0- 
deethylase activity as did 2,3,7,8-tetrachlorodibenzo-p-dioxin 
and polychlorinated biphenyls. However, the Sesbania 
drummondii induced increase was 15-fold, much less than the 
40-fold increase with 2,3,7,8-tetrachlorodibenzo-p-dioxin and 
50-fold increase with the polychlorinated biphenyls.
The overall response profile of the hepatic monooxygenase 
system (cytochromes, reductases, enzyme activities) of White 
Leghorn chickens to Sesbania drummondii was somewhat different 
from that reported for the classical inducers. Sesbania 
drummondii is a complex mixture of compounds, and in the 
chicken, may be a new unique type of inducer. However, further 
studies will be necessary to confirm this.
Usually compounds that are inducers of the microsomal 
monooxygenase system in avian species are also inducers of the 
monooxygenase systems in mammals. However, this was not the 
case with Sesbania drummondii. A depression, rather than
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induction, of cytochrome P-450 content and all the activities 
of the hepatic monooxygenase system was observed in microsomes 
from the £. drummondii-treated rat.
Although the specific activities (nmole of product per min per 
mg of microsomal protein) for all the substrates catalyzed by 
microsomes from jJ. drummondi i-treated chickens were higher 
than those for controls, the molar activities (nmoles product 
per min per nmole cytochrome P-450) were essentially the same 
except in the case of aldrin epoxidase and ethoxyresorufin 0- 
deethylase, which were 2-fold and 7-fold higher, respectively, 
with microsomes from the Sesbania drummondii-treated chickens, 
compared with microsomes from control chickens. These data 
suggest induction of at least 1 new isozyme in the chicken 
liver. In rats, S. drummondii appeared to suppress the 
constitutive isozymes and, in the case of ethoxyresorufin 0- 
deethylase induce a novel isozyme of lower activity. More 
rigorous proof remains to be established. At the present time 
it is not known whether the same component in Sesbania 
drummondii produces the effects seen in chickens and rats. 
The mechanisms for monooxygenase induction of chickens and 
depression in rats by £. drummondii are not presently known. 
Whether similar responses will occur in other avian and 
mammalian species will require further study.
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EXPERIMENT 2 - Evaluation of the effects of the bicarbonate- 
azide extraction buffer/vehicle on the hepatic cytochrome P- 
450 monooxygenase systems of chickens and rats.
OBJECTIVES;
1. To compare the effect of treatment with the
bicarbonate-azide extraction buffer/vehicle vs.
no treatment on hepatic microsomal cytochrome P-
450 specific content in chickens and rats.
2. To compare the effect of treatment with
bicarbonate-azide extraction buffer/vehicle vs. no 
treatment on two selected hepatic cytochrome P-450 
mediated enzyme activities: aminopyrine N-
demethylase and ethoxyresorufin O-deethylase.
MATERIALS AND METHODS;
a . shemisais;
The chemicals and biochemicals were as described in detail in 
Experiment l.
b . Animals:
Four male and female 250- to 350-g White Leghorn chickens were 
group housed in a commercial brooder. Six male 300- to 
400-g Sprague Dawley rats were maintained 3 per cage on a 
12-hr light/dark cycle in a temperature (21-24 C) and humidity
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(40—60%) controlled environment. Chickens and rats received 
feed (Purina chick Startena and Purina rat chow) and water ad 
libitum. Both species were acclimated for one week before the 
study began. The chicken experiment was performed with one 
group of 2 treated and 2 control animals. The rat experiment 
was performed with one group of 3 treated and 3 control 
animals.
C. Treatments:
The treated animals received three daily gavages of the sodium 
bicarbonate-sodium azide buffer (BBN) (25mM sodium 
bicarbonate, pH 7.4; 0.02% sodium azide). The control animals 
were not given the extracts. The volume of extract 
administered was calculated by multiplying the body weight of 
the animal and the dose as percentage of body weight. The 
treated chickens received daily doses equal to 0.8% of body 
weights and the treated rats received 0.4% of body weights.
D. Preparation of hepatic microsomes:
Microsomes were prepared from the pooled livers of the group, 
treated or control, as described in detail in Experiment 1.
E. Protein determination:
The concentration of protein in the microsomal suspensions was 
determined as described in detail in Experiment l.
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F. Cytochrome P-450:
The concentration of cytochrome P-450 of the microsomes was 
determined as described in detail in Experiment 1.
G. Hepatic microsomal monooxvcrenaBe activities;
1. Aminopyrine N-demethvlase:
The aminopyrine N-demethylase activity of the microsomal 
suspensions was measured as described in detail in Experiment 
1.
2. Ethoxyresorufin Q-deethvlase:
The O-dealkylation of 7-ethoxyresorufin was measured as 
previously described in detail in Experiment 1.
RESULTS;
The cytochrome P-450 content and hepatic microsomal 
monooxygenase activities of chickens and rats treated with the 
bicarbonate-azide buffer vs. those animals not treated with 
the buffer were essentially the same (Table 4). BBN treated- 
chickens had only slightly higher cytochrome P-450 content and 
ethoxyresorufin O-deethylase activity and slightly lower 
aminopyrine N-demethylase activity than the untreated 
controls. The BBN-treated rats showed slightly lower 
cytochrome P-450 content but virtually identical aminopyrine 
N-demethylase and ethoxyresorufin O-deethylase activities to 
the control rats.
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Table 4: The effect of bicarbonate-azide buffer (BBN) vehicle on
cytochrome P-450 content and hepatic microsomal 
monooxygenase activities in chickens and rats
Chickens Rats
Control BBN Control BBN
Cytochrome P-450 0.19 
(nmole/mg protein)
0.21 0.61 0.55
Aminopyrine N-demethylase 1.33 
(nmoles HCHO/min 
/mg protein)
1.19 1.40 1.41
Ethoxyresorufin 0-
deethylase 47 
(pmoles resorufin/min/ 
mg protein)
61 201 199
Values are the mean of duplicate analyses per group.
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DISCUSSION:
Azide is a known potent inhibitor of heme-iron containing 
enzymes such as catalase, peroxidase, and cytochrome oxidase 
(Keilin, 1936-1937; Smith e£ al., 1977; Winston and Cederbaum, 
1982). Therefore, it was of interest to determine whether the 
oral intake of azide with bicarbonate buffer altered the 
hepatic microsomal cytochrome P-450 monooxygenase system. 
Results of this study indicate that the bicarbonate-azide 
buffer when administered orally does not induce changes in the 
cytochrome P-450 monooxygenase system of chickens and rats. 
This finding was likely due to the relatively small amount of 
azide administered to our experimental animals. Our chickens 
and rats received approximately 5 mL per day of a 0.02% 
solution of sodium azide which was equivalent to a dosage of 
1 mg of sodium azide per day or 3 mg of sodium azide per kg of 
body weight. In comparison, the acute lethal dosage of oral 
sodium azide in the rat is 27 mg per kg of body weight 
(Gosselin al., 1984). This study was performed to support 
the results of Experiment 1 in which treated animals were 
gavaged with a solution consisting of an extract of S. 
drummondii in the BBN buffer and the control animals did not 
receive the extract nor the buffer. This also supports the 
use of BBN buffer in our studies of £5*. drummondii-induced 
effects in chickens and rats. Subsequent experiments utilized 
control animals treated with the BBN buffer rather than 
nontreated controls.
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EXPERIMENT 3 - Comparison of the effects of an extract of 
Sesbania drummondii on the hepatic cytochrome P-450 
monooxygenase systems of male versus female rats.
OBJECTIVES:
1. To determine if the Sj_ drummondii-induced effects 
on the hepatic cytochrome P-450 monooxygenase
system in rats is altered by the sex of the animal.
MATERIALS AND METHODS:
A. Chemicals:
The chemicals and biochemicals were as described in detail in 
Experiment l.
B. Animals:
Eight adult male (300-400 g) and eight adult female (250- 
300 g) Sprague-Dawley rats were housed in groups of 4 in wire 
mesh bottom cages. Food and water were available £d libitum.
The room where the rats were kept was environmentally
controlled at 21-24 C with a 12 hr light/dark cycle. The rats 
were acclimated for 7 days prior to their random assignment to 
control and treatment groups. The study was performed with 
2 groups of 4 animals, 2 treated and 2 control in each group, 
for both male and female rats.
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c. Treatment?:
Extracts of Sj. drummondii were prepared as described in detail 
in Experiment 1. The treated groups were weighed daily for 3 
consecutive days and then gavaged with the extract of s.  
drummondii. Control groups were also weighed daily for 3 days 
and were given equivalent volumes of the BBN extraction buffer 
(without Si. drummondii). The volume of extract given was 
calculated by multiplying the body weight of the rat, the dose 
as percentage of body weight, and the concentration of the 
extract. Treated and control rats received daily doses equal 
to 0.5% of body weight.
0. Preparation of hepatic microsomes;
Microsomes were prepared from the pooled livers of the group, 
treated or control, as described in detail in Experiment 1.
E. Protein determination;
The concentration of microsomal protein was determined as 
described in detail in Experiment 1.
F. Cytochrome P-450:
The cytochrome P-450 content of the microsomal suspensions was 
measured as described in detail in Experiment 1.
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RESULTS:
The cytochrome P-450 content of drummondii-treated male and 
female rats is shown in Table 5. Decreases in the cytochrome 
P-450 content were observed in the microsomes of both S. 
drummondii-treated male and female rats. The magnitude of 
reduction in the cytochrome P-450 content was slightly greater 
in the treated-male rats than the treated-female rats. Male 
S. drummondii-treated rats had an approximate 40% reduction 
whereas the treated females had an approximately 30% reduction 
in cytochrome P-450 content. Control female rats were also 
noted to have lower cytochrome P-450 contents than their male 
counterparts.
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Table 5: Cytochrome P-450 content of Sesbania <iniimnnrt< < -traatad
male and female rats
Sex
Cytochrome P-450* 
Control Treated
Hale
Female
0.96 0.56 
0.75 0.53
* Cytochrome P-450 expressed as nmole cytochrome p-450/mg 
protein. Values are the means, n ■ 2.
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BISQISSIQS:
Sex-related differences in the hepatic biotransformation of 
xenobiotics are well established in the rat (Conney, 1967; 
Kato, 1974; Gustafsson and Stenberg, 1974). These differences 
result in variable pharmacologic and toxicologic responses to 
a number of xenobiotics. In general, male rats exhibit higher 
rates of metabolic conversion of a number of substrates 
including hexobarbital, aminopyrine and ethylmorphine than do 
females (Conney, 1967; Kato, 1974; Gustafsson and Stenberg, 
1974). As a result, xenobiotics may be more rapidly 
detoxicated or bioactivated in the male rat. An example of 
clinical toxicosis related to the capability of male rats to 
convert chemicals to reactive intermediates faster than 
females is observed with carbon tetrachloride. Male rats are 
more susceptible to liver injury produced by carbon 
tetrachloride than are females (Sipes and Gandolfi, 1986).
Some of the sex-related variances in xenobiotic 
biotransformation are due to differences in their hepatic 
cytochrome P-450 monooxygenase systems. Differences between 
male and female rats have been observed in cytochrome P-450 
specific content, NADPH-cytochrome P-450 reductase, and 
cytochrome P-450-mediated activities (Sipes & Gandolfi, 1986; 
Chengelis, 1988). In general, male rat hepatic microsomes 
contain 20 to 30% more of the above components. Our results 
concur with this finding. We observed control male Sprague-
8 0
Dawley rats to have 22% higher cytochrome P-450 content than 
their female counterparts.
Sex-related variances in xenobiotic biotransformation by the 
hepatic cytochrome P-450 monooxygenase system reflect 
differences in the profile of cytochrome P-450 isozymes in the 
liver microsomes (Sipes and Gandolfi, 1986). cytochrome P-450 
forms specific for both male (P-450h) and female (P-450i) rats 
have been identified (Sipes and Gandolfi, 1986). The balance 
between male and female sex hormones contribute to the 
relative properties of the cytochrome P-450 isozyme forms 
(Sipes and Gandolfi, 1986). Expression of cytochrome P-450h 
is dependent on testosterone and subject to neonatal 
imprinting by androgens which may be mediated through the 
male-specific pattern of growth hormone release (Ryan and 
Levin, 1990). Female rats do not have detectable amounts of 
cytochrome P-450h, even after removal of the ovaries, unless 
testosterone was administered in conjunction with ovariectomy 
(Waxman et al., 1985). However, a recent report questions the 
role of androgens. Bitar and Shapiro (1987) recently found 
that androgenic regulation of the hepatic monooxygenase system 
occurs only at suprapharmacologic levels and that females were 
in fact unresponsive to physiological levels of testosterone.
Not all animal species have demonstrated sex-related 
differences in hepatic biotransformation. Despite the large
8 1
sex variations observed in rats and certain strains of mice, 
these variations are uncommon in other species (Sipes and 
Gandolfi, 1986). Male and female birds of the same species 
are seldom very different (Ronis and Walker, 1989).
The ^  drummondii-induced depression of cytochrome P-450 in 
adult rats was not altered by the sex of the animal. A 
reduction of cytochrome P-450 content was observed in both 
male and female rats. From this limited study, it appears that 
the male is slightly more sensitive to drummondii- i n d u c e d  
depression than the female. However, additional experiments 
utilizing more groups of animals are required before 
statements of significance may be made.
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EXPERIMENT 4 - Evaluation of the effects of an extract of 
Sesbania drummondii on microsomal membrane stability.
OBJECTIVES;
1. To determine if the Sesbania drummondii-induced 
effects on the hepatic cytochrome P-450 
monooxygenase system are the result of changes in 
microsomal membrane stability as measured by 
glucose-6-phosphatase activity.
MATERIALS AND METHODS:
A. Chemicals:
The ammonium salt of molybdic acid, disodium salt of EDTA, the 
Fiske and Subbarow reducer (l-amino-2-naphthol-4-sulfonic 
acid, 0.8%, sodium sulfite and sodium bisulfite), monosodium 
salt of D-glucose-6-phosphate and L-histidine were obtained 
from Sigma Chemical Co. (St. Louis, MO). Dibasic sodium 
phosphate and trichloroacetic acid were purchased from 
Mallinckrodt, Inc. (Paris, KY). These chemicals and 
biochemicals were of analytical grade or better.
b . Animals:
One day-old White Leghorn chickens were obtained from the 
Department of Veterinary Science, Louisiana State University, 
Baton Rouge, LA. At 4 weeks of age, the birds were sexed and
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the male chickens were separated for use in experimental 
studies. Fifty-four of the male chickens (200-400 g) were 
group housed , 18 per cage, in commercial brooders. Twenty- 
four male Sprague-Dawley rats (300-500 g) were obtained from 
Hilltop Labs, Inc. (Scottsdale, PA). The rats were maintained 
2 per cage in stainless steel wire mesh cages in a temperature 
(21-24 C) and humidity (40-60%) controlled room. Feed (Purina 
chick Startena and Purina rat chow) and water were freely 
available to the animals at all times. The chickens were 
randomly placed into 1 control and 2 treatment groups. Each 
group consisted of 6 subgroups containing 3 birds each. The 
rats were randomly assigned into one of 2 groups, control or 
treatment. Each rat group contained 6 subgroups consisting of 
2 rats in each.
C. Treatment:
Extracts from the 1988 £j_ drummondii crop were prepared as 
described in detail in Experiment l. The animals were weighed 
and then gavaged with the Sj_ drummondii extract, if assigned 
to a treatment group, or with the bicarbonate-azide buffer 
(BBN), if assigned as a control, for three consecutive days. 
The volume of extract administered was determined by 
multiplying the animal's body weight, the dose as percentage 
of body weight, and the concentration of extract. The treated 
rats received daily doses equal to 0.5% of body weight and the 
treated chickens received 0.5% or 0.75% of body weight.
Control animals received equivalent volumes of BBN. The 
treatment dose (0.5% of body weight) was slightly higher for 
rats and slightly lower for chickens than used in earlier 
studies but was selected so that the two animals would receive 
the same relative dose. Typical clinical signs and necropsy 
changes were observed with the 0.5% dose in rats but not in 
chickens. These treated chickens did not appear as 
clinically-affected as had been observed at higher doses but 
typical changes at necropsy were still apparent. To insure 
that maximal drummondii induced effects would be studied, 
a higher dose (0.75% of body weight) was chosen as a second 
treatment group in chickens.
D. Preparation of hepatic microsomes:
Microsomes were prepared from pooled livers of the subgroups, 
treated or control, as described in detail in Experiment 1.
E. Protein determination:
The protein concentration of the microsomes was determined as 
described in detail in Experiment 1.
F. Cytochrome P-450:
The cytochrome P-450 content of the microsomes was measured as 
described in detail in Experiment 1.
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G. Glucose-6-phosphatase:
Glucose-6-phosphatase was measured by determining the rate of 
release of inorganic phosphate from glucose-6-phosphate as 
described by Fiske and Subbarow (1925) and modified by Aronson 
and Touster (1974). The glucose-6-phosphatase reagent assay 
mixture was prepared by combining solutions of sodium- 
glucose-6-phosphate (0.1 M, pH 6.5), L-histidine (35mM, pH 
6.5), sodium-EDTA (10 mM, pH 7.0) and water in a volume ratio 
of 2:5:1:1, respectively. The reagent assay mixture was 
stored frozen to inhibit bacterial growth and thawed to room 
temperature before use. Microsome suspensions were diluted in 
0.125 M KCL to a concentration of approximately 0.20 mg per mL 
in the dilutions. Glass test tubes were prepared on ice for 
control, standard, or sample solutions. Three control tubes 
were utilized in this assay; they contained water, microsomal 
protein only, or 0.45 mL of the reagent assay mixture. A 
standard solution contained 0.5 n m o l e of sodium phosphate. 
The standard was demonstrated to be linear in this assay from 
0.50 to 2.0 jLtmole of sodium phosphate (Appendix 8). Triply 
distilled water was added to the blank and standard tubes to 
equal a final volume of 0.5 mL in each tube. The reagent 
assay mixture (0.45 mL) was transferred to the sample test 
tubes. All test tubes were preincubated for 5 min in a 37 C 
shaking water bath. After preincubation, the reactions were 
started by adding 0.05 mL of diluted microsomes to the sample 
test tubes and the microsome blank. The reactants, controls.
and standards were then incubated for 20 min in a shaking 
water bath. The reactions were stopped by plunging the test 
tubes into ice and adding 2.5 mL of 8% TCA. The acidified 
samples were centrifuged for 5 min at 3000 g and 5 C to 
precipitate the protein. Aliquots of the supernatant 
solutions (2.0 mL) were removed from each test tube and added 
to clean 18 x 150 millimeter glass test tubes containing 2.3 
mL of water. A solution of ammonium molybdate (0.5 mL of 2.5% 
w/v in 5 N sulfuric acid) was added to the diluted aliquots. 
The solutions were mixed, and 0.2 mL of Fiske and Subbarow 
reducer reagent was added. The solutions were again mixed, 
and after exactly 10 min the optical density of the solutions 
was read at 660 nm on a spectrophotometer. The glucose-6- 
phosphatase activity was expressed as the rate of release of 
inorganic phosphate in f m o l e s  per min per mg of microsomal 
protein or per nmole of cytochrome P-450. The glucose-6- 
phosphatase assay was found to be linear with time (15-30 min) 
and with protein concentration (0.10-0.20 mg/mL) in control 
microsomes from both chickens and rats (Appendix 9-10).
H. Statistical Analysis:
The significance of difference between control and treated 
groups was determined using an unpaired Student's £-test. The 
acceptable level of significance for this study was 
established at p < 0.05.
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RESULTS:
The glucose-6-phosphatase activities in hepatic microsomes of 
chickens and rats treated with Sesbania drummondii are given 
in Table 6. No differences in the glucose-6-phosphatase 
activity were observed with Sesbania drummondii treatment at
0.5% of body weight in either the chicken or rat. Sesbania 
drummondii administered at a higher dosage to chickens (0.75% 
body weight) also did not significantly alter the glucose-6- 
phosphate activity. One interesting observation in this study 
was that control chicken hepatic microsomes had higher 
glucose-6-phosphate activity than control rat hepatic 
microsomes.
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Table 6: Glucose-6-phosphatase activity of Sesbania drummondli-
treated chickens and rats
Treatment group ymoles Phosphate/min/mg protein
Chickens
Control (0.5% BW) 
Sssbonia (0.5% b w ) 
Sesbania f0.75% BW)
0.44
0.37
0.47
+
+
+
0.03
0.04
0.08
Rats
Control (0.5% BW) 
Sesbania (0.5% BW)
1
0.31
0.29
+
±
0.04
0.04
Data are expressed as group means ± SEM, n = 6. Values were 
not significantly different (P < 0.01) from control values.
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DISCUSSION:
Hepatic microsomal glucose-6-phosphatase is located mainly in 
the endoplasmic reticulum where it catalyzes the terminal 
stages of both gluconeogenesis and glycogenolysis (Gierow and 
Jergil, 1982; Burchell e£ al., 1988). The reaction catalyzed 
by this enzyme is illustrated by the following equation 
(Gierow and Jergil, 1982):
glucose-6-phosphate + H20 ------- ^  glucose + PO^
Because of its location, glucose-6-phosphatase is commonly 
used as a marker enzyme for the endoplasmic reticulum. Since 
the microsomal cytochrome P-450 monooxygenase system is also 
located in the endoplasmic reticulum, measures of glucose-6- 
phosphatase activity may be useful in determining the 
condition of other endoplasmic reticulum-associated enzymes 
such as the monooxygenase system. Our earlier studies in the 
rat indicated that £. drummondi i-treatment results in a 
depression of the cytochrome P-450 monooxygenase system. This 
was shown by decreases in the cytochrome P-450 content and in 
several cytochrome P-450 mediated enzyme activities. The fact 
that the glucose-6-phosphatase activity was not altered 
suggests that the decrease in mixed function monooxygenase 
activity following £. drummondii-treatment probably was not 
related to loss of integrity of the microsomal membrane, e.g., 
via lipid peroxidation.
The significance of higher glucose-6-phosphatase activity in 
control chicken hepatic microsomes than control rat hepatic 
microsomes is not known. Perhaps this might relate to the 
fact that chickens maintain higher blood glucose levels than 
mammals and therefore require higher levels of this important 
gluconeogenic enzyme.
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B. PHASE II - CHARACTERIZATION OF SESBANIA DRUMMONDII
EFFECTS ON THE CATALYTIC PROPERTIES OF THE HEPATIC 
CYTOCHROME P-450 MONOOXYGENASE SYSTEMS. COMPARISON WITH 
EFFECTS CAUSED BY_EHENPBARBITAL AND B-NAPHTHOFLAVONE,
OBJECTIVES:
1. To compare the effects of Sesbania drummondii. 
phenobarbital, and B-naphthoflavone on chicken and 
rat hepatic microsomal metabolism of aminopyrine.
2. To compare the effects of Sesbania drummondii. 
phenobarbital, and B-naphthoflavone on chicken and 
rat hepatic microsomal metabolism of aldrin.
3. To compare the effects of Sesbania drummondii. 
phenobarbital, and B-naphthoflavone on chicken and 
rat hepatic microsomal metabolism of the 
alkoxyphenoxazones: methoxyphenoxazone, 
ethoxyphenoxazone, pentoxyphenoxazone, and . 
benzyloxyphenoxazone.
MATERIALS AND METHODS:
A. Chemicals:
4-Aminophenol (99% pure) and B-naphthoflavone (5,6- 
benzoflavone, 90-95% pure) were obtained from Sigma Chemical 
Co. (St. Louis, MO). Aldrin (99% pure) and dieldrin (98% 
pure) were obtained from Alltech Associates, Inc. (Deerfield, 
IL) . t-Chlordane (99% pure) was obtained from the EPA
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(Research Triangle Park, NC) . Methoxyphenoxazone,
e t h o x y p h e n o x a z o n e , p e n t o x y p h e n o x a z o n e  , a n d  
benzyloxyphenoxazone (all 99% pure) were purchased from 
Molecular Probes, Inc. (Junction City, OR). Resorufin (75% 
dye content) was obtained from Aldrich Chemical Co. 
(Milwaukee, WI). Phenobarbital, sodium injection (65 mg/mL) 
was obtained from Elkins-Sinn, Inc. (Cherry Hill, NJ) . All 
other chemicals and biochemicals were of research grade or 
better and were obtained from various commercial sources.
B. Animals;
One day-old White Leghorn chickens were obtained from the 
Department of Veterinary Science, Louisiana State University, 
Baton Rouge, LA. At 4 weeks of age, the male birds were 
separated from the females and used in experimental studies. 
Ninety of the male chickens (200-400 g) were group housed, 18 
per cage, in commercial brooders. The chickens were randomly 
placed into one of 5 groups, l control and 4 treatments. Each 
group of 18 birds consisted of 6 subgroups containing 3 
chickens each.
Forty-eight male Sprague-Dawley rats (300-500 g) were 
purchased from Hilltop Labs, Inc. (Scottsdale, PA). The rats 
were maintained 2 per cage in stainless steel wire mesh cages 
in a temperature (21-24 C) and humidity (40-60%) controlled 
room. Feed (Purina chick Startena and Purina rat chow) and
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water were available ag libitum. The rats were randomly 
assigned into one of 4 groups, l control and 3 treatments. 
Each rat group of 12 contained 6 subgroups consisting of 2 
rats each.
C. Treatment:
Extracts from the 1988 S. drummondii crop were prepared as 
described in detail in Experiment l, Phase I. A suspension of 
B-naphthof lavone (50 mg/mL) was prepared by adding 20 mL of 
corn oil to 1000 mg of B-naphthoflavone. For 3 days, animals 
were weighed and then treated with either bicarbonate-azide 
buffer (BBN), £. drummondii extract, phenobarbital, or B- 
naphthoflavone. BBN and S. drummondii extract were 
administered by gavage. The volume of extract given was 
determined by multiplying the animal's body weight times the 
dose as percentage of body weight divided by concentration of 
the extract. Similar volumes of BBN alone were given to the 
control animals. The S. drummondii-treated rats received 
daily doses equal to 0.5% of body weight and the chickens 
received 0.5% or 0.75% of body weight. The treatment dose of
0.5% of body weight was slightly higher for rats and slightly 
lower for chickens than was used in some of the earlier 
studies, but was selected so that the two animals would 
receive the same relative dose. Typical clinical signs and 
necropsy changes were observed with the 0.5% dose in rats but 
not chickens. The chickens receiving the 0.5% dose of extract
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did not appear as clinically ill as had been observed before, 
even though typical changes were observed on postmortem 
examination. In order to insure that maximal £. drummondii- 
induced effects would be studied, a higher dose (0.75% of body 
weight) was chosen as an additional treatment group in the 
chicken.
Phenobarbital was injected through the abdominal musculature 
of the lower left abdominal quadrant into the peritoneal 
cavity using a sterile 22 gauge needle. The volume of 
phenobarbital given was equal to a dosage rate of 60 mg of 
phenobarbital per kg of body weight. fi-Naphthoflavone was
also given by injection into the peritoneal cavity but at a 
dosage rate of 50 mg of B-naphthof lavone per kg of body weight 
and through an eighteen gauge needle.
D. Preparation of hepatic microsomes;
Microsomes were prepared from pooled livers of the subgroups, 
treated or control, as described in detail in Experiment l. 
Phase I.
E. Protein determination:
The concentration of protein of the microsomes was determined 
as described in detail in Experiment 1, Phase I.
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F. Cytochrome P-450:
The cytochrome P-450 content of the microsomes was measured as 
described in detail in Experiment l, Phase I.
G. Hepatic microsomal monooxvqenase activities:
1. Aminopvrine N-demethvlase:
The microsomal-mediated metabolism of aminopyrine was measured 
by analysis of the formation of formaldehyde as shown in 
Figure 3. Optimal assay conditions with respect to incubation 
time, concentration of microsomal protein, and substrate 
concentration were empirically determined for control chicken 
and rat hepatic microsomes (Appendices 11-12). These 
conditions (Table 7) were utilized in determining the 
aminopyrine N-demethylase activities of the control, S. 
drummondii-. phenobarbital-, and the B-naphthoflavone-treated 
animals. The components of the reaction mixture were the same 
as described in detail in Experiment 1, Phase I. However in 
these assays, the reactions were stopped by the addition of 1 
mL of 20% rather than 70% trichloroacetic acid.
2. Aldrin qpoxiflas.e:
The microsomal-mediated metabolism of aldrin was determined by 
analysis of the formation of dieldrin (Figure 4) . Optimal 
assay conditions with respect to incubation time, microsomal 
protein concentration, and substrate concentration were 
empirically determined for control chicken and rat hepatic
P-450
\
Aminopyrine
H— N
formaldehyde
4-methylaminoantipyrIne
Figure 3. The cytochrome P-450 monooxygenase-catalyzed 
N-demethylation of aminopyrine.
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Table 7: Optimized conditions for the assay of aminopyrine N-
demethylase activity in hepatic microsomes from control
chickens and rats
Condition Chicken Rat
Time (min) 15 15
Protein concentration 
(mg/mL) 0.5 0.5
Substrate concentration 
(mM) 10.0 10.0
All assays were performed at 37°C. The assays were 
conducted in duplicate using a single control chicken or 
rat hepatic microsomal preparation over a range of 5 - 6 
protein concentrations, 5 incubation times, and 6 
aminopyrine substrate concentrations. The protein 
concentration and incubation times yielded maximal 
product formation in the linear range (see Appendices 11- 
12) .
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Table 8: Optimized conditions for the assay of aldrin epoxidase
activity in hepatic microsomes from control chickens and 
rats
Condition Chicken Rat
Time (min) 15 15
Protein concentration 
(mg/mL) 0.2 0.2
Substrate concentration 
(MM) 50.0 50.0
All assays were performed at 37°c. The assays were conducted 
in duplicate using a single control chicken or rat hepatic 
microsomal preparation over a range of 4 - 5 protein
concentrations, 5 - 6  incubation times, and 6 aldrin substrate 
concentrations. The protein concentrations and incubation 
times yielded maximal product formation in the linear range 
(see Appendices 13-14).
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microsomes (Appendices 13-14). These conditions (Table 8) 
were utilized in determining the aldrin epoxidase activities 
of control, £. drummondii-. phenobarbital-, and B- 
naphthoflavone-treated animals. The components of the 
reaction mixture and the quantitation of dieldrin were as 
described in detail in Experiment l, Phase I. However, two 
modifications to the extraction procedure were made in the 
assay. First, the extraction solution was changed from hexane 
to 2,2,4—trimethylpentane to reduce the possibility of solvent 
evaporation. The second modification was the addition of an 
internal standard, t-chlordane (0.2 ppm), to the 2,2,4- 
trimethylpentane extraction solution to minimize instrument 
error due to the injection of unequal sample aliquots.
3. Alkoxvphenoxazone Q-dealRlvlase:
The 0-dealkylations of methoxy-, ethoxy-, pentoxy-, and 
benzyloxyphenoxazone were measured by the fluorometric methods 
of Burke and Mayer (1983) and that of Burke al. (1985). 
These reactions are described in Figure 5. Microsome 
dilutions were prepared in 0.125 M KCL. Stock solutions (ImM) 
of the alkoxyphenoxazone substrates were placed into 
dimethylsulfoxide (water was removed over 3A molecular sieves) 
and sonicated in glass reagent vials. A stream of nitrogen 
gas was passed over the solutions, the vials were capped, 
covered with aluminum foil, and stored frozen (0 C). Stock 
solutions were thawed to room temperature on the day of an
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P-450
H 0
R - H phenoxazone
R - OH hydroxyphenoxazone (Resorufin)
R ■ CH30 methoxyphenoxazone (MPOD)
R - C2H50 ethoxyphenoxazone (EPOD)
R - C5H110 pentoxyphenoxazone {PPOD)
R - C6H5CH20 benzyloxyphenoxazone (BPOD)
Figure S. Cytochrome P-450 monooxygenaee-medieted O-deelkylation of 
the aiJtoxyphenoxazonea.
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assay and then refrozen. Optimal assay conditions (for each 
of the alkoxyphenoxazone O-dealkylations) with respect to 
incubation time and concentration of microsomal protein were 
determined in control, S. drummondii-. phenobarbital-, and 5- 
naphthoflavone-treated chicken and rat hepatic microsomes in 
order to insure that the reactions were conducted under 
conditions of protein and time linearity (Appendices 15-22). 
These conditions are summarized in Tables 9-12. The reaction 
mixtures contained microsomal protein, 5 /iM substrate (10 f th  
of lmM stock solution), 0.1 M potassium phosphate buffer (pH 
7.6), and 250 /iM NADPH in a total volume of 2 mL. A cuvette 
containing the mixture was placed into the sample compartment 
of an Aminco-Bowman spectrophotofluorometer (Travenol
Laboratories, Inc., Deerfield, IL). The compartment was kept 
warm (37 C) with a circulating temperature bath. The cuvettes 
were preincubated for 2 min, the reactions started with NADPH, 
and the mixtures incubated for another 2 min to assure that 
maximal linear velocities were obtained. The reaction was then 
followed for an additional l to 4 min depending on the rate of 
resorufin production. Reaction rates were measured directly 
from the increasing fluorescence of the reaction mixture at 
530 nm excitation wavelength and 585 nm emission wavelength. 
The resorufin concentration was quantified by standard 
addition with a 2-20 /iL aliquot of resorufin (25 n K in 
methanol) added to the cuvette after a suitable reaction 
period.
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Table 9: Optimized conditions for the assay of methoxyphenoxazone
O-dealkylase activity in hepatic microsomes from control
chickens and rats
Animal Treatment Time
(min)
Protein cone 
(mg/mL)
Chicken Control 2 0.100
Sesbania 2 0.050
Phenobarbital 2 0.100
fi-naphthof1avone 2 0.050
Rat Control 3 0.100
Sesbania 4 0.100
Phenobarbital 2 0.050
B-naphthoflavone 2 0.050
All assays were performed at 37°C. The assays were 
conducted using a single control or treated chicken or 
rat hepatic microsomal preparation over a range of 2 
protein concentrations and 5 incubation times. The 
protein concentrations and incubation times yielded 
maximal product formation in the linear range (see 
Appendix 15-16).
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Table 10: Optimized conditions for the assay of ethoxyphenoxazone
O-dealkylase activity in hepatic microsomes from control
chickens and rats
Animal Treatment Time
(min)
Protein conc. 
(mg/mL)
Chicken Control 2 0.0250
Sesbania 2 0.0250
Phenobarbital 2 0.0250
B-Naphthoflavone 2 0.0125
Rat Control 2 0.0125
Sesbania 2 0.0250
Phenobarbital 2 0.0125
B-Naphthof1avone 2 0.0125
All assays were performed at 37°C. The assays were 
conducted using a single control or treated chicken or 
rat hepatic microsomal preparation over a range of 2 
protein concentrations and 5 incubation times. The 
protein concentrations and incubation times yielded 
maximal product formation in the linear range (see 
Appendices 17-18).
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Table 11: Optimized conditions for the assay of pentoxyphenoxazone 
O-dealkylase activity in hepatic microsomes from control 
chickens and rats
Animal Treatment Time
(min)
Protein conc. 
(mg/mL)
Chicken Control 3 0.100
Sesbania 3 0.100
Phenobarbital 3 0.200
B-Naphthoflavone 2 0.100
Rat Control 3 0.100
Sesbania 4 0.100
Phenobarbital 1 0.025
B-Naphthoflavone 2 0.050
All assays were performed at 376C. The assays were 
conducted using a single control or treated chicken or 
rat hepatic microsomal preparation over a range of 2 
protein concentrations and 6 - 8  incubation times. The 
protein concentrations and incubation times yielded 
maximal product formation in the linear range (see 
Appendices 19-20).
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Table 12: Optimized conditions for the assay of
benzyloxyphenoxazone O-dealkylase activity in hepatic
microsomes from control chickens and rats
Animal Treatment Time
(min)
Protein cone 
(mg/mL)
Chicken Control 2 0.1000
S.esbania 2 0.1000
Phenobarbital 2 0.0500
B-Naphthoflavone 2 0.0250
Rat Control 2 0.0500
Sesbania 2 0.1000
Phenobarbital 1 0.0125
fi-Naphthoflavone 2 0.0500
All assays were performed at 37°C. The assays were 
conducted using a single control or treated chicken or 
rat hepatic microsomal preparation over a range of 2 
protein concentrations and 4 - 6  incubation times. The 
protein concentrations and incubation times yielded 
maximal product formation in the linear range (see 
Appendices 21-22).
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H. Statistical Analyses:
Statistical analyses of the data were performed using an 
analysis of variance (ANOVA) among the chicken or rat 
experimental groups. This was accomplished by determining the 
mean and standard deviation for each group. Differences among 
the means and standard deviations were tested for significance 
using Scheffe's multiple range test (Snedecor and Cochran, 
1980). These calculations were carried out on an IBM-PC/AT 
computer (IBM, Dallas, TX) using the STATGRAPHICSr program 
(version 2.1) by Statistical Graphics Corp. (Rockville, MD) . 
The acceptable level of significance for this study was 
established at p < 0.05.
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RESULTS:
Thorough characterization of xenobiotic-induced changes on the 
catalytic function of the cytochrome P-450 monooxygenase 
system requires analysis of both the specific activity (in 
terms of mg microsomal protein) and the molar activity or 
turnover number (in terms of nmoles of cytochrome P-450). 
Therefore, before these activities could be determined, it was 
necessary first to determine the protein concentration and the 
cytochrome P-450 content of the control and treated chicken 
and rat hepatic microsomes.
The effect of treatment with Sesbania drummondii. 
phenobarbital, and B-naphthoflavone on the cytochrome P-450 
content of chicken and rat hepatic microsomes is shown in 
Table 13. The Sesbania drummond i i-induced effects on 
cytochrome P-450 content confirm the changes seen in the 
preliminary study (Table 2). Sesbania drummondii treatment 
induced a significant 2-fold increase in chicken and a 2-fold 
decrease in rat cytochrome P-450 content. The magnitude of 
induction of chicken cytochrome P-450 did not appear to be 
improved by increasing the dosage. Chickens treated with the 
higher dosage (0.75% of body weight) had an induction of 
cytochrome P-450 content nearly identical to that of the lower 
treatment dosage (0.5% of body weight).
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Table 13: The effect of Sesbania drummondii. phenobarbital, and
B-naphthoflavone on chicken and rat hepatic cytochrome 
P-450 specific content and absorbance maxima.
Cytochrome P-450
Treatment
Concentration 
(nmoles/mg protein)
A. max 
(nm)
Chicken
Control 0.17 + 0.02* 450.9 + 0.7*
Sesbania (0.5% BW) 0.33 + 0.04b 450.6 ± 0.6*
Sesbania (0.75% BW) 0.32 + 0.04b 450.6 + 0.4*
Phenobarbita1 0.36 + 0.03b 450.6 + 0.3*
6-Naphthoflavone 0.63 + 0. 06c 448.4 ± 0.4b
Rat
Control 0.86 ± 0.11* 449.5 + 0.2
Sesbania (0.5% BW) 0.48 ± 0.04b 449.6 + 0.6*
Phenobarbital 2.14 ± 0.24e 449.1 + 0. 3b
B-Naphthoflavone 1.22 + 0.06b 447.4 + 0. 3C
Values are the mean ± SEM, n = 6.
Means with like superscripts within the same species are not
significantly different (P > 0.05).
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Phenobarbital and B-naphthoflavone treatments resulted in 
significant increases of cytochrome P-450 content in both 
chicken and rat hepatic microsomes. The magnitude of the 
increase in cytochrome P-450 content indicated species 
similarities in response to phenobarbital but species 
differences in response to B-naphthoflavone. Approximately 2 
to 2.5-fold increases in cytochrome P-450 content were found 
in both chickens and rats treated with phenobarbital. 
However, treatment with B-naphthoflavone resulted in a nearly 
4-fold increase in chicken but only a 1.5-fold increase in rat 
cytochrome P-450 content. The magnitude of the induction of 
cytochrome P-450 content with Sesbania drummondii treatment 
of chickens closely paralleled that of phenobarbital. Neither 
of the Sesbania drummondii chicken treatment groups 
significantly differed from the phenobarbital treatment group.
In addition to changes in enzyme activity, the cytochrome P- 
450 inducers can also change the enzyme's spectral properties. 
The wavelength at which the carbon monoxide complex of reduced 
cytochrome P-450 produces peak absorption is a useful 
indicator of qualitative changes in cytochrome P-450 content. 
The effects of Sesbania d r u m m o n d i i  . phenobarbital, and B- 
naphthoflavone on this parameter (A max) are also listed in 
Table 13. Treatment with B-naphthoflavone in chickens and 
rats produced the characteristic blue shift in the peak 
absorption by 2 nm, i.e., to 448nm. Sesbania drummondii-
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treatment of chickens and rats did not appear to alter the 
wavelength maximum.
Aminopyrine N-demethvlase:
The aminopyrine N-demethylase activities of chicken and rat 
hepatic microsomes from animals treated with Sesbania 
drummondii. phenobarbital, and B-naphthoflavone are displayed 
in Table 14. The aminopyrine N-demethylase specific 
activities in chickens and rats treated with Sesbania 
drummondii verify the results of the preliminary study (Table 
3) . A 2-fold increase in chicken and a 2-fold decrease in rat 
specific activity were again observed with Sesbania 
drummondii. Chickens administered Sesbania drummondii at the 
greater percentage of body weight (0.75%) had significantly 
higher specific activities than chickens treated at 0.5% of 
body weight. Species differences were observed in the 
aminopyrine N-demethylase specific activities of hepatic 
microsomes from animals treated with the classic inducers, 
phenobarbital and B-naphthoflavone. Treatment with
phenobarbital resulted in increased activities in both 
species. However, treatment with B-naphthoflavone increased 
the activity only in the chicken. The magnitude of the 
increase in specific activity was similar for both 
phenobarbital, B-naphthoflavone and Sesbania drummondii 
treatments of chickens.
Table 14: The effect of Sesbania iinwinmm phenobarbital, and B-
naphthoflavone on aminopyrine N-demethylase activity in
chicken and rat hepatic microsomes.
Treatment
nmoles Formaldehyde formed/ min
per mg protein per nmole P-450
Chicken
Control 3.14 + 0.30* 19.03 + 2.58*
Sesbania fO.5% BW) 6.15 + 1.10b 18.43 + 1.12*
Sesbania fo.75% BW) 8.57 + 1. 89' 27.11 + 3.82b
Phenobarbital 8.13 ± 0.92be 22.71 ± 3.16*b
fi-Naphthoflavone 6.48 ± 1.01* 10.33 ± 1.46'
Rat
Control 3.76 + 0.58* 4.35 + 0.64*
Sesbania ro.5% BW) 1.71 + 0.32b 3.61 ± 0.70*
Phenobarbital 11.32 1.25' 5.31 + 0.37b
fl-Naphthof1avone 3.14 + 0.38* 2.58 + 0.25'
Values are the mean ± SEM, n = 6.
Means with like superscripts within the same species are not
significantly different (P > 0.05).
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Similarities among some groups and differences among others 
were observed in the treatment-induced relative changes in 
molar and specific activity of aminopyrine N-demethylase. The 
molar activity, unlike the specific activity, of chickens and 
rats treated with Sesbania drummondii at 0.5% of body weight 
was not significantly different from controls. Treatment of 
chickens with Sesbania drummondii at 0.75% of body weight, 
however, resulted in a molar activity significantly different 
from control and the low dosage Sesbania drummondii treatment. 
The molar activity of the high dosage Sesbania drummondii 
treatment overlapped the molar activity of phenobarbital, a 
finding also observed with specific activity. The aminopyrine 
N-demethylase molar activity of phenobarbital-treated chickens 
differed from controls in rat but not chicken hepatic 
microsomes. B-Naphthoflavone produced significantly different 
aminopyrine N-demethylase molar activities in both chickens 
and rats.
&lflrin_gpoKidase;
The aldrin epoxidase activities in chicken and rat hepatic 
microsomes from animals treated with Sesbania drummondii. 
phenobarbital, and fi-naphthoflavone are shown in Table 15. 
The aldrin epoxidase specific activities of chickens and rats 
treated with Sesbania drummondii at 0.5% of body weight are 
similar to the findings from the preliminary study (Table 3). 
Sesbania drummondii-treatment induced an increase in chicken
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Table 15: The effect of Sesbania drummondii. phenobarbital, and fi- 
naphthoflavone on aldrin epoxidase activity in chicken 
and rat hepatic microsomes.
Treatment
nmoles Dieldrin produced / min
per mg protein per nmole P-451
Chicken
Control 1.70 + 0.18* 10.29 ± 1.27*
Sesbania (0.5% BW1 5.20 + 1.29b 15.64 2.36b
Sesbania (0.75% BW) 6.81 + 1.30* 21.58 ± 2.81e
Phenobarbital 8.43 + 1.80® 23.57 + 5.89'
B-Naphthoflavone 1.65 + 0»28* 2.63 + 0.38d
Rat
Control 4.58 + 0.30* 5.40 + 0.55*
£e?bania (0.5% BW) 2.01 + 0. lBb 4.24 + 0.17b
Phenobarbital 23.54 + 2.24c 11.03 + 0.28'
6-Naphthoflavone 2.07 + 0. 3Bb 1.70 + 0.32d
Values are the mean ± SEM, n “ 6.
Means with like superscripts within the same species are not
significantly different (P > 0.05).
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and a decrease in rat aldrin epoxidase specific activities. 
The magnitude of the decrease in the rat was 2-fold as had 
been observed in the preliminary study. However, the 
magnitude of the increase in chicken specific activity was 3- 
fold, less than the 4-fold increase observed previously. The 
chickens of the preliminary study had been treated with 
Sesbania drummondii extract at a dosage of 0.80% of their body 
weight. Increasing the dosage of Sesbania drummondii to 0.75% 
in the chicken increased induction to 4-fold.
The greatest increase of aldrin epoxidase specific activity in 
all the treatment groups from both species was observed with 
phenobarbital. Approximately 5-fold inductions were observed 
in both chickens and rats treated with phenobarbital. Species 
differences in aldrin epoxidase specific activity were 
observed with 6-naphthoflavone treatment. No change in 
activity was observed in chickens, whereas rats exhibited a 2- 
fold decrease in activity in the B-naphthoflavone treatment 
groups. The aldrin epoxidase specific activities of Sesbania 
drummondii- and B-naphthoflavone-treated rats were not 
significantly different.
When aldrin epoxidase activity was expressed in terms of nmole 
cytochrome P-450, significant differences were observed among 
controls, Sesbania drummondii. phenobarbital, and B- 
naphthoflavone treatment groups in both chickens and rats.
1 1 6
Only the two Sesbania druromondii-treatment groups in chickens 
were not significantly different.
Alkoxvohenoxazone O-dealkvlases;
Species differences were observed for both specific activities 
and molar activities of the four alkoxyphenoxazone O- 
dealkylases. These differences were observed in response to 
treatment with Sesbania drummondii as well as with the two 
chemical inducers, phenobarbital and S-naphthoflavone.
Methoxvohenoxazone O-dealkvlase:
Methoxyphenoxazone O-dealkylase activity of chicken and rat 
hepatic microsomes from animals treated with Sesbania 
drummondii. phenobarbital and 6-naphthoflavone are shown in 
Table 16. The methoxyphenoxazone O-dealkylase specific 
activities of both chickens and rats treated with Sesbania 
drummondii were different from controls. A 2-fold increase in 
chickens' and a 3-fold decrease in rats' specific activity 
were observed in animals treated with Sesbania drummondii at 
0.5% of body weight. A slight, but not significant, increase 
in specific activity occurred in chickens treated with 
Sesbania drummondii at 0.75% of body weight over those treated 
at the lower dosage. Phenobarbital treatment resulted in a 
slight, but not significant, increase in specific activity in 
treated chickens and a 3-fold increase in treated rats. The 
greatest induction of methoxyphenoxazone O-dealkylase
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Table 16: Methoxyphenoxazone O-dealkylase activity of Sesbania 
drummondii. phenobarbital and S-naphthoflavone-treated 
chickens and rats
pmoles. resorufin produced / min
Treatment per mg protein per nmole P-450
Chicken
Control 88 + 16* 526 ± 81,b
Sesbania fo.5% BW) 185 + 47** 571 ± 165,b
Sesbania (0.75% bw) 223 + 57£ 707 ± 152b
Phenobarbital 142 + 28,b 394 ± 71*
B-Naphthoflavone 1295 + 206d 2064 ± 279e
Rat
Control 55 + 6* 64 ± 7*
Sesbania (0.5% BW) 16 + 4b 35 ± 9b
Phenobarbital 177 + 32e 83 ± lle
B-Naphthoflavone 522 + 120d 430 ± 103d
Values are the mean + SEM, n - 6.
Means with like superscripts within the same species are not
significantly different (P > 0.05).
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activity, however, resulted from B-naphthoflavone treatment. 
Increases of 15-fold in chicken and 9-fold in rat specific 
activities occurred with B-naphthoflavone treatment.
Fewer differences between treatment groups were evident in 
methoxyphenoxazone O-dealkylase molar activities. In the 
chicken hepatic microsomes, only treatment with B- 
naphthoflavone resulted in molar activity significantly 
different from the controls and other treatment groups. In 
contrast, the methoxyphenoxazone O-dealkylase molar activities 
in rat hepatic microsomes from each of the treatment groups 
and controls were significantly different from each other.
Ethoxvphenoxazone O-dealkvlase:
The ethoxyphenoxazone O-dealkylase activity of hepatic 
microsomes from chickens and rats treated with Sesbania 
drummondii. phenobarbital, and B-naphthoflavone are listed in 
Table 17. Fewer changes in both specific and molar activities 
were induced in the treated chickens for ethoxyphenoxazone 0- 
dealkylation than in the 3 other alkoxyphenoxazone 0- 
dealkylases. The effect of Sesbania drummondii treatment on 
ethoxyphenoxazone o-dealkylase activity was different from the 
observations of the preliminary study (Table 3). The
ethoxyphenoxazone 0-dea Iky lase specific activities of chicken 
hepatic microsomes were not significantly different between 
controls and birds treated with Sesbania drummondii and
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Table 17: Ethoxyphenoxazone O-dealkylase activity of 
Sesbania drummondli. phenobarbital, and 
B-naphthoflavone-treated chickens and rats
Treatment
pinoles resorufin produced / min
per mg protein per nmole p-450
Chicken
Control 388 + 91* 2401 ± 857*
Se^bapi^ <0.5% BW) 479 + 106* 1482 ± 377*
Sesbania to.75% BW) 463 + 108* 1465 ± 278*
Phenobarbital 594 + 163* 1673 + 544*
6-Naphthoflavone 10652 + 882b 17070 ± 2000b
Bat
Control 371 + 118* 427 ± 99*
Sesbania fO.5% BW) 300 + 75* 636 ± 177b
Phenobarbital 1634 + 167b 769 ± 81b
S-Naphthoflavone 6687 + 1232c 5508 + 1089c
Values are the mean ± SEM, n = 6.
Means with like superscripts within the same species are not
significantly different (P > 0.05).
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phenobarbital. Only treatment with B-naphthof lavone resulted 
in significant induction (27-fold) of specific activity in 
chickens.
A pattern similar to the ethoxyphenoxazone O-dealkylase 
specific activities of chickens was observed in the rat for 
treatments with Sesbania drummondii and B-naphthoflavone. 
Sesbania drummondii treatment of rats failed to significantly 
reduce the ethoxyphenoxazone O-dealkylase specific activity 
and B-naphthof lavone treatment markedly increased the specific 
activity. The magnitude of the B-naphthoflavone-induced 
increase in the rat however, was less than observed in the 
chicken (only 18-fold). The rat was also different from the 
chicken with regard to phenobarbital treatment. The rat, but 
not the chicken, exhibited a moderate induction of specific 
activity of 4-fold with phenobarbital treatment.
The ethoxyphenoxazone O-dealkylase molar activities of the 
treated groups followed a pattern similar to the specific 
activities in the chicken but not the rat. Only B- 
naphthoflavone-treated chickens exhibited a different 
ethoxyphenoxazone O-dealkylase molar activity, whereas 
controls, Sesbania drummondii-. and phenobarbital-treated 
chickens yielded molar activities that were not significantly 
different. In the rat, only B-naphthoflavone treatment 
exhibited a molar activity concurrent with the change in
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specific activity. The ethoxyphenoxazone O-dealkylase molar 
activity of the 6-naphthoflavone-treated rat was markedly 
different from all other groups. Treatment with Sesbania 
drummondii produced a molar activity significantly different 
from controls as was seen with the specific activity. This 
activity was also statistically similar to treatment with 
phenobarbital, a finding not observed for specific activity.
Pentoxvphenoxazone O-dealkvlaser 
The pentoxyphenoxazone O-dealkylase activity in hepatic 
microsomes from chickens and rats treated with Sesbania 
drummondii. phenobarbital, and B-naphthoflavone is given in 
Table 18. Pentoxyphenoxazone O-dealkylase activity was the 
only cytochrome P-450-mediated enzyme activity in which both 
chickens and rats treated with Sesbania drummondii expressed 
the same relative change in activity compared to controls. 
Sesbania drummondii administered to chickens at 0.5% of body 
weight caused a slight decrease in specific activity that was 
not significantly different from controls. The
pentoxyphenoxazone O-dealkylase specific activity of chickens 
treated at 0.75% of body weight and rats treated at 0.5% of 
body weight with Sesbania drummondii were both significantly 
lower than the corresponding control activity. Rats, however, 
showed a greater decrease in specific activity than the 
chickens (3-fold versus 1.5-fold, respectively).
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Table 18: Pentoxyphenoxazone O-dealkylase activity of 
Sesbania drummondii, phenobarbital, and 
B-naphthoflavone-treated chickens and rats.
pinoles resorufin produced / min
Treatment per mg protein per nmole P-450
Chicken
Control 10 ± 2* 60 + 7*
Sesbania (0.5% BW) 9 ± 1* 28 + 7b
Sesbania (0.75% BW) 6 ± 2b 20 + 5•*
Phenobarbital 4 ± lb 13 + 2e
B-Naphthoflavone 86 ± 9e 137 + 12d
Rat
Control 18 + 4* 21 5'
Sesbania (0.5% BW) 6 + lb 12 ± l1
Phenobarbital 3548 + 384c 1666 + 153'
B-Naphthoflavone 82 + 12d 68 8‘
Values are the mean ± SEM, n = 6.
Means with like superscripts within the same species are not 
significantly different (P > 0.05).
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Phenobarbital treatment of rats resulted in a very large 
induction of pentoxyphenoxazone O-dealkylase specific activity 
(197-fold) over that of controls. In contrast, phenobarbital 
treatment of chickens resulted in an actual decrease in the 
pentoxyphenoxazone O-dealkylase specific activity. The 
decreased specific activity with phenobarbital treatment of 
the chicken was statistically similar to the decrease observed 
with Sesbania drummondii treatment at 0.75% of body weight. 
The pentoxyphenoxazone O-dealkylase specific activity of both 
chickens and rats treated with B-naphthoflavone were 
significantly higher than controls. B-Naphthoflavone 
treatment of chickens induced the pentoxyphenoxazone 0- 
dealkylase specific activity nearly 9-fold, higher than any 
other treatment. The B-naphthoflavone-induced increase in the 
rat, however, was only 4-fold.
The molar activities of pentoxyphenoxazone O-dealkylase 
followed a pattern similar to the specific activities in the 
rat, but not the chicken. In the rat, the pentoxyphenoxazone 
o-dealkylase molar activity was distinctly different among 
control, druiniiionrii i . phenobarbital, and B-naphthof lavone 
treatments. The chicken pentoxyphenoxazone O-dealkylase molar 
activities showed statistically distinct differences among 
control, phenobarbital and B-naphthof la vone-treated groups and 
similarities among phenobarbital and drummondii (0.75%).
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Benzyloxyphenoxazone O-dealkylase;
Benzyloxyphenoxazone O-dealkylase activity of chicken and rat 
hepatic microsomes from animals treated with Sesbania 
drummondii. phenobarbital, and B-naphthoflavone are shown in 
Table 19. Treatment of chickens with Sesbania drnmmond i i at 
both dosages resulted in benzyloxyphenoxazone specific 
activities that were not significantly different from 
controls. The Sesbania drummondii treatment of rats, however, 
had significantly lower (2-fold) specific activities than 
controls. The benzyloxyphenoxazone O-dealkylase activities of 
chickens and rat hepatic microsomes treated with phenobarbital 
followed a pattern of induction similar to pentoxyphenoxazone 
O-dealkylation. Phenobarbital treatment of rats resulted in 
a very large increase in benzyloxyphenoxazone O-dealkylase 
specific activity (98-fold) while the phenobarbital-treated 
chicken showed a significant decrease in specific activity 
(1.5-fold). Treatment of both species with B-naphthoflavone 
resulted in a marked induction of benzyloxyphenoxazone 0- 
dealkylase specific activities. A 32-fold increase in chicken 
and a 5-fold increase in rat benzyloxyphenoxazone O-dealkylase 
specific activity were induced with B-naphthoflavone
treatment.
Effects on the molar activities of benzyloxyphenoxazone 0- 
dealkylase observed in chickens and rats treated with Sesbania 
drummondii were opposite to the specific activities. The
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Table 19: Benzyloxyphenoxazone O-dealkylase activity of Sesbania 
drummondii, phenobarbital, and B-naphthoflavone-treated
chickens and rats.
pmoles resorufin produced / min
Treatment per mg protein per nmole P-450
Chicken
Control 40 + 7* 239 + 33
Sesbania (0.5% BW) 42 + 7* 127 + 221
Sesbania (0.75% BW) 43 + 9* 136 + 191
Phenobarbital 26 + 4b 71 + 10'
fi-Naphthoflavone 1307 + 130c 2088 + 190'
Control 97 + 20* 113 + 23'
Sesfcania (0.5% bwj 44 + 10b 93 + 19'
Phenobarbital 9527 + 2462e 4431 + 940'
S-Naphthoflavone 536 + 75d 450 + 42‘
Values are the mean ± SEM, n 6.
Means with like superscripts within the same species are not
significantly different (P > 0.05).
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chicken benzyloxyphenoxazone O-dealkylase molar activities 
were significantly different from controls whereas the rats' 
molar activities were not significantly different with 
Sesbania drummondji treatment. Both phenobarbital and B- 
naphthoflavone treatments in chickens and rats resulted in 
benzyloxyphenoxazone O-dealkylase molar activities distinctly 
different from controls and Sesbania drummondi i-treated 
animals.
A general overview of the catalytic activities induced by 
Sesbania drummondii. phenobarbital, and B-naphthoflavone are 
presented in Figures 6 and 7. These figures illustrate the 
degree of induction (the reaction rate with induced microsomes 
divided by the rate with the control microsomes) of the three 
treatment groups for each of the six cytochrome P-450-raediated 
activities for both chickens and rats. In the S. drummondii- 
treated chicken (Figure 6), the catalytic properties were 
similar to the catalytic properties of chickens treated with 
phenobarbital and were different from the catalytic properties 
of chickens treated with B-naphthof lavone. Additional support 
for the similarities between phenobarbital and £>. drummondii 
are added by the similar spectral properties. The total 
cytochrome P-450 specific contents and the absorbance maxima 
were similar between these two treatments.
The catalytic properties of Sesbania drummondii-treated rats
presented in Figure 7 are clearly different from those of 
phenobarbital and B-naphthoflavone treatments. These 
differences were also evident in the spectral properties of 
these treatments.
0) 
(t> 
— 
— 
< 
— 
r+
O 
0) 
o
<
— 
— 
<0 
33
128
unity
Figure
induction of CP450-mediated activities 
in hepatic microsomes from chickens 
treated with S.drum, PB and BNF
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6. Degree of induction of cytochrome p-450-mediated 
activities of hepatic microeomes from chickens treated 
with Sesbania drummondii. phenobarbital, and B
naphthoflavone.
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Induction of CP450-mediated activities 
in hepatic microsomes from rats 
treated with S.drum, PB and 6NF
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Figure 7. Degree of induction of cytochrone F-450-Mdiated
activities of hepatie eieroaoaaa free rata treated with 
Saebanla drummondi!. phenobarbital, and B-naphthof lavone.
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DISCUSSION;
The cytochrome P-450 isozymes exhibit a unique overall profile 
of substrate selectivity. Examining the catalytic properties 
of the cytochrome P-4 50-dependent monooxygenase system in 
hepatic microsomes following treatment is a useful means of 
characterizing the effects of treatment on the cytochrome P- 
450 isozyme profile. However, there are limitations to 
catalytic characterization because many of the cytochrome P- 
450 isozymes exhibit overlapping substrate selectivities (Ryan 
and Levin, 1990).
In order to evaluate the effect of a new compound on the 
hepatic cytochrome P-450 monooxygenase system, it is essential 
to simultaneously compare the effects with those induced by 
positive and negative controls in the same animal system. 
This is because of the many factors related to the host (sex, 
age, health) and its environment (temperature, humidity, diet) 
that are known to alter the cytochrome P-450 monooxygenase 
system (Sipes and Gandolfi, 1986).
In our preliminary investigations, we compared the effects of 
Sesbania drummondii-treatment on the hepatic cytochrome P-450 
monooxygenase systems in chickens and rats with the effects in 
negative controls only. Therefore, our understanding of the 
changes induced by S. drummondii was limited because 
comparisons with known inducers of this system could only be
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made with literature reports. This is less of a problem in 
the rat due to the abundance of published data. However, in 
the chicken, there are few reports and these are usually 
limited to studies of chicken embryos or adults.
Our goal in this study was to compare the effects of Sesbania 
drummondii treatment on the catalytic properties of the 
hepatic cytochrome P-450 monooxygenase systems of chickens and 
rats to the effects induced by two classical cytochrome P-450 
inducers, phenobarbital and B-naphthoflavone. We studied six 
cytochrome P-450-mediated activities of varying degrees of 
selectivity and specificity. In addition, we obtained general 
information about the effects of the treatments on the 
cytochrome P-450 monooxygenase system by performing spectral 
determinations of cytochrome P-450.
Spectral determinations of cytochrome P-450 allow for 
convenient measures of cytochrome P-450 specific content and 
absorbance maximum. These measures provide some general 
information about the cytochrome P-450 system but have limited 
utility for identifying specific forms of cytochrome P-450.
Host of the inducers of the cytochrome P-450 system increase 
the specific content of cytochrome P-450. However, this is 
not true for all cytochrome P-450 inducers. A few inducers 
increase the amount of some of the cytochrome P-450 forms
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while decreasing the content of others resulting in no overall 
change in the total specific content (Ryan and Levin, 1990). 
The two classical inducers, phenobarbital and B- 
naphthoflavone, increased the cytochrome P-450 content in both 
chickens and rats. Sesbania drummondii treatment also 
resulted in an increase in chicken but a decrease in rat total 
cytochrome P-450 specific content. The magnitude of the S. 
drummondii increase in the cytochrome P-450 specific content 
was 2-fold, virtually the same as the increase observed in 
chickens treated with phenobarbital. This finding differed 
from published reports in which phenobarbital treatment of 
chickens increased the cytochrome P-450 content by 3-4 fold 
(Strittmater and Umberger, 1969; Powis g£ al* * 1976; Darby et 
al*, 1985; Lorr and Bloom, 1987) . The reason our
phenobarbital-treated chickens showed smaller inductions is 
not known. The age of the chickens should not have been a 
factor because phenobarbital induction of cytochrome P-450 of 
greater than 3-fold has been reported in chickens from embryos 
to adults (Powis gt al., 1976; Lapadula gt al., 1984).
The maximum absorption (Soret maximum) of the carbon monoxide- 
reduced difference spectrum provides additional evidence of 
cytochrome P-450 induction. 3-Methylcholanthrene-type of 
inducers in both rats and chickens shift the absorbance 
maximum from the 450 nm peak seen in controls to a peak at 448 
nm (Ronis and Walker, 1989). fi-Naphthoflavone treatment of
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chickens and rats in our study shifted the absorbance maximum 
by 2 nm in agreement with literature reports. Sesbania 
drummondii treatment did not shift the maximal absorption in 
either the chicken or the rat, which clearly distinguished it 
from 3-methylcholanthrene-type of induction. However, no 
other useful conclusions about patterns of change consistent 
with any other cytochrome P-450 isozyme can be drawn from this 
data. Identical absorption maxima have been obtained by 
several investigators for several of the cytochrome P-450 
isozymes (Ryan and Levin, 1990).
The six cytochrome P-450-mediated activities characterized for 
comparisons of the catalytic properties of the hepatic 
cytochrome P-450 monooxygenase systems of the treated groups 
differed in their selectivity and specificity for the major 
inducible forms of cytochrome P-450. Three of the activities 
(aminopyrine N-demethylase, aldrin epoxidase, ethoxyresorufin 
O-deethylase) were evaluated because they yielded interesting 
data in the preliminary study. The three other activities 
(methoxy-, pentoxy-, and benzyloxyphenoxazone O-dealkylase) 
were studied because of their high specificity for cytochrome 
P-450 isozymes.
Aminopyrine N-demethylase in the rat hepatic microsome has 
been associated with the phenobarbital-inducible form of 
cytochrome P-450 (Lubet £t al., 1985). Our results in the rat
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and chicken agreed with this finding. Phenobarbital treatment 
induced this activity in both species. However, aminopyrine 
N-demethylase activity has limited utility because the induced 
rates of this activity are small (only 2.5 to 3-fold higher 
than uninduced controls) and the activity is not considered to 
be highly specific for the phenobarbital-inducible cytochrome 
P-450 (Lubet et &1., 1985; Ronis and Walker, 1989).
Guengerich e£ &1. (1982) reported that aminopyrine N-
demethylase was expressed by six of eight purified rat 
cytochrome P-450 forms, some inducible and some constitutive. 
In our experiment, the aminopyrine N-demethylase activity was 
increased in rats with phenobarbital treatment and in chickens 
with phenobarbital and B-naphthof lavone treatment. Therefore, 
we could distinguish between these two inducers in the rat but 
not the chicken with this activity. Ronis and Walker (1989) 
concluded that aminopyrine was a relatively poor substrate for 
avian monooxygenases because the aminopyrine N-demethylase 
activity in avian hepatic microsomes was only 25% of the 
corresponding activity in the rat hepatic microsomes. Our 
data in control chicken hepatic microsomes vs. rat hepatic 
microsomes for this activity disagrees with their conclusion. 
We observed virtually the same specific activity in both 
species.
Treatment with Sesbania drummondii altered the aminopyrine N- 
demethylase specific activity in both species. In the rat
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treated with £. drummondii. the specific activity was much 
smaller than observed in control, phenobarbital, and fi- 
naphthoflavone-treated animals. In the chicken, the specific 
activity was increased with S. drummondii treatment to a level 
of activity similar to B-naphthoflavone with the 0.5% dosage 
and then to an activity similar to phenobarbital for the 0.75% 
dosage treatment. These data suggest two points. First, the 
increase in the specific activity with increasing dosage of S. 
drummondii indicate that a dose-response relationship between 
S. drummondii treatment and the activity may exist. The 
second observation is that this activity is not useful in 
distinguishing which of the cytochrome P-450 forms might be 
induced by Sesbania drummondii. Comparisons of the molar 
activity of aminopyrine N-demethylase in the chicken confirm 
the lack of utility of this cytochrome P-450-mediated 
activity.
The aldrin epoxidase assay has also been associated with the 
phenobarbital-inducible form of cytochrome P-450 but with 
greater specificity (Lubet et &1., 1985). We found this to be 
true in both chickens and rats. Phenobarbital treatment 
markedly increases aldrin epoxidase specific activity in both 
species, whereas, B-naphthof lavone treatment did not alter the 
specific activity in the chicken and actually induced a 
decrease in the rat specific activity. Recently, Wolff and 
Guengerich (1987) have questioned the specificity of the
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aldrin epoxidase assay in rats. They found that seven 
purified cytochrome P-450 isozymes characteristic for the male 
and phenobarbital-treated rat catalyzed aldrin epoxidation. 
This work did confirm that aldrin epoxidation was not related 
to the cytochrome p-448 isozyme family.
One advantage to the aldrin epoxidase assay in the rat and the 
chicken is that the activity is induced higher by 
phenobarbital over the activity in uninduced controls than the 
corresponding induction of aminopyrine N-demethylase activity. 
Despite this advantage, the aldrin epoxidase assay has 
additional limitations in the avian cytochrome P-450 system. 
Aldrin is considered to be a relatively poor, non-specific 
substrate in birds (Ronis and Walker, 1989). Our data in 
uninduced chickens versus rats support the contention that 
aldrin is a poor substrate in birds as chickens exhibited only 
30% of the activity observed in rats.
Sesbania drummondii treatment induced changes in aldrin 
epoxidation in both chickens and rats. A pronounced increase 
in aldrin epoxidase activity (3 to 4-fold) and molar activity 
was observed in £. drummondii-treated chickens. The magnitude 
of this induction was similar to phenobarbital with the 0.75% 
treatment group. This suggests that aldrin is equally good as 
a substrate for the cytochrome P-450 forms induced by either 
S. drummondii or phenobarbital in the chicken.
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Rats treated with £. drummondii showed a significant 2-fold 
decrease in aldrin epoxidase specific activity. This 50% 
depression in activity was virtually identical to the 
depression in activity induced by 6-naphthoflavone. Wolff and 
Guengerich (1987) have previously reported that B- 
naphthoflavone decreases aldrin epoxidation in rat hepatic 
microsomes. The reason the rat hepatic microsomes from 
animals treated with S. drummondii and B-naphthoflavone do not 
catalyze the epoxidation of aldrin as well as uninduced 
control animals is not known. Perhaps, these treatments alter 
the geometry of the active site of the cytochrome P-450 enzyme 
such that aldrin is not effectively bound and thus catalyzed. 
It is also unclear whether £. drummondii and B-naphthoflavone 
induce similar molecular changes that result in the decreased 
activity.
Presently, the O-dealkylation of various alkoxyphenoxazone 
derivatives are the most specific of the cytochrome P-450- 
mediated activities for distinguishing between inducible 
cytochrome P-450 isozymes in rat hepatic microsomes. Marked 
induction of the O-dealkylation of pentoxy- and 
benzyloxyphenoxazone is associated with the major 
phenobarbital-inducible isozyme in the rat, cytochrome P-450 
IIBl (Burke and Mayer, 1983; Burke et al., 1985). Marked 
induction of the O-dealkylation of ethoxyphenoxazone 
(ethoxyresorufin) is associated with the major 3-
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methylcholanthrene-inducible isozyme in the rat, cytochrome P- 
450 IA1 (Burke and Mayer, 1983; Burke fit al.f1985).
The induction pattern of liver microsomal alkoxyphenoxazone 0- 
dealkylases has also proved useful in studying liver 
microsomes of some nonmammalian species e.g., the channel 
catfish (Ankley fit &1*, 1987; Winston fit al., 1989) and the 
alligator (Jewell fit aJL., 1989). The utility of the hepatic 
microsomal metabolism of the alkoxyphenoxazones as a probe for 
the different types of cytochrome P-450 inducers in the avian 
species has not been reported. Studies in birds have thus far 
been limited to the ethoxy-derivative of hydroxyphenoxazone 
(Sawyer fit al*, 1986; Carpenter et al., 1985). Only one of 
these studies used White Leghorn chickens, thus there is a 
very limited data base on the induction pattern of 0- 
dealkylation in substituted alkoxyphenoxazones in avian 
species in general, and especially in the chicken.
In our study, we observed that the alkoxyphenoxazone O- 
dealkylase activities of chickens and rats were similar in 
uninduced animals but were markedly different after induction 
with phenobarbital and B-naphthoflavone. In uninduced 
chickens, the highest alkoxyphenoxazone O-dealkylase activity 
was with ethoxyphenoxazone as the substrate followed in 
decreasing order by methoxyphenoxazone, benzyloxyphenoxazone, 
and pentoxyphenoxazone. The rate of metabolism of the
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alkoxyphenoxazones in the uninduced rat followed a pattern 
similar to that of chickens with ethoxyphenoxazone showing the 
fastest and pentoxyphenoxazone showing the slowest rate of 
metabolism. In contrast, in the rat, benzyloxyphenoxazone was 
metabolized faster than methoxyphenoxazone.
Phenobarbital treatment in the rat has been associated with a 
marked induction (> 30-fold) of the O-dealkylation of pentoxy- 
and benzyloxyphenoxazones (Burke and Mayer, 1983; Burke et 
al., 1985). In good agreement with the literature, we
observed as much as a 200-fold increase in pentoxyphenoxazone 
O-dealkylation and a 100-fold increase in benzyloxyphenoxazone 
O-dealkylation. Much smaller increases occurred in the 
phenobarbital pretreated rat with ethoxyphenoxazone (4-fold) 
and methoxyphenoxazone (3-fold). In contrast, we observed in 
the phenobarbital pretreated chicken similar small increases 
in the metabolism of ethoxyphenoxazone (1.5-fold) and 
methoxyphenoxazone but opposite effects (2-fold decreases) 
with pentoxyphenoxazone and benzyloxyphenoxazone. Therefore, 
in marked contrast to the rat enzymatic system, none of these 
alkoxyphenoxazone O-dealkylase activities appear to be 
significantly induced in the phenobarbital pretreated chicken. 
Perhaps other derivatives of phenoxazone will prove to be more 
useful in phenobarbital treated birds. To the best of our 
knowledge, only ethoxyphenoxazone O-dealkylase has been 
characterized and found to be unchanged in phenobarbital
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pretreated birds (Carpenter £& si., 1984 and 1985) . Why
phenobarbital pretreatment in chickens failed to induce either 
the O-dealkylation of pentoxy- or benzyloxyphenoxazone is not 
presently known. Two possibilities are that 1) phenobarbital 
induction induces a gene subfamily in the chicken different 
from P-450IIB1, the isozyme in the rat that is selective for 
pentoxy- and benzyloxyphenoxazone or 2) different regulatory 
mechanisms of induction exist between the two species.
Treatment with the 3-methylcholanthrene-type of cytochrome P- 
450 inducers in the rat has been associated with a marked 
induction (> 30-fold) of ethoxyphenoxazone O-dealkylase 
activity (Burke and Mayer, 1983; Burke e£ al., 1985). Burke 
et al. (1985) reported inductions in the metabolism of 
ethoxyphenoxazone of 51-fold with 3-methylcholanthrene and 74- 
fold with B-naphthoflavone in Sprague-Dawley rats. Matsubara 
Si* (1983) observed a smaller increase of 12-fold in male 
Wistar rats treated with B-naphthoflavone. In our 
investigation, we observed a nearly 20-fold induction of the 
O-dealkylation of ethoxyphenoxazone in rats pretreated with fi- 
naphthoflavone. Much smaller increases of 9-fold with 
methoxyphenoxazone, 5-fold with pentoxyphenoxazone, and 6-fold 
with benzyloxyphenoxazone O-dealkylation were observed in our 
B-naphthof lavone treated rats. The degree of induction of the 
O-dealkylation of ethoxyphenoxazone in our B-naphthoflavone- 
treated chickens was similar in magnitude (27-fold) to the
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rats. Sawyer £& si. (1986) reported an even higher degree of 
induction of ethoxyphenoxazone O-dealkylation (37-fold) in 3- 
methylcholanthrene-treated White Leghorn cockerels. Carpenter 
et al. (1985) reported that fl-naphthoflavone treatment 
resulted in a 13-fold induction of ethoxyphenoxazone 0- 
dealkylase in Japanese quail. However, an even greater 
induction of benzyloxyphenoxazone O-dealkylase in White 
Leghorn chickens pretreated with B-naphthof lavone was observed 
in our study. B-Naphthoflavone treatment of chickens also 
produced higher degrees of induction in the metabolism of 
methoxyphenoxazone (14-fold) and pentoxyphenoxazone (9-fold) 
than was observed in the rat. Therefore, it appears that the 
O-dealkylation of benzyloxyphenoxazone and ethoxyphenoxazone 
are useful probes for studying B-naphthoflavone induction in 
the chicken.
As might be expected, the mixed-type of cytochrome P-450 
inducers in rats combine many of the inducing characteristics 
of both phenobarbital and 3-methylcholanthrene on the O- 
dealkylation of the alkoxyphenoxazones. similar to 
phenobarbital treatment in the rat, Aroclor 1254 treatment 
induces the metabolism of pentoxy- and benzyloxyphenoxazone. 
However, Burke al. (1985) reported that Aroclor was much 
less effective than phenobarbital at inducing either 
depentylation (22-fold compared to 283-fold by phenobarbital) 
or debenzylation (30-fold compared to 95-fold by
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phenobarbital). Other authors have observed higher levels of 
induction in these two activities with Aroclor. Lubet gfc al. 
(1985) observed that Aroclor 1254 increased the metabolism of 
pentoxyphenoxazone by 52-fold compared to a 94-fold increase 
with phenobarbital. Winston and Narayan (1990) also observed 
that Aroclor 1254 induced pentoxyphenoxazone O-dealkylation 
50% as effectively as phenobarbital (38-fold compared to 75- 
fold by phenobarbital) in agreement with Lubet et al., (1985) . 
However, in contrast to Burke gt al. (1985), Winston and 
Narayan (1990) observed that Aroclor 1254 actually induced the 
metabolism of benzyloxyphenoxazone (60-fold) higher than that 
of phenobarbital treatment (25-fold). This suggests that 
benzyloxyphenoxazone may be a more specific probe for mixed- 
type rather than phenobarbital-type inducers in the rat. 
Whether this will also be true for avian species treated with 
Aroclor is not presently known.
In addition, in the rat Aroclor 1254 induces ethoxyphenoxazone 
O-dealkylation in a manner similar to that of 3- 
methylcholanthrene. Burke e£ al. (1985) observed the rate of 
the O-deethylation reaction to be virtually the same after 
Aroclor treatment (61-fold) as after induction by 3- 
methylcholanthrene (51-fold).
To the best our knowledge, in the chicken treated with mixed- 
type inducers only ethoxyphenoxazone O-dealkylation has been
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characterized. Rifkind e£ si. (1984) observed a marked 50- 
fold induction in chicken embryos treated with 4 
polychlorinated biphenyl congeners.
The O-dealkylation of the alkoxyphenoxazones has been 
evaluated in rats treated with a number of nonclassical 
cytochrome P-450 inducers including isosafrole, SKF-525A, 
pregnenolone 16a-carbonitrile, imidazole N-substituted 
antifungal agents, and ethanol (Burke et al.. 1985; Rodrigues, 
1987; Winston and Narayan, 1990). The changes induced by 
these compounds are variable and generally not as large or 
specific as those induced by the classical types of inducers. 
However, one distinction noted between the classical and 
nonclassical inducers is that phenobarbital, 3- 
methylcholanthrene, B-naphthoflavone, and Aroclor all 
stimulate metabolism of methoxyphenoxazone at appreciably 
higher rates than in controls, whereas, pregnenolone 16a- 
carbonitrile, isosafrole, SKF 525A, and ethanol stimulate 
metabolism of methoxyphenoxazone at virtually control rates 
(Burke et al., 1985; Winston and Narayan, 1990).
Comparison of the effects of Sesbania drummondii treatment of 
chickens on the metabolism of pentoxy- and 
benzyloxyphenoxazones do not verify association with 
phenobarbital inducible isozymes because these 2 activities 
are not strongly induced in phenobarbital treated chickens as
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they are in rats. However, there was a similar pattern in the 
metabolism of pentoxyphenoxazone by microsomes from chickens 
treated with £. drummondii at 0.75% of body weight as those 
from chickens treated with phenobarbital. Both treatments 
significantly decreased the specific activity compared to 
controls. However, the S. drummondii treated chickens 
differed from the phenobarbital treatment for the metabolism 
of benzyloxyphenoxazone. Phenobarbital treatment in chickens 
again depressed this activity but £. drummondii treatment had 
no effect. No differences between the above changes in these 
activities were observed for specific vs. molar activity in 
the chicken.
The Sesbania drummondii- treated rat was clearly different from 
phenobarbital-treated rats based on the pentoxyphenoxazone and 
benzyloxyphenoxazone O-dealkylase specific activity. Marked 
increases in the specific activities of both substrates 
occurred with phenobarbital, whereas, marked decreases 
occurred with S. drummondii treatment. This distinction was 
also present for the metabolism of pentoxyphenoxazone in terms 
of molar activity but absent for the molar activity of 
benzyloxyphenoxazone. This suggests that some of the 
differences induced by £. drummondii treatment in the rat are 
due to the decrease in the total concentration of cytochrome 
P-450.
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Chickens treated with Sesbania drummondii were clearly 
different from B-naphthoflavone-treated birds with regard to 
the 3-methylcholanthrene-associated alkoxyphenoxazones. B- 
Naphthoflavone treatment markedly increased the metabolism of 
ethoxy-, pentoxy-, and benzyloxyphenoxazone, whereas £>. 
drummondii treatment caused no apparent induction of these 
specific activities. B-Naphthoflavone and S. drummondii also 
showed no similarities in alkoxyphenoxazone O-dealkylation 
when they were compared in terms of molar activities. This 
observation was much different from that of the preliminary 
study in which we observed a marked induction of 
ethoxyresorufin O-dealkylase in chickens treated with £. 
drummondii. The reason for this discrepancy between our two 
studies is not known. The two studies had differences in the 
year that the S. drummondii crop was harvested, the methods of 
the assay, and in the laboratory and personnel where the assay 
was performed.
Sesbania drummondii-treated rats exhibited ethoxyphenoxazone 
O-dealkylation specific activity virtually the same as 
uninduced rats. In contrast, the B-naphthof lavone-treated rat 
exhibited a marked increase in the metabolism of 
ethoxyphenoxazone. The molar activities between these two 
groups were also different.
In the chicken, only the methoxyphenoxazone O-dealkylase
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specific activity of g. drummondii-treated birds was 
significantly greater than controls. This increase was 
slightly greater than that induced by phenobarbital but was 
much less than that induced by B-naphthof lavone. This 
difference was not as evident for molar activities. The 
metabolism of methoxyphenoxazone in terms of the nmole of 
cytochrome P-450 present in the reaction was similar for 
control, g. drummondii. and phenobarbital treatments. The 
Sesbania drummondi i-treated rat again exhibited specific and 
molar methoxyphenoxazone activities different from control and 
induced treatments.
A few observations are evident from the above comparisons of 
alkoxyphenoxazone O-dealkylation of Sesbania drummondii vs. 
phenobarbital and B-naphthoflavone treatments of chickens and 
rats. The treatment effects of g. drummondii in the rat were 
clearly different from the effects of phenobarbital and B- 
naphthoflavone on the alkoxyphenoxazones O-dealkylation. The 
S. drummondii treatment effects of chickens were definitely 
different from the B-naphthoflavone treatment. But
unfortunately because one or more of the alkoxyphenoxazone 0- 
dealkylases are not specifically induced by phenobarbital in 
the chicken, we can not clearly compare g. drummondii to 
phenobarbital with these activities. However, in at least one 
activity, pentoxyphenoxazone o-dealkylase, both g. drummondii 
and phenobarbital induced similar changes.
147
C. PHASE III ~ EFFECTS OF SESBANIA DRUMMONDII ON HEPATIC
NADPH-DEPENDENT CYTOCHROME P-450 REDUCTASE. COMPARISON
WITH EFFECTS CAUSED BY PHENOBARBITAL AND 6-
NAPHTHOFLAVONE.
OBJECTIVES:
1. To compare the effects of Sesbania drummondii. 
phenobarbital, and B-naphthoflavone on chicken and rat 
hepatic microsomal NADH- and NADPH-cytochrome c 
reductase activities.
2. To determine the NADPH-dependent cytochrome P-450 
reductase contribution to the Sesbania drummondii-. 
phenobarbital-, and B-naphthoflavone-induced changes in 
hepatic microsomal monooxygenase activities by 
comparing NADPH-dependent metabolism to organic 
hydroperoxide-mediated (NADPH-independent) metabolism of 
aminopyrine and aldrin.
MATERIAL? A W  METH9P? '
A. Chemicals:
4-Aminophenol (99% pure), B-naphthoflavone (5,6-benzoflavone, 
90-95% pure), cumene hydroperoxide (80% w/v), and tert-butyl 
hydroperoxide (70 % w/v) were obtained from sigma Chemical Co. 
(St. Louis, MO) . Aldrin (99% pure) and dieldrin (98% pure) 
were obtained from Alltech Associates, Inc. (Deerfield, IL). 
t-Chlordane was obtained from the EPA (Research Triangle Park,
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NC). Phenobarbital, sodium injection, (€5 mg/mL) was obtained 
from Elkins-Sinn, Inc. (Cherry Hill, NJ). All other chemicals 
and biochemicals were of research grade or better and were 
obtained from various commercial sources.
B. Animals:
Male White Leghorn chickens and Sprague-Dawley rats were 
obtained, cared for, and assigned to treatment groups as 
described in detail in Phase II.
c. Treatment :
Animals were treated with either bicarbonate-azide buffer 
(controls), S. drummondii extract, phenobarbital, or B- 
naphthoflavone as described in detail in Phase II.
D. Preparation of hepatic microsomes:
Microsomes were prepared from pooled livers of the subgroups, 
treated or control, as described in detail in Experiment 1, 
Phase I.
E. Protein determination:
The concentration of protein of the microsomes was determined 
as described in detail in Experiment 1, Phase I.
F. cytochrome P-450:
The cytochrome P-450 content of the microsomes was measured as
described in detail in Experiment 1, Phase I.
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G. NADH- and NADPH-cvtochrome c reductase:
NADH- and NADPH-cytochrome c reductase activities were assayed 
as described in detail in Experiment 1, Phase X.
H. Hepatic microsomal monooxvaenase activities:
I. NADPH-dependent metabolism:
a. Aminopvrine N-demethvlase:
The microsomal-mediated metabolism of aminopyrine was 
determined as described in detail in Phase I, Experiment 1 
with the modifications described in Phase II. An NADPH- 
generating system was used to initiate this reaction.
b. Aldrin epoxidasei
The microsomal-mediated metabolism of aldrin was measured as 
described in detail in Phase I, Experiment 1 with the 
modifications described in Phase II. An NADPH-generating 
system was a component of the reaction mixture for this assay.
2. Organic hvdroperoxide-mediated metabolism ;
a. Aminopvrine N-demethvlase;
1) Cumene hydroperoxide: The assay for the cumene
hydroperoxide-mediated metabolism of aminopyrine was similar 
to the NADPH-dependent assay detailed in Phase I, Experiment 
1 and Phase II except for a few modifications. The first
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change was the elimination of the NADPH generating system 
(NADP+, glucose 6-phosphate, and glucose 6-phosphate 
dehydrogenase) from the reaction mixture and replacing it with 
cumene hydroperoxide (Figure 8). A fresh stock suspension of 
cumene hydroperoxide (0.15 M in potassium phosphate buffer, 
1.0 M, pH 7.4) was added to the reaction mixture to start the 
reaction. The final concentration of cumene hydroperoxide in 
the reaction mixture was 0.5 mM (Winston and Cederbaum, 1982 
and 1983b). The microsomal protein concentration and the 
incubation time were changed in the assay to optimize the 
conditions for linearity. Appendices 23-24 illustrate the 
optimum conditions for the cumene hydroperoxide-mediated 
metabolism of aminopyrine in control chicken and rat hepatic 
microsomes. These conditions (Table 20) were utilized in 
determining the cumene hydroperoxide-mediated aminopyrine N- 
demethylase activity of control, g .  drummondii- . 
phenobarbital, and B-naphthoflavone-treated animals.
2) t-Butyl hydroperoxide: The assay for the t-butyl
hydroperoxide-mediated metabolism of aminopyrine was very 
similar to the cumene hydroperoxide-mediated assay described 
above. The reaction, however, was initiated by adding t- 
butylhydroperoxide (0.15 M stock solution in potassium 
phosphate buffer, 1.0 M, pH 7.4) (Figure 8). The final 
concentration of t-butyl hydroperoxide in the reaction mixture 
was 0.5 mM (Winston and Cederbaum, 1982 and 1983b). Optimal
Cumene hydroperoxide
Figure 8. Chemical structures
t-Butyl hydroperoxide
of the organic hydroperoxides.
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Table 20: Optimized conditions for the assay of cumene
hydroperoxide-mediated aminopyrine N-demethylase activity
in hepatic microsomes from control chickens and rats
Condition Chicken Rat
Time (min) 10 10
Protein concentration 
(mg/mL) 1.0 1.0
Substrate concentration 
(mM) 10. 0 10.0
All assays were performed at 37°C. The assays were 
conducted in duplicate using a single control chicken or 
rat hepatic microsomal preparation over a range of 3 
protein concentrations, 5 incubation times, and 6 
concentrations of the aminopyrine substrate. The protein 
concentrations and incubation times yielded maximal 
product formation in the linear range (see Appendices 23- 
24) .
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assay conditions with respect to microsomal protein 
concentration and incubation time were determined using t- 
butyl hydroperoxide with control chicken and rat hepatic 
microsomes (Appendices 25-26). These conditions (Table 21) 
were utilized in measuring the t-butyl hydroperoxide-mediated 
aminopyrine N-demethylase activities in control, £. 
drummondii-. phenobarbital, and B-naphthoflavone-treated 
chickens and rats.
b. Aldrin epoxidase:
1. Cumene hydroperoxide: The assay for the cumene
hydroperoxide-mediated metabolism of aldrin was similar to the 
NADPH-dependent method detailed in Phase I, Experiment 1 and 
Phase II except for a few modifications. The first change 
involved substituting cumene hydroperoxide for the NADPH 
generating system. A stock cumene hydroperoxide suspension 
(0.0525 M) was freshly prepared by adding the concentrate to 
potassium phosphate buffer solution (0.25 H, pH 6.8). This 
suspension (0.5 mM final concentration in the reaction 
mixture) was used instead of aldrin to initiate the reaction. 
The concentration of cumene hydroperoxide selected for the 
aldrin epoxidase assay was the same concentration used by 
Winston and Cederbaum (1982,1983b) with the aminopyrine N- 
deroethylase assay.
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Table 21: Optimized conditions for the assay of t-butyl
hydroperoxide-mediated aminopyrine N-demethylase activity
in hepatic microsomes from control chickens and rats
Condition Chicken Rat
Time (min) 15 15
Protein concentration
(mg/mL) 2.0 2.0
Assays were performed at 37°C using 10.0 mM aminopyrine 
substrate concentration. The assays were conducted over a 
range of 3 protein concentrations and 3 incubation times using 
a single control chicken or rat hepatic microsomal 
preparation. The protein concentrations and incubation times 
yielded maximal product formation in the linear range (see 
Appendices 25-26).
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To the best of our knowledge, the organic hydroperoxide- 
mediated metabolism of aldrin has not been previously reported 
with rat or chicken hepatic microsomes. Additional changes in 
the microsomal protein concentration and incubation time were 
necessary to assure maximal linear velocity of the reaction. 
A linear range for protein concentration and time were 
determined for control chicken and rat hepatic microsomes 
(Appendices 27-28). These conditions (Table 22) were utilized 
in measuring the cumene hydroperoxide-mediated metabolism of 
aldrin in control, S. drummondii-. phenobarbital, and B- 
naphthoflavone-treated chickens and rats. It was also 
necessary to reduce the extraction volume of 2,2,4- 
trimethylpentane from 5 mL to 2 mL in order to measure the 
smaller concentrations of dieldrin produced.
2. t-Butyl hydroperoxide: The assay for the t-butyl
hydroperoxide-mediated metabolism of aldrin was essentially 
the same as described above except that t-butyl hydroperoxide 
was used instead of cumene hydroperoxide. A freshly prepared 
stock solution (0.05 M in 0.25 M potassium phosphate buffer, 
pH 6 .8 ) was added to the reaction mixture to start the 
reaction. The final concentration of t-butyl hydroperoxide in 
the reaction mixture was 0.5 mM. Again, changes in the 
microsomal protein concentration and in the incubation time 
were necessary in order to achieve maximal linear reaction 
velocities. A linear range of protein concentration and
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Table 22: Optimized conditions for the assay of cumene 
hydroperoxide-mediated aldrin epoxidase activity in 
hepatic microsomes from control chickens and rats
Condition Chicken Rat
Time (min) 2 2
Protein concentration 
(mg/mL) 0.4 0.2
Substrate concentration 
(jiM) 50.0 50.0
All assay were performed at 37®c. The assays were conducted 
in duplicate using a single control chicken or rat hepatic 
microsomal preparation over a range of 3 protein 
concentrations, 5-6 incubation times, and 5 concentrations of 
aldrin substrate. The protein concentrations and incubation 
times yielded maximal product formation in the linear range 
(see Appendices 27-28)•
incubation tine were determined with control chicken and rat 
hepatic microsomes (Appendices 29-30). These optimal 
conditions (Table 23) were used in measuring the t-butyl 
hydroperoxide-mediated metabolism of aldrin in control, 
drummondii-, phenobarbital, and B-naphthoflavone-treated 
chickens and rats.
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Table 23: Optimized conditions for the assay of t-butyl
hydroperoxide-mediated aldrin epoxidase activity in
hepatic microsomes from control chickens and rats
Condition Chicken Rat
Time (min) 10 5
Protein concentration
(mg/mL) 0.5 0.4
Assays were performed at 37°C using 50 m M aldrin substrate 
concentration. The assays were conducted in duplicate using 
a single control chicken or rat hepatic microsomal preparation 
over a range of 3 protein concentrations and 6 incubation 
times. The protein concentrations and incubation times 
yielded maximal product formation in the linear range (see 
Appendices 29-30).
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i. statistical Analyse^ :
Statistical analyses of the data were performed using an 
analysis of variance (ANOVA) among the chicken or rat 
experimental groups. This was accomplished by determining the 
mean and standard deviation for each group. Differences among 
the means and standard deviations were tested for significance 
using Scheffe's multiple range test (Snedecor and Cochran, 
1980). These calculations were carried out on an IBM-PC/AT 
computer (IBM, Dallas,TX) using the STATGRAPHICS* program 
(version 2.1) by Statistical Graphics Corp. (Rockville, MD). 
The acceptable level of significance for this study was 
established at P < 0.05.
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RESULTS:
NADH-and NADPH-cvtochrome c reductase:
The effect of Sesbania drummondii treatment on NADH- and 
NADPH-cytochrome c reductase activities in chicken and rat 
hepatic microsomes (Table 24) corroborated the findings of the 
preliminary study (Table 2). Significant differences were not 
observed for NADH-cytochrome c reductase activity in either 
species treated with Sesbania drummondii. The NADPH- 
cytochrome c reductase activity was significantly increased 
with S. drummondii treatment of chickens (0.75%) but unchanged 
in the treated-rats. Treatment with phenobarbital stimulated 
changes in rat but not chicken reductase activity. A 
significant decrease in rat and no change in chicken NADH- 
cytochrome c reductase activity occurred with phenobarbital 
treatment. Likewise, NADPH-cytochrome c reductase activity in 
the chicken was unaffected by phenobarbital. A change of 
NADPH-cytochrome c reductase activity was observed in the 
phenobarbital-treated rat but, instead of a decrease, a 
significant increase in activity occurred. B-Naphthoflavone 
treatment had no effect on either NADH- or NADPH-cytochrome c 
reductase activities of either chicken and rat hepatic 
microsomes.
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Table 24: The effect of Sesbania drummondi1. phenobarbital, and B-
naphthoflavone on chicken and rat hepatic NADH- and
NADPH-cytochrome c reductase activities.
Cytochrome c reductase
Treatment NADH- NADPH-
Chicken
Control 159 + 22* 84 + H»b
Sesbania (0.5% BW) 166 41* 122 ± 23b
Sesbania (0.75% BW) 166 + 18* 176 + 31e
Phenobarbital 138 + 28* 82 + 13*
B-Naphthoflavone 163 + 24* 84 + 19*b
Rat
Control 606 + 132* 151 + 15*
Sesbania (0.5% BW) 538 ± 50* 145 + 22*
Phenobarbital 344 + 20b 235 + 9b
B-Naphthoflavone 646 + 32* 131 + 6*
Values are the mean + SEM, n = 6.
Reductase activity expressed as nmole cytochrome c reduced / 
min / mg protein.
Means with like superscripts within the same species are not 
significantly different (P > 0.05).
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Hepatic microsomal monooxvaenase activities;
NADPH-deoendent metabolism;
Aminopyrine N-deroethvlase:
The effect of Sesbania drummondii. phenobarbital, and B- 
naphthoflavone on NADPH-dependent aminopyrine N-demethylase 
activity in chicken and rat hepatic microsomes (Table 14) is 
described in detail in Phase II.
Aldrin eooxidase:
The effect of Sesbania drununondii. phenobarbital, and B- 
naphthof lavone on NADPH-dependent aldrin epoxidase activity of 
chicken and rat hepatic microsomes (Table 15) is described in 
detail in Phase II.
Organic hydroperoxide-mediated metabolism:
Aminopvrine N-demethvlase:
Cumene hydroperoxide: Species differences were evident
in the capability of cumene hydroperoxide to support the N- 
demethylation of aminopyrine (Table 25). Cumene hydroperoxide 
appeared to more effectively mediate aminopyrine N- 
demethylation in rat hepatic microsomes resulting in specific 
activities nearly 2 -fold greater than the corresponding 
specific activity in the NADPH-dependent reaction. In 
contrast, the chicken hepatic microsomal fraction was less 
effective in catalyzing the aminopyrine N-demethylation with 
cumene hydroperoxide as the oxygen and electron donor. The
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Table 25: The effect of Sesbania druranondil. phenobarbital, and
B-naphthoflavone on cumene hydroperoxide-mediated
aminopyrine N-demethylase activity in hepatic 
microsomes from chickens and rats
Treatment
nmoles Formaldehyde formed / min
per mg protein per nmole P-450
Chicken
Control 1.35 + 0.17* 8.12 + 0.72,b
Sesbania fo.5% BW) 2.82 + 0.48b 8.62 + 1. 33*
Sesbania fO.75% BW) 3.02 + 0.76b 9.49 + 1.29*
Phenobarbital 2.33 + 0.26b 6. 52 + 0.85b
B-Naphtho f1avone 2.39 + 0.31b 3.82 + 0.50c
Rat
Control 8.10 + 0.91* 9.48 + 0.56,b
Seshania <0.5% bw> 4.79 + 0. 58b 10.09 + 0.91b
Phenobarbital 17.98 + 2.72e 8.39 + 0.65*
B-Naphthoflavone 8.27 + 0.89* 6.80 + 0.69‘
Values are the mean ± SEM, n = 6.
Means with like superscripts within the same species are not 
significantly different (P > 0.05).
specific activities of the cumene hydroperoxide reactions were 
50% (or less) of the corresponding NADPH-dependent mixed 
function oxidase reactions. Despite the quantitative 
differences in specific activity, the cumene hydroperoxide- 
and NADPH-mediated aminopyrine N-demethylase activities showed 
similar patterns of change as a function of pretreatment in 
each of the treated groups. The cumene hydroperoxide-mediated 
aminopyrine N-demethylase specific activities of chickens 
treated with Sesbania drummondii. phenobarbital, and 6 - 
naphthoflavone were all approximately 2 -fold greater than that 
of the controls. However, unlike the NADPH-dependent 
reaction, no significant difference between the two chicken 
Sesbania drummondii treatment groups was observed in the 
cumene hydroperoxide-mediated reaction. The specific 
activities of the cumene hydroperoxide-mediated reactions of 
rats treated with Sesbania drummondii. phenobarbital, and B- 
naphthoflavone followed the identical pattern of change as 
that of the NADPH-dependent reaction. Sesbania drummondii 
treatment resulted in a decrease, phenobarbital an increase, 
and 6 -naphthoflavone,no change in the cumene hydroperoxide- 
mediated aminopyrine N-demethylase specific activity.
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Similarities were also present between molar activities of the 
cumene hydroperoxide-mediated and NADPH-dependent N- 
demethylation of aminopyrine. In chickens, both dosage 
treatments with Sesbania drummondii were similar to controls 
and different from the phenobarbital and B-naphthof lavone 
molar activities. Sesbania drummondii treatment of rats 
resulted in molar activities statistically similar to control 
and phenobarbital-treated animals. The cumene hydroperoxide- 
mediated aminopyrine N-demethylase molar activity of animals 
treated with phenobarbital were not significantly different 
from control chicken and rat activities. In contrast, 
treatment with B-naphthoflavone resulted in a significant 
change in the cumene hydroperoxide-mediated molar activity of 
both species that was different from all other groups.
t-Butyl hydroperoxide: t-butyl hydroperoxide was less
effective in mediating the N-demethylation of aminopyrine in 
both chicken and rat hepatic microsomes (Table 26). The 
specific activities of t-butyl hydroperoxide-mediated 
aminopyrine N-demethylation in both species, control and 
treated, were much lower than the corresponding activities 
using NADPH or cumene hydroperoxide. Treatment-induced 
changes in the specific activities also differed with t-butyl 
hydroperoxide. No change in specific activity was observed in 
chicken hepatic microsomes from any of the treatment groups. 
The t-butyl hydroperoxide-mediated aminopyrine
166
Table 26: The effect of Sesbania flciUUDffiQsm' phenobarbital, and 
B-naphthoflavone on t-butyl hydroperoxide- 
mediated aminopyrine N-demethylase activity in hepatic 
microsomes from chickens and rats.
Treatment
nmoles Formaldehyde formed / min
per mg protein per nmole P-450
Chicken
Control 0.46 ± 0.17* 2.82 4 0.98*
Sesbania (0.5% BW) 0.49 + 0.13* 1.52 4 0.42b
Sesbania fO.75% BW) 0.59 + 0.20* 1.84 4 0. 47,b
Phenobarbital 0.41 + 0.15* 1.14 4 0.44b
B-Naphthoflavone 0.50 + 0. 24* 0.80 4 0.36b
Rat
Control 0.71 + 0.111 0.83 4 0.09*
Sesbania fO.5% BW) 0.42 4 0.05b 0.88 4 0.08*
Phenobarbital 1.92 4 0.28c 0.90 4 0.04*
fl-Naphthoflavone 0.94 4 0.21d 0.77 4 0.17*
Values are the mean ± SEM, n - 6.
Means with like superscripts within the same species are not
significantly different (P > 0.05).
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N-demethylase specific activity of rats followed a similar 
pattern of change as observed with cumene hydroperoxide and 
NADPH but with one distinct difference, i.e., the changes in 
specific activity that were similar included a decrease with 
Sesbania drummondii treatment and an increase with 
phenobarbital treatment. However, with B-naphthoflavone 
treatment, the t-butyl hydroperoxide-mediated reaction was 
slightly, but significantly, increased. No change in activity 
was observed in the B-naphthoflavone treated rat with the 
NADPH and cumene hydroperoxide reaction systems.
Differences between treated groups were less evident when the 
t-butyl hydroperoxide-mediated aminopyrine N-demethylase 
activities were expressed per nmole of cytochrome P-450. For 
example, the molar activities of chickens treated with 
Sesbania drummondii. phenobarbital, and B-naphthoflavone were 
different from controls but not different from each other. No 
differences between the treated groups and controls were 
observed in the rat t-butyl hydroperoxide-mediated molar 
activities.
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Aldrin epoxidase:
Cumene hydroperoxide: Species differences were apparent
in the capability of cumene hydroperoxide to mediate the 
epoxidation of aldrin (Table 27). Cumene hydroperoxide was 
able to mediate aldrin epoxidation as effectively as NADPH in 
rat hepatic microsomes. This was suggested by the similar 
aldrin epoxidase specific activities in rat control hepatic 
microsomes utilizing NADPH and cumene hydroperoxide. In 
contrast, cumene hydroperoxide was much less effective in 
mediating aldrin epoxidation in the chicken hepatic microsome. 
The cumene hydroperoxide-mediated aldrin epoxidase specific 
activity of control chicken microsomes was only 25% of the 
NADPH-dependent specific activity.
Despite the quantitative differences in specific activity 
between the two systems in the chicken, the pattern of change 
in activity induced by the various treatment regimens was 
similar. Treatment with Sesbania drummondii and phenobarbital 
resulted in a similar increase in specific activity 
significantly greater than controls. However, phenobarbital 
treatment did not significantly increase the activity over 
that of Sesbania drummondii-treatment as had been observed 
with the NADPH reaction. Treatment with B-naphthoflavone 
resulted in no change in the specific activity of the cumene 
hydroperoxide-mediated aldrin epoxidase reaction.
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Table 27*. The effect of Sesbania drummondii. phenobarbital, and 6- 
naphthoflavone on cumene hydroperoxide-mediated aldrin 
epoxidase activity in hepatic microsomes from chickens 
and rats.
Treatment
nmoles Dieldrin produced / min
per mg protein per nmole P-450
Chicken
Control 0.42 + 0.05* 2.50 + 0.29*
Sesbania (0.5% BW) 1.82 ± 0. 44b 5.53 + 0.99b
Sesbania (0.75% BW) 2.19 ± 0.57b 6.88 + 0.99b
Phenobarbital 2.12 ± 0.39b 5.89 + 1.02b
B-Naphthof1avone 0.42 + 0.06* 0.67 0.09c
Rat
Control 4.07 + 0. 31*b 4.78 + 0.35*
Sesbania (0.5% BW) 1.66 + 0.25c 3.49 + 0. 43b
Phenobarbital 4.59 + 0.56b 2.15 + 0.17c
B-Naphthoflavone 3.75 + 0. 33* 3.08 + 0.17b
Values are the mean ± SEM, n * 6.
Means with like superscripts within the same species are not
significantly different (P > 0.05).
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The specific activity of the cumene hydroperoxide-mediated 
aldrin epoxidase of rat hepatic microsomes followed a pattern 
of changes similar to the NADPH-dependent reaction with one 
distinct difference. The effect of Sesbania drummondii and B- 
naphthof lavone treatments on the cumene hydroperoxide-mediated 
epoxidation of aldrin coincided with the changes in specific 
activity observed in the NADPH-dependent reaction. Sesbania 
drummondii treatment resulted in a 2-fold decrease and B- 
naphthoflavone resulted in no change of the specific activity 
of aldrin epoxidase. The effect of treatment with 
phenobarbital differed markedly between the two reaction 
systems. Phenobarbital treatment elevated the NADPH-dependent 
reaction 5-fold but did not induce a change in the cumene 
hydroperoxide-mediated reaction system.
The changes in cumene hydroperoxide-mediated aldrin epoxidase 
molar activity of both treated chickens and rats paralleled 
the activities of the NADPH-dependent reaction system. All 4 
rat groups had molar activities that were distinctly 
different. Induced changes in molar activities of treated 
chickens distinguished the controls from Sesbania drummond i i 
and phenobarbital, and from B-naphthoflavone treatment. 
Treatment with phenobarbital and Sesbania drummondii at 0.75% 
of body weight, however, were not significantly different from 
the 0.5% body weight Sesbania drummondii treatment.
t-Butyl hydroperoxide: t-butyl hydroperoxide was a poor
mediator of aldrin epoxidation in both chicken and rat hepatic 
microsomes (Table 28). The specific activities of aldrin 
epoxidase were much lower in both species with the t-butyl 
hydroperoxidase-dependent than with the NADPH plus oxygen and 
cumene hydroperoxide-dependent reaction systems. The effect 
of treatments on t-butyl hydroperoxide-mediated aldrin 
epoxidase specific activity in both chickens and rats were 
similar to the effects observed with the cumene hydroperoxide- 
mediated reaction system. Treatment of chickens with Sesbania 
drummondii and phenobarbital resulted in an increase of 
similar magnitude in the specific activity whereas B- 
naphthoflavone treatment had no effect on activity. The 
effect of treatments on the rat t-butyl specific activities 
were distinctly different from the effects observed with 
cumene hydroperoxide and NADPH.
Sesbania drummondii treatment resulted in a slight but not 
significant drop in specific activity. Treatment with 
phenobarbital increased the specific activity 2-fold. No 
effect on the t-butyl hydroperoxide-mediated aldrin epoxidase 
activity was observed in rat hepatic microsomes from animals 
treated with B-naphthoflavone.
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Table 28: The effect of Sesbania drummondii. phenobarbital, and B- 
naphthoflavone on t-butyl hydroperoxide-mediated aldrin 
epoxidase activity in hepatic microsomes from chickens 
and rats.
Treatment
nmoles Dieldrin produced / min
per mg protein per nmole P-450
Chicken
Control 0.03 + 0.01* 0.19 + 0.01*
Sesbania fO.5% BW) 0.13 ± 0. 03b 0.41 + 0.06b
Sesbania fO.75% BW) 0.14 + 0.04b 0.44 ± 0.06b
Phenobarbital 0.13 + 0.03b 0.37 0.07b
B-Naphthoflavone 0.04 + 0.01* 0.05 + 0.01*
Rat
Control 0. B0 + 0. 05'b 0.94 + 0.09*
Sesbania fo.5% BW) 0.62 + 0.10* 1.30 ± 0.17b
Phenobarbital 1.83 + 0. 21c 0.86 ± 0.02“
B-Naphthoflavone 0.86 + 0.12b 0.71 + 0.09*
Values are the mean ± SEN, n * 6.
Means with like superscripts within the same species are not
significantly different (P > 0.05).
The relative differences in the t-*butyl hydroperoxide-mediated 
aldrin epoxidase molar activities of treated chickens exactly 
paralleled the changes observed in the cumene hydroperoxide- 
mediated reaction. The relative difference in molar activity 
in the rat treatment groups was unique to the t-butyl 
hydroperoxide-mediated reaction. Treatment with Sesbania 
drummondii altered the specific activity; however, treatment 
with phenobarbital did not significantly alter the molar 
activity. Treatments with phenobarbital and B-naphthoflavone 
in rat hepatic microsomes had overlapping t-butyl 
hydroperoxide-mediated aldrin epoxidase molar activities.
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DISCUSSION:
The cytochrome P-450 monooxygenase system is a coupled enzyme 
system composed of two enzymes: cytochrome P-450 and NADPH 
cytochrome P-450 reductase (Sipes and Gandolfi, 1986). 
Accompanying this complex is cytochrome b5 and its associated 
reductase, cytochrome b5 reductase (Sipes and Gandolfi, 1986).
The cytochrome P-450 component of this system was found to be 
affected by treatments with an extract of Sesbania drummondii. 
Changes in the cytochrome P-450 specific content were observed 
in chickens and rats treated with Sesbania drummondii. The 
cytochrome b5 specific content was unaffected by S. drummondii 
treatment in either species. The NADPH-cytochrome c reductase 
activity was increased in the chicken and unaffected in the 
rat by Sesbania drummondii treatment, whereas neither chickens 
nor rats demonstrated changes in NADH-cytochrome c reductase 
with treatment. Sesbania drummondii treatment was also 
observed to change several cytochrome P-450-mediated 
activities in both chickens and rats. However, because these 
enzyme activities are influenced by contributions of both the 
cytochrome P-450 and reductase components of the cytochrome P- 
450 monooxygenase system it is not possible to distinguish the 
relative contribution of changes in either component to the 
overall change in activity.
The purpose of the Phase III study was to evaluate the effect
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of Sesbania drummondii on the reductase component of the 
hepatic cytochrome P-450 monooxygenase system. This was done 
by first comparing S. drummondii. phenobarbital, and fl- 
naphthoflavone treatments on chicken and rat hepatic 
microsomal NADH- and NADPH-cytochrome c reductase activities.
NADH- and NADPH-cytochrome c reductase activities are an 
indirect measure of the reductase components of the cytochrome 
P-450 system. The cytochrome c reductase activities are not 
a measure of the reductase specific contents but instead 
measure the rate of electron transfer from the reductases.
None of the treatments altered the rate of electron transfer 
from NADH-cytochrome b5 reductase in the chicken. And in the 
rat, only phenobarbital treatment altered the rate of electron 
transfer from this reductase by decreasing the reduction of 
cytochrome c. The significance of this finding as it relates 
to phenobarbital induction in the rat is not known.
Phenobarbital treatment in the rat had the opposite effect on 
the NADPH-cytochrome c reductase activity. In agreement with 
literature reports (Snyder and Remmer, 1979), an increase of 
1 .6 -fold over the control rate was observed in the rate of 
electron transfer from NADPH cytochrome P-450 reductase in 
rats treated with phenobarbital. Neither Sesbania drummondii 
nor B-naphthoflavone treatment affected NADPH-cytochrome c
reductase activity in the rat. In contrast, chickens treated 
with phenobarbital did not induce NADPH-cytochrome c reductase 
activity. This finding disagreed with a report by Pilch and 
Combs (1981) that described a nearly 2-fold increase in NADPH- 
cytochrome c reductase activity in 1 2 -day old cockerels given 
phenobarbital and fed diets supplemented with vitamin E and 
selenium. To the best of our knowledge, there are no other 
reports of the effect of phenobarbital treatment on chicken 
NADPH-cytochrome c reductase activity. Sesbania drummondii 
administered at a dosage of 0.75% of body weight to the 
chicken, was the only treatment that increased the NADPH- 
cytochrome c reductase activity. This increase was slightly 
lower than observed in the preliminary study. This difference 
may be due to a dose-related effect. Increases in activity of 
1.5-fold with 0.5% treatment and 2.0-fold with 0.75% treatment 
were observed in this study, whereas a 2.5-fold increase was 
observed with treatment at 0 .8 % of body weight in the 
preliminary study.
From these observations it appears Sesbania drummondii 
increases the rate of electron transfer from the NADPH 
cytochrome P-450 reductase component of the cytochrome P-450 
monooxygenase system in the chicken but not the rat. Sesbania 
drummondii does not change the rate of electron transfer from 
the NADH cytochrome b5 reductase in either the chicken or the 
rat. However, it is not possible to determine from these data
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what these findings represent in terns of the overall 
cytochrome P-450 nonooxygenase system.
It is well established (White and Coon, 1980) that the NADPH 
cytochrome P-450 reductase is the rate limiting component of 
the cytochrome P-450 catalytic cycle. Therefore, changes 
induced in the rate of electron transfer may result in
increased cytochrome P-450 enzyme activity. The contribution 
of the NADPH cytochrome P-450 reductase to the cytochrome P- 
450-mediated activity can be determined by comparing the 
NADPH-dependent metabolism to the organic hydroperoxide 
(NADPH-independent) metabolism of cytochrome P-450 substrates.
Organic hydroperoxides can replace NADPH and oxygen in 
supporting the metabolism of xenobiotics by the liver
microsomal cytochrome P-450 system (Kadlubar et ai., 1973; 
Rahimluta and O'Brien, 1974). This type of activity reflects 
the ability of cytochrome P-450 to act as a peroxygenase as 
illustrated below (White and Coon, 1980):
-SH + ROOH --- *^52— 5 * SOH + ROH
The organic hydroperoxides have performed in a number of 
different hydroxylation reactions including: aliphatic
(Nordblom and Coon, 1977) and aromatic hydroxylation
(Rahimtula and O'Brien, 1974), N- or O-dealkylation (Nordblom
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and Coon, 1977), alcohol dehydrogenation (Rahimtula and 
O'Brien, 1977) and alkene epoxidation (White and Coon, 1980).
Two cytochrome P-450-mediated activities, aminopyrine N- 
demethylase and aldrin epoxidase, were selected for 
comparisons of NADPH-dependent versus organic hydroperoxide- 
dependent metabolism in sesbania drummondii. phenobarbital, 
and B-naphthoflavone-treated animals. Aminopyrine N- 
demethylase has been studied using both of these systems in 
the rat but not the chicken (Kadlubar , 1973; Winston
and Cederbaum, 1983a and 1983b; Estabrook et al., 1984). To 
the best of our knowledge, aldrin epoxidase has not been 
previously reported utilizing organic hydroperoxides in either 
species.
In the Sesbania drummondii-treated chicken, increases in both 
the NADPH-dependent aminopyrine N-demethylase and aldrin 
epoxidase specific and molar activities were observed. 
Difference between these two activities, however, were evident 
for cumene hydroperoxide as the mediator. The specific 
activity of the cumene hydroperoxide-dependent metabolism of 
aminopyrine was similarly increased as the NADPH-dependent 
metabolism, whereas the molar activity was unchanged from the 
control rate with the cumene hydroperoxide-dependent reaction 
but increased in the NADPH-dependent reaction at the 0.75% 
dosage treatment with £. drummondii. This suggests that the
distinct difference in the NADPH-dependent aminopyrine N- 
demethylase activity in the chicken treated with £. drummondii 
may not be due only to a change in the cytochrome P-450 
isozyme profile responsible for the metabolism of aminopyrine 
but may instead be due to the induction of the NADPH 
cytochrome P-450 reductase which when increased is no longer 
rate limiting resulting in a higher rate of activity. When 
this change is removed as was done by substituting the cumene 
hydroperoxide, the difference in the molar activity between 
control and S. drummondi i-treated chickens is no longer 
observed. Similar to the results with S. drummondii. 
differences in aminopyrine N-demethylase molar activity were 
not observed with phenobarbital treatment of chickens. This 
finding is more difficult to explain in terms of the reductase 
component because phenobarbital in the chicken did not 
increase the rate of electron transfer from the NADPH 
cytochrome P-450 reductase. Perhaps instead, phenobarbital 
altered the cytochrome P-450 isozyme profile such that the 
vector arrangement between the reductase and the cytochrome P- 
450 isozymes was more efficient for electron transfer. The 
difference induced by B-naphthoflavone treatment in chickens 
was equally evident for both NADPH- and cumene hydroperoxide- 
dependent aminopyrine N-demethylase reaction suggesting that 
the increase in activity was truly due to induction of a 
specific cytochrome P-450 isozyme family.
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In contrast to the aminopyrine N-demethylase activity in the 
chicken, aldrin epoxidation was induced in both NADPH and 
cumene hydroperoxide systems for both specific and molar 
activities with Sesbania drummondii treatment. This implies 
that £>. drummondii induces the isozyme family responsible for 
the metabolism of aldrin because the induction of the 
reductase component does not contribute to the increased 
activity. This was also true for phenobarbital treatment. 
Aldrin epoxidase activity was increased with and without NADPH 
which also indicates that an isozyme family that metabolizes 
aldrin is induced by phenobarbital. The effect of B- 
naphthoflavone treatment on the metabolism of aldrin was 
similar in both NADPH and cumene hydroperoxide systems. The 
findings with phenobarbital and B-naphthoflavone were not 
unexpected since neither of these inducers were found to 
increase NADPH cytochrome P-450 reductase in the chicken.
In the rat, Sesbania drummondii treatment decreased both 
NADPH-dependent metabolism of aminopyrine and aldrin. We can 
conclude that this decrease is partially the result of a 
decrease in the cytochrome P-450 component because we observed 
a decrease in the cytochrome P-450 specific content as well as 
normalizing of the aminopyrine N-demethylase activity to the 
control rate by expressing the activity as per nmole of P-450. 
However, we did observe a specific decrease in the aldrin 
epoxidase molar activity which may indicate a specific change
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in the constitutive isozyme profile. This finding may also be 
partly the result of £. d r u m m o n d i i  induced faulty transfer of 
electrons from the reductase component to the cytochrome P-450 
isozyme. This was the question addressed by using cumene 
hydroperoxide. We found that the cumene hydroperoxide- 
mediated aldrin epoxidase reaction followed a pattern similar 
to the NADPH-dependent reaction for both aminopyrine N- 
demethylation and aldrin epoxidation. This implies that in 
terms of aldrin epoxidation in the rat, Sesbania drummondii 
treatment does not appear to cause a faulty electron transfer 
because if it had then the cumene hydroperoxide-dependent 
activity would have approached the rate of the NADPH-dependent 
activity. Instead, it appears that S. drummondii treatment of 
the rat actually changed the isozyme profile such that aldrin 
is less effectively metabolized.
The contribution of the NADPH cytochrome P-450 reductase 
component of the cytochrome P-450-mediated metabolism of 
aminopyrine is clearly established by comparing cumene 
hydroperoxide-dependent metabolism to NADPH-dependent 
metabolism in phenobarbital-treated rats. Phenobarbital 
treatment increases both specific and molar activities of 
NADPH-dependent aminopyrine metabolism. However, with the 
cumene hydroperoxide-dependent metabolism, and when the rate 
of the reaction is adjusted for the total cytochrome P-450 
content, the molar activity for the phenobarbital-treated rats
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is equivalent to that of control rats. This suggests that the 
phenobarbital induction of the NADPH cytochrome P-450 
reductase in rats result in an abundance of this component 
which is no longer rate limiting and the metabolism proceeds 
at a greater rate.
The relationship of the reductase component to aldrin 
epoxidation in the phenobarbital-treated rat was not clearly 
established using cumene hydroperoxide. In the NADPH- 
dependent epoxidation of aldrin, phenobarbital treatment 
resulted in a marked increase in activity. However, with the 
cumene hydroperoxide-dependent reaction the specific activity 
was not different from controls. But when adjusted for the 
elevation of total cytochrome P-450 specific content, the 
difference of phenobarbital treatment was evident. There are 
two possible explanations for this finding. Firstly, the 
increase in the aldrin epoxidase activity that occurs with 
phenobarbital treatment is related to the induction of the 
NADPH reductase component and not to specific changes if the 
cytochrome P-450 isozymes. The second explanation addresses 
mechanistic complications with cumene hydroperoxide. In 
addition to contributing electrons and oxygen, cumene 
hydroperoxide also is reported to interact with the binding 
domain of cytochrome P-450 (Rahimtula and O'Brien, 1975; 
O'Brien and Rahimtula, 1980). This phenomena is likely to 
effect particular isozymes of cytochrome P-450 more than
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others and potentially block the ability of a substrate to 
interact with that cytochrome and be metabolized. This 
complication could explain our findings with cumene 
hydroperoxide and aldrin in phenobarbital-treated rats. 
Cumene hydroperoxide may have bound to the substrate binding 
site of the phenobarbital-inducible cytochrome P-450 form and 
inhibited the binding of aldrin. The constitutive forms of P- 
450 possibly were not affected by cumene hydroperoxide binding 
and this resulted in similar rates of metabolism of aldrin in 
control and phenobarbital-treated rats. The second 
explanation is more likely the reality because phenobarbital 
induces a specific cytochrome P-450 form (P-450IIB1) in the 
rat which is highly specific for aldrin.
Cumene hydroperoxide did not change the effect of 6- 
naphthoflavone treatment on rat N-demethylation of 
aminopyrine. No difference between the cumene hydroperoxide 
and the NADPH-dependent reactions were noted. This finding 
was not unexpected since B-naphthoflavone is not known to 
induce the NADPH-cytochrome P-450 reductase in the rat. 
However, the decrease in the NADPH-dependent aldrin epoxidase 
activity observed in B-naphthoflavone-treated rats, was not 
present in the cumene hydroperoxide-dependent reaction. This 
contradicts the hypothesis that the decrease in the NADPH- 
dependent aldrin expoxidation activity with B-naphthoflavone 
was related to the induction of an isozyme with lower affinity
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for aldrin. This nay instead indicate that B-naphthoflavone 
treatment in the rat changes the vectorial alignment between 
the cytochrome P-450 forms and the reductase such that 
effective electron transfer is not achieved. When electrons 
were directly given the B-naphthoflavone induced cytochromes, 
a similar rate of metabolism was observed as for the controls.
As previously discussed, cumene hydroperoxide can interact 
with the binding domain of cytochrome P-450. This appears to 
be a problem for the phenobarbital-inducible P-450 to interact 
with aldrin but not with aminopyrine. This problem can be 
avoided by replacing cumene hydroperoxide with t-butyl 
hydroperoxide in the cytochrome P-450-mediated activities 
(Rahimtula and O'Brien, 1975? O'Brien and Rahimtula, 1980). 
The chemical structures of the two organic hydroperoxides 
(Figure 8) are markedly different. They differ in intrinsic 
electrophilicity and in steric requirements resulting in 
variation in regioselectivity (White and Coon, 1980).
Some differences between rat and chicken aminopyrine N- 
demethylase and aldrin epoxidase activities were observed with 
t-butyl hydroperoxide replacement of cumene hydroperoxide. In 
the chicken, the t-butyl dependent aminopyrine N-demethylation 
was unchanged for Sesbania drummondii. phenobarbital, and B- 
naphthoflavone treatments as compared to controls. The most 
likely explanation for this finding was that t-butyl
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hydroperoxide is not very effective at contributing electrons 
and/or oxygen to the cytochrome P-450 forms that metabolize 
aminopyrine in the chicken. This was suggested by the very 
small rates of formaldehyde production observed in all groups.
As was observed in the chicken, t-butyl hydroperoxide is a 
poor mediator of aminopyrine N-demethylation in the rat. t- 
Butyl hydroperoxide-dependent aminopyrine N-demethylase 
specific activities were much lower than those for cumene 
hydroperoxide. However the differences among the treatment 
groups were the same with the two organic hydroperoxides. 
These differences were not evident when the activity was 
expressed per nmole of P-450 which also suggests t-butyl 
hydroperoxide is a poor and non-selective mediator of aldrin 
epoxidation.
t-Butyl hydroperoxide was also less effective in mediating 
aldrin epoxidation than was cumene hydroperoxide in the 
chicken. However, the differences among the treatment groups 
were still evident. Aldrin epoxidation appears to be a much 
more sensitive assay than aminopyrine N-demethylation and 
provides for a useful assay to distinguish the effects of t- 
butyl hydroperoxide with cumene hydroperoxide.
The utility of t-butyl hydroperoxide in studying organic
hydroperoxide-mediated metabolism was most evident for aldrin 
epoxidation in the rat. Cumene hydroperoxide was hypothesized 
to interfere with aldrin epoxidation in phenobarbital-treated 
rats resulting in equivalent rates of aldrin metabolism in 
both controls and phenobarbital-treated rats. This was 
confirmed with t-butyl hydroperoxide. An increase in aldrin 
epoxidase specific activity in phenobarbital-treated rats was 
observed with t-butyl hydroperoxide as has been previously 
observed in the NADPH-dependent reaction. However, the t- 
butyl hydroperoxide-dependent aldrin epoxidase molar activity 
for rats treated with phenobarbital was not different from 
controls which may suggest that phenobarbital induction of the 
reductase does contribute to some of the increase in activity. 
The explanation of the change in NADPH-dependent aldrin 
epoxidase activity by B-naphthoflavone treatment in rats 
received additional support with t-butyl hydroperoxide. The 
t-butyl hydroperoxide-dependent results agreed with the cumene 
hydroperoxide-dependent results in that control and B- 
naphthoflavone treated rats metabolize aldrin at similar rates 
and that the decreased activity observed in the NADPH- 
dependent reaction may be due to faulty electron transfer 
between the reductase and cytochrome components of the 
cytochrome P-450 monooxygenase system.
With the one exception of t-butyl hydroperoxide-dependent 
metabolism of aminopyrine in the chicken, no major differences
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between cumene hydroperoxide and t-butyl hydroperoxide were 
observed in Sesbania drummondii-treated chickens or rats.
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D. PHASE IV ~ INDUCTION OF MICROSOMAL ENZYMES BY SESBANIA
DRUMMONDII AS DETERMINED BY SDS-PAGE AND WESTERN
BLOTS WITH ANTI-CYTOCHROME Ezi^S ANTIBODIES t
COMPARISON WITH EFFECTS CAUSED BY PHENOBARBITAL AND 
fi-NAPHTHOFLAVONE.
OBJECTIVES;
1. To compare the effects of Sesbania drummondii, 
phenobarbital, and B-naphthoflavone on the SDS-PAGE 
patterns of chicken and rat hepatic microsomes.
2. To determine cross-reactivities of anti-cytochromes P-450
with proteins induced by Sesbania drummondii.
phenobarbital, and B-naphthoflavone in chicken and rat 
hepatic microsomes.
MATERIALS AND METHODS:
A. SUsmifialS;
1. Sodium dodecylsulfate polyacrylamide gel
electrophoresis (SDS PAGE): Acrylamide, N,N'-methylene-bis-
acrylamide (bis), ammonium persulfate, N,N,N',N'- 
tetramethylethylenediamine (TEMED), and bromophenol blue were 
purchased from Bio-Rad Laboratories (Richmond, CA). Protein 
standards consisting of rabbit muscle phosphorylase B (97,400 
MW), bovine serum albumin (66,000 MW), hen egg white ovalbumin 
(45,000 MW), bovine carbonic anhydrase (31,000 MW), soybean
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trypsin inhibitor (21,500 MW), and hen egg white lysozyme 
(14,400 MW) were also obtained from Bio-Rad. Tris 
[hydroxymethyl] aminomethane hydrochloride (Tris-HCL buffer), 
glycine, and 2-mercaptoethanol were purchased from Sigma 
Chemical Co. (St. Louis, MO). Sodium dodecyl sulfate (SDS) 
was obtained from Mallinckrodt, Inc. (Paris, KY), and 
Coomassie blue R-250 was purchased from Amresco (Solon, OH).
2. Western blotting: Goat polyclonal antibodies raised 
against rabbit cytochrome P-450 form and LM2 (IIB1) were 
purchased from Oxford Biomedical Research, Inc. (Oxford, MI). 
Rabbit polyclonal antibodies to rat cytochrome P-450 forms b 
and c were generously provided by Dr. M.J.J. Ronis (Department 
of Pediatrics, University of Arkansas Medical School, Little 
Rock, AR) . Goat anti-rabbit IgG-alkaline phosphatase 
conjugate and 5-bromo-4-chloro-3-indole phosphate (BCIP) were 
purchased from Bio-Rad Laboratories (Richmond, CA). Rabbit 
anti-goat IgG-alkaline phosphatase conjugate, p-nitro blue 
tetrazolium (NBT), tris[hydroxymethyl]aminomethane (Tris 
buffer), glycine, and Triton X-100 were obtained from Sigma 
Chemical Co. (St. Louis, MO). Sodium dodecylsulfate and 
methanol were obtained from Mallinckrodt, Inc. (Paris, KY). 
Nitrocellulose membranes were purchased from Schleicher and 
Schuell (Keene, NH), and 3MM chromatography paper was obtained 
from Whatman Limited (England). Dried milk powder (Carnation 
brand) and gelatin (Knox brand) were purchased from a local
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grocery store. All other chemicals were reagent grade.
B. Animals;
Hale White Leghorn chickens and Sprague-Dawley rats were 
obtained, cared for, and assigned to treatment groups as 
described in detail in Phase II.
C. Treatment;
Animals were treated with either bicarbonate-azide buffer 
(controls), S. drummondii extract, phenobarbital, or 6- 
naphthoflavone as described in detail in Phase II.
D. Preparation of microsomes:
Microsomes were prepared from pooled livers of the subgroup, 
treated or control, as described in detail in Experiment 1, 
Phase I.
E. Protein determination;
The concentration of protein of the microsomal suspensions was 
determined as described in detail in Experiment 1, Phase I.
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F. Sodium_dQdecvlsulfate polvacrvlamide gel electrophoresis
IS p S .P&S E l:
Discontinuous SDS-PAGE gels were prepared and run essentially 
according to the method of Laemmli (1970).
1. Preparation of gels: Slab gels were prepared at 10%
(w/v) total monomer concentration from a stock solution 
containing acrylamide and bis at a ratio of 29.2 : 0.8. Tris- 
HCL buffer (pH 8.7) and SDS were included at final 
concentrations of 0.375 M and 0.1% (w/v), respectively.
Monomer solutions were deaerated and polymerization was 
effected by addition of 0.05% each TEMED (v/v) and ammonium 
persulfate (w/v). Separating gels (ca. 80 x 60 x 0.75 mm) 
were cast and electrophoresed in a Bio-Rad Mini-Protein II 
apparatus. Stacking gels, comprised of 4% total monomer,
0.125 M Tris-HCL buffer (pH 6.9) and 0.1% SDS (w/v) were 
polymerized after deaeration via addition of 0.1% (v/v) TEMED 
and 0.05% (w/v) ammonium persulfate and were cast over
separating gels with a teflon comb in place to form sample 
wells.
2. Preparation of samples: Protein samples were 
diluted to give a final concentration of 2 Mg/ml protein in a 
buffer containing 0.1 M Tris-HCL (pH 6.9), 16% (v/v) glycerol, 
1.6% (w/v) SDS, 4% (v/v) 2-mercaptoethanol, and 0.008% (w/v) 
bromophenol blue, and boiled for 10 min. Aliquots of each
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sample containing 30 f ig protein were underlayed in the sample 
wells after assembly of the "upper" electrode buffer chamber. 
A mixture of protein standards prepared in the same manner 
were included in one sample well.
3. Electrophoresis: The gel sandwiches and upper 
buffer chamber were assembled together with the lower buffer 
chamber, and electrode buffer containing 25 mM Tris (pH 8.3),
0.192 M glycine, and 0.1% (w/v) SDS was added. A potential 
difference of ca. 200 V was applied across the gel (ca. 30 
mA/gel) with an EC105 Minicell (E-C Apparatus Corp., St. 
Petersburg, FL) constant voltage power supply for ca. 60 min 
until the tracking dye reached the bottom of the gel.
4. Staining and destaining: At the end of the run,
electrophoresis was stopped and gels were removed from 
sandwiches. Gels were shaken in a staining solution 
containing 0.1% (w/v) Coomassie blue R-250, 40% (v/v)
methanol, and 10% (v/v) acetic acid for at least 2 hr.
5. Measurement: Molecular weights were determined by 
comparing the relative mobility of the microsomal protein 
bands to the logarithms of the protein molecular weight 
markers.
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6. Storage: Completed gels were dried between two
layers of BioGelWrap (BioDesign Inc., Carmel, NY). Gels 
preserved in this way can be stored indefinitely.
G. Western blotting:
Electrophoretic transfer of proteins from SDS-polyacrylamide 
gels to nitrocellulose membranes was accomplished essentially 
by the method of Towbin al. (1979). Immunoreactive
proteins were detected with a secondary antibody-alkaline 
phosphatase conjugate used in conjunction with 5-bromo-4- 
chloro-3-indole phosphate and p-nitro blue tetrazolium (Blake 
et al., 1984).
l. Electrophoretic transfer: Transfer buffer,
containing 0.25M Tris buffer (pH 8.3), 0.192 M glycine, 0.1% 
(w/v) SDS, and 20% (v/v) methanol, was prepared and prechilled 
to 4 C. Microsomal proteins were separated on SDS 
polyacrylamide gels. Gels were equilibrated in transfer 
buffer for at least 15 min. Nitrocellulose membranes were cut 
to the dimensions of each gel and soaked in transfer buffer 
for 15 to 30 min. Proteins were transferred from gels to 
nitrocellulose membranes in a Bio-Rad Trans-Blot 
electrophoretic transfer cell assembled according to the 
manufacturers directions. Briefly, a fiber pad saturated in 
transfer buffer was placed on the cathode-side panel of the 
gel holder and topped with a piece of chromatography paper cut
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to fit the fiber pad. The pre-$quilibrated gel was then laid 
atop the paper, the pre-wet membrane was placed on top of the 
gel, and a second piece of saturated chromatography paper 
covered the membrane. Care was taken to prevent the formation 
of air pockets between each layer. The blotting sandwich was 
completed by placing a second saturated fiber pad on top and 
closing the gel holder. The holder was mounted in the cell, 
ca. 2.5 L transfer buffer was added, and the buffer was 
stirred throughout the transfer. A potential difference of 
ca. 60 V (ca. 200 mA) was applied across the cell with an 
EC105 Hinicell (E-C Apparatus Corp., St. Petersburg, FL) 
constant voltage power supply and transfer was completed in 
ca. 5 hrs.
2. Development of the blot: Membranes were removed
from the blotting cell and shaken for two hrs at 37 C in a 
solution of 50 mM Tris buffer (pH 7.4), 0.2 M Naci, and 0.05% 
(v/v) Triton X-100 (Tris-buffered saline or TBS) containing 5% 
(w/v) milk powder. Membranes were then washed by shaking for 
10 min in two changes of TBS. Incubation with primary 
antibodies (anti-P-450) at recommended dilutions in TBS 
containing 1% (w/v) gelatin was effected at 37 C with shaking 
for l hr. Membranes were again washed by shaking for 10 min 
in two changes of TBS and incubation with the secondary 
antibody-alkaline phosphatase (AP) conjugate at the 
recommended dilution in TBS containing 1% (w/v) gelatin was
effected at 37 C with shaking for 1 hr. Membranes were washed 
by shaking for 10 min in 2-4 changes of TBS. Alkaline 
phosphatase-linked proteins were detected by reaction with NBT 
and BCIP: membranes were shaken in 25 mL of a solution of 
sodium bicarbonate (pH 9.8) and 2 mM MgCl2, containing 125 /il 
of 30 mg/mL NBT in 70% aqueous dimethylformamide and 125 /;L of 
15 mg/mL BCIP in dimethylformamide until purple bands 
appeared.
196
RESULTS:
1. SDSrPolvacrvlamide gel electrophoresis:
Microsomal protein profiles from control, £. drummondii-. 
phenobarbital-, and 6-naphthoflavone-treated chickens and rats 
are shown in Figures 9 and 10. The electrophoretic patterns 
of chicken microsomal proteins were similar for control, S. 
drummondii. phenobarbital, and 6-naphthof lavone treatments but 
showed increased staining intensity of specific bands with the 
treatments. B-Naphthoflavone treatment produced the most 
distinct protein profile of the treated chickens with a 
markedly increased staining intensity of protein bands 
corresponding to molecular weights of 50,000, 53,500 and
56,000. Microsomes from phenobarbital-treated chickens 
produced two protein bands slightly more intense than controls 
corresponding to molecular weights of 53,500 and 56,000. S. 
drummondii treatment of chickens produced a dose-dependent 
increase in the staining activity of three protein bands 
corresponding to 50,000, 52,500, and 55,000 molecular weights.
The electrophoretic patterns of rat microsomes were similar 
for control and Sesbania drummondii treatments but were 
distinctly different for phenobarbital and 6-naphthoflavone 
treatments. B-Naphthoflavone treatment markedly induced two 
protein bands of 52,500 and 55,000 molecular weights. Two 
microsomal protein bands of 55,000 and 60,000 molecular 
weights were also induced with phenobarbital-treated rat
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Figure 9. SDS-polyacrylamide gel electropherosis of control and 
Sesbania drummondii. phenobarbital, and Jl-naphthoflavone- 
stimulated microsomal proteins of chickens.
Microsomal suspensions containing 30 jig of proteins were 
loaded on a 10% separating gel and subjected to gel 
electrophoresis as described in the methods section.
Lane S: Molecular weight standards; Lane 1: Control
chicken microsome; Lane 2: Sesbania drummondii-treated 
(0.5%) chicken microsome; Lane 3: Sesbania drummondii- 
treated (0.75%) chicken microsome; Lane 4; Phenobarbital- 
induced chicken microsome; Lane 5: fl-naphthoflavone-
induced chicken microsome.
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Figure 10. SDS-polyacrylamide gel electrophoresis of control and
S e g f r a n l f t______ drummondii. phenobarbital, and fl-
naphthoflavone-stimulated microsomal proteina of rata.
Microsomal suspensions containing 30 jig of proteina were
loaded on a 10% separating gel and subjected to gel
electrophoresis as described in the methods section.
A. SDS-page of "classical”cytochrome P-450 inducers.
Lane Si Molecular weight standards; Lane It Control
rat microsome; Lane 2: Phenobarbital-induced rat
microsome; Lane 3: B-naphthoflavone-induced rat
microsome.
B. SOS-page of Sesbania drummondii-treated microsome.
Lane St Molecular weight standards; Lane It Control
rat microsome; Lane 2t Sesbania drummondii-treated 
rat microsome; Lane 3: Phenobarbital-treated rat
microsome.
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microsomes. The electrophoretic pattern with £. drummondii 
treatment of rats exhibited similar protein bands to control 
microsomes, but the bands were of lower intensity.
2. Western blots;
The results of the cross-reactivity studies of chicken and rat 
hepatic microsomes with antibodies to rat cytochromes P-450IA1 
and P-450IIB1 are summarized in Table 29. strong cross­
reactivity with the antibody against rat P-450IA1 was seen 
with 6-naphthoflavone-treated rats and 6-naphthoflavone- and
S . drummondii-treated chickens (Figure 11). There were two 
protein bands recognized with rat anti-P-450IAl in the 
Sesbania drummondi i-treated chicken. One of the bands 
corresponded to the chicken 6-naphthoflavone protein band and 
the other band was of a lower molecular weight. The control 
chicken microsomal protein showed weak cross-reactivity with 
this antibody. No cross-reactivity of the £S. drummondii- 
treated rat microsomal protein was observed with the antibody 
against rat P-450IA1.
The antibody against rat cytochrome P-450XIB1 strongly cross­
reacted with a microsomal protein from the phenobarbital- 
treated rat and weakly cross-reacted with the control rat 
microsomal protein (data not shown). All of the chicken 
microsomal proteins weakly cross-reacted with this antibody.
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Figure 11. Western blot showing cross reactivity between antibodies
ho rat P-450 XA1 with liver microsoake from rats induced
by B-naphthoflavone and with liver microsomes from
control, Sesbania drummondii-. and B-naphthoflavone-
induced chickens.
Lane li Control rat microsome; Lane 2t B-naphthoflavone- 
induced rat microsome; Lane 3: S.drummondii-treated rat 
microsome; Lane 4: control chicken microsome; Lane 5: B-
naphthof lavone-induced chicken microBome; Lane 6:
s.dT-nrrmondii- (0.5%) induced chicken microsome (0.5%);
Lane 7s s.rtmmmondil-lnduced chicken microsome (0.75%).
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Table 29; Cross-reactivity detected in hepatic microsomes from 
control, Sesbania drummondii-. phenobarbital-, and - 
naphthof lavone-treated chickens and rats using polyclonal 
antibodies prepared against members of rat cytochrome P- 
___________ 450 isozymes._______
Species Treatment Antibody to rat P-450
IAl IIB1
Chicken Control +• +-
S. drummondii fO.5%1 2 bands +-
S. drummondii fO.75%1 2 bands +-
Phenobarbital ND +-
8-Naphthoflavone ++ +-
Rat Control
S. drummondii - -
Phenobarbital ND + +
B-Naphthoflavone ++
++ Indicates cross-reactivity with a single protein band
+- Indicates weak cross-reactivity with a single protein
band
Indicates no cross-reactivity 
ND Not determined
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DISCUSSION:
SDS-gel electrophoresis has become a fundamental approach for 
the assessment of protein profiles of microsomal preparations. 
The discontinuous gel system of Laemmli (1970) has proven most 
effective for resolution of cytochromes P-450. Under optimal 
conditions isozymes differing in minimum molecular weights by 
only 500 daltons can be separated by this system (Ryan and 
Levin, 1990).
Induction in chicken and depression in rat hepatic microsomal 
proteins with Sesbania drummondii treatment were found using 
SDS-gel electrophoresis and confirmed the altered catalytic 
activities observed previously. This was indicated by 
increases in protein band staining intensity in the chicken 
microsomal proteins and decreases in protein band staining 
intensity in the rat microsomal proteins with S. drummondii 
treatment. The induction of cytochrome P-450 in the S. 
drummondii-treated chicken was also observed to be dose- 
dependent in gels.
The Sesbania drummondii-induced chicken microsomal protein 
profile as measured by the molecular weights of the protein 
bands did not closely parallel the protein profiles of 
phenobarbital or 6-naphthoflavone. S . drummondii treatment 
resulted in induction of protein bands that were not induced 
by either the classical inducers. Few comparisons of the £.
drummondii gel protein profile to that of other inducers are 
possible because of the limited study of SDS-gel 
electrophoresis in avian microsomes. Hexachlorobenzene, 
reported to be a mixed-type of inducer in rats, was found in 
quail microsomal proteins to have an electrophoretic pattern 
similar to that produced by 6-naphthoflavone (Carpenter e£ 
al., 1985). Methyl isobutyl ketone and n-hexane administered 
to adult White Leghorn hens increased protein bands of similar 
molecular weights to phenobarbital induction (Abou-donia g t  
al.. 1985). S,S,S-Tri-n-butyl phosphorothrithioate (DEF) was 
also shown in the White Leghorn hen to induce an 
electrophoretic protein profile similar to that of 
phenobarbital (Lapadula et al.. 1984). Using electrophoretic 
analysis, Sundstrom e£ &1, (1989) reported that 17a-
ethynylestradiol potentiated the two protein bands of 3- 
methylcholanthrene treatment in primary cultures of livers 
from 16- to 17-day old chicken embryos. Sinclair et al. 
(1989) observed that ethanol and glutethimide administered to 
cultured chick hepatocytes induced two microsomal proteins of 
50,000 and 53,000 molecular weights. The proteins induced in 
the Sinclair al* (1989) report were of a similar molecular 
weight to those induced in our Sesbania drummondii-treated 
chickens. However, caution in interpreting gel data is 
necessary because several cytochromes P-450 have identical 
minimum molecular weights, and other microsomal proteins such 
as epoxide hydrolase migrate to the same region of the gel (Lu
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et al.» 1975; Ryan and Levin, 1990). In addition, the value 
of the molecular weights for cytochromes P-450 as determined 
by the protein resolution may vary with electrophoretic 
conditions, including sources of reagents, buffer conditions, 
percentage of acrylamide, standards, and running time.
Sesbania drummondii treatment of rats resulted in a microsomal 
protein profile that was similar to that of control rat 
microsomal protein but with lower protein band staining 
intensity. There was no resemblance between the £.
drummondii-treated rat microsomal protein profile and that of 
either phenobarbital or B-naphthoflavone.
Some of the above limitations of SDS-gel electrophoresis can 
be addressed through immunochemical identification. 
Immunoblotting techniques (western blots) have been used 
successfully to identify cytochromes P-450 in different 
tissues and species and to examine the influence of inducers 
on microsomal levels of certain isozymes (Ryan and Levin, 
1990).
Cross-reactivity in western blots was used to examine the 
appearance of cytochrome P-450 isozymes resulting from 
Sesbania drummondii treatment that were structurally related 
to known, inducible rat forms. Antibody directed against rat 
cytochrome P-450IA1 detected two microsomal proteins from £.
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drummondii-treated chickens, suggesting that treatment with an 
extract of Sesbania drummondii induces cytochrome P-450 forms 
in the chicken from the I gene family. One of the two protein 
bands detected corresponded with the protein band observed 
with B-naphthoflavone treatment which indicates that £. 
drummondii treatment induces an orthologue of rat P-450IA1 in 
the chicken. However, there was a second protein band 
detected in the S. drummondi i-treated chicken microsomal 
protein that was not observed with any of the other 
treatments. There are several possible explanations for the 
detection of two protein bands with £. drummondii treatment of 
chickens. The first hypothesis is the second band may 
represent an orthologue to rat P-450IA2 (P-450d). This could 
be possible because the polyclonal antibody against P-450IA1 
has been reported to cross-react with P-450IA2 isozyme of the 
rat (Ryan and Levin, 1990). Both cytochromes P-450IA1 and P- 
450IA2 are induced by 3-methylcholanthrene-type inducers in 
the rat. The presence of an orthologue in the chicken related 
to rat P-450IA2 has not, to the best of our knowledge, been 
reported. However, orthologues to this rat cytochrome have 
been detected in the mouse, rabbit, and human (Nebert et: &X., 
1989b). This hypothesis may be discounted, however, because 
in our study B-naphthoflavone, which reportedly induces both 
P-450IA1 and P-450IA2 in the rat, induced only one protein 
band (supposedly P-450IA1) in both rats and chickens that 
cross reacted with the antibody against the rat P-450IA1. A
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second hypothesis explaining the detection of the second band 
was that Sesbania drummondii treatment induced a new unique 
cytochrome P-450 isozyme in the chicken that shares an epitope 
to the rat P-450IA1 form. The third hypothesis is that the 
two protein bands observed with the £. drummondii-treated 
chicken microsomes were the result of protein degradation. 
However, this problem was unlikely since both bands were seen 
in the 50,000 to 60,000 molecular weight cytochrome P-450 
region and microsomal protein samples kept for up to two years 
at 70 C have shown no change in pattern of cross-reactivity 
(Ronis gt al., 1990).
The western blot results clearly indicated species differences 
in the effects of Sesbania drummondii treatment on cytochrome 
P-450 isozymes. In contrast to the two protein bands detected 
in chickens, no bands were detected in the rat S. drummondii- 
treated microsomal protein with the antibody against rat P- 
450IA1.
Less definitive conclusions about the western blot of Sesbania 
drummondii treatment of chickens and the antibody against rat 
P-450IIB1 can be drawn from our study because of the weak 
cross-reactivity of all the chicken groups with this antibody. 
Similar weak cross-reactivities to this antibody have been 
reported in a number of wild sea birds (Ronis si., 1990). 
The lack of strong cross-reactivity of our phenobarbital-
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treated chicken microsomal protein with the antibody against 
rat P-450IIB1 indicates that this rat antibody does not 
discriminate the phenobarbital-inducible cytochrome P-450 
isozyme of the chicken. This finding, in addition to our 
reported difference in alkoxyphenoxazone metabolism, support 
the contention that phenobarbital induces different cytochrome 
P-450 forms in chickens versus rats.
The results of the western blot of the Sesbania drummondii- 
treated rat microsomal protein clearly indicate no detection 
by the antibody against rat P-450IIB1 suggesting that this 
treatment does not induce the cytochrome P-450IIB1 isozyme in 
the rat.
CHAPTER 3 
SUMMARY AND CONCLUSIONS
Preliminary investigations indicated an extract of Sesbania 
drummondii induces different responses in chicken versus rat 
hepatic microsomal cytochrome P-450 monooxygenase systems. 
Groups of 4- to 8-week old White Leghorn chickens and Sprague- 
Dawley rats were given extracts of Sesbania drummondii by 
gavage for 3 days. Doses, which were 0.8% and 0.4% of daily 
body weights, respectively for chickens and rats, were 
adjusted to induce similar clinical changes in the two 
species. The hepatic microsomal cytochrome P-450
monooxygenase system of untreated control and treated animals 
were compared using cytochrome P-450 specific content, 
cytochrome b5 specific content, NADH- and NADPH-cytochrome c 
reductase activity, and six cytochrome P-450-mediated 
activities. Increases of 2-fold in the cytochrome P-450 
content, NADPH-cytochrome c reductase, aminopyrine N- 
demethylase, aniline hydroxylase, ethoxycoumarin o-deethylase, 
and aryl hydrocarbon hydroxylase activities; 4-fold in aldrin 
epoxidase activity; and 15-fold in ethoxyresorufin O- 
deethylase activity were observed in Sesbania drummondii- 
treated chickens. In contrast, the treated rats had nearly 2- 
fold decreases in these values. These findings indicated 
marked phylogenetic differences in control, regulation, or 
expression of the microsomal mixed function monooxygenase
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systems between these avian and mammalian species in response 
to Sesbania drummondii extract.
The changes induced in the chicken and rat hepatic microsomal 
cytochrome P-450 monooxygenase system were not due to the 
sodium bicarbonate-sodium azide buffer used to prepare the 
Sesbania drummondii extract. The cytochrome P-450 specific 
content, aminopyrine N-demethylase and ethoxyresorufin 0- 
deethylase activities were essentially the same in chickens 
and rats treated with the buffer versus animals not given the 
buffer. This was of particular concern because azide is an 
effective ligand and inhibitor of heme-iron containing 
enzymes such as catalase, peroxidase, and cytochrome oxidase 
(Keilin, 1936-1937; Smith et al., 1977; Winston and Cederbaum, 
1982).
The loss of mixed function monooxygenase activity in the rat 
and the induced activity in the chicken probably were not due 
to a general loss of microsomal membrane stability or 
proliferation of endoplasmic reticulum, respectively as 
glucose-6-phosphatase, a microsomal membrane marker enzyme, 
was not changed by Sesbania drummondii treatment in either 
species. This was also confirmed by the fact that neither 
species exhibited changes in cytochrome b5 specific content. 
This also indicates that there is no alteration in either 
species of general cytochrome anabolism or catabolism.
Additional studies focusing on the individual enzyme 
components as well as the functionality of the intact 
cytochrome P-450 monooxygenase system were conducted to 
further elucidate the effects of an extract of Sesbania 
drummondii on the chicken versus rat hepatic microsomal 
cytochrome P-450 system. The cytochrome P-450 enzyme component 
was assessed through characterization of cytochrome P-450 
specific contents, cytochrome P-450 absorbance maxima, 
electrophoretic patterns, and immunochemical profiles of the 
hepatic microsomal proteins from chickens and rats treated 
with Sesbania drummondii. The NADPH-cytochrome P-450 
reductase component was evaluated by measuring NADPH- 
cytochrome c reductase activities and by determining the 
relative contribution of this enzyme to the overall changes 
induced by Sesbania drummondii on various microsomal 
cytochrome P-450-dependent roonooxygenase activities. This was 
accomplished by comparing organic hydroperoxide-mediated 
(NADPH-independent) metabolism with NADPH-dependent metabolism 
of two cytochrome P-450 substrates. All of these studies were 
also performed with phenobarbital and 6-naphthoflavone 
treatments (two "classical" cytochrome P-450 inducers) of 
chickens and rats for comparison.
Sesbania drummondi treatment induced unique profiles in the 
catalytic properties of the chicken versus rat hepatic 
cytochrome P-450 monooxygenase system. Groups of White
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Leghorn chickens and Sprague-Dawley rats were treated with 
either bicarbonate-azide buffer (control) , Sesbania drummondii 
extract, phenobarbital, or B-naphthoflavone. The Sesbania
druminondii- treated rats received daily doses equal to 0.5% of 
body weight and the chickens received 0.5% or 0.75% of body 
weight. The catalytic properties of the hepatic cytochrome P- 
450 monooxygenase system were determined by characterizing 
cytochrome P-450-mediated enzyme activities of both low and 
high degrees of specificity for cytochrome P-450 isozyme 
families. The activities studied were aminopyrine N- 
demethylase, aldrin epoxidase, and the O-dealkylation of 
various alkyl-substituted alkoxyphenoxazones. With few 
exceptions, Sesbania drummondii induced catalytic changes 
differently than those induced by the two ,,classical,, 
inducers, phenobarbital and B-naphthoflavone.
Aminopyrine N-demethylase activity has been associated with 
the phenobarbital-inducible cytochrome P-450 isozyme family 
(P-450IIB1) . With Sesbania drummondii treatment, the specific 
activity of aminopyrine N-demethylase was increased 2-fold in 
chickens and decreased 2-fold in rats. In comparison, 
phenobarbital treatment increased aminopyrine N-demethylase 
specific activity nearly 3-fold in both chickens and rats and 
B-naphthoflavone treatment increased the activity in the 
chicken by 2-fold but did not alter the activity in the rat. 
Aminopyrine N-demethylase activity did not effectively
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discriminate between the different induced cytochrome P-450 
isoforms as the induced rates of this activity with 
phenobarbital were small in both species and in the chicken 
there was little distinction between the rates with 
phenobarbital and B-naphthof1avone induction.
Aldrin epoxidase activity has also been associated with 
phenobarbital-inducible cytochrome P-450 but with greater 
specificity. Aldrin epoxidation in the Sesbania drummondii- 
treated chicken paralleled phenobarbital treatment, whereas in 
the treated rat this activity paralleled B-naphthoflavone 
treatment. The aldrin epoxidase specific activity was 
increased 4-fold in chickens and decreased 2-fold in rats with 
Sesbania drummondii treatment. In comparison, phenobarbital 
increased aldrin epoxidase specific activity by 5-fold in both 
chickens and rats. B-Naphthoflavone-treatment had no effect 
on chicken aldrin epoxidation and in the rat decreased this 
activity nearly 2-fold.
The O-dealkylation of various alkoxyphenoxazone derivatives 
are presently the most specific of the cytochrome p-450- 
mediated activities for distinguishing between the inducible 
cytochrome P-450 isozymes in rat hepatic microsomes (Burke and 
Mayer, 1983; Burke et al., 1985). Studies in birds, thus far, 
have been limited to the ethoxy-derivative of 
hydroxyphenoxazone. To the best of our knowledge, the utility
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of the hepatic microsomal metabolism of various substituted 
alkoxyphenoxazones as probes for the phenobarbital and B- 
naphthoflavone induction of cytochrome P-450 in chickens has 
not been described.
The chicken exhibited markedly different induction patterns of 
the alkoxyphenoxazone O-dealkylases to phenobarbital and B- 
naphthof lavone than did the rat. As anticipated B- 
naphthoflavone treatment of rats resulted in a marked increase 
(18-fold) of ethoxyphenoxazone O-dealkylase activity with much 
smaller increases with the other substrates. In contrast, the 
highest increased activity in the B-naphthoflavone-treated 
chicken was benzyloxyphenoxazone O-dealkylation (32-fold) 
followed closely by ethoxyphenoxazone O-dealkylation (27- 
fold) . In good agreement with the literature, phenobarbital 
treatment of the rat resulted in very large increases in 
pentoxy- (197-fold) and benzyloxyphenoxazone O-dealkylation 
(98-fold). However, none of the alkoxyphenoxazone 0- 
dealkylase activities were induced in the phenobarbital- 
treated chicken. In fact, the O-dealkylation of pentoxy- and 
benzyloxyphenoxazone were actually decreased in the 
phenobarbital-treated chicken. These data suggest benzyloxy- 
and ethoxyphenoxazone are useful probes for distinguishing B- 
naphthoflavone inducible cytochrome P-450 isozymes in 
chickens. However, in marked contrast to the rat enzymatic 
system, none of the alkoxyphenoxazone O-dealkylase activities
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appear to be induced in the phenobarbital-treated chicken.
The catalytic profile of the alkoxyphenoxazone O-dealkylases 
clearly distinguished Sesbania drummondii treatment from 
phenobarbital and B-naphthof lavone induction in the rat and B- 
naphthoflavone induction in the chicken. Sesbania drummondii 
treatment of rats induced marked decreases in pentoxy- and 
benzyloxy O-dealkylase specific activities, whereas, 
phenobarbital treatment induced marked increases in these same 
activities. Ethoxyphenoxazone O-dealkylase, the activity 
markedly increased with B-naphthoflavone treatment, was 
unchanged in the rat with Sesbania drummondii treatment.
Microsomal-dependent alkoxyphenoxazone metabolism in chickens 
administered Sesbania drummondii extract was clearly 
distinguishable from that of chickens given B-naphthoflavone. 
B-Naphthoflavone treatment markedly increased the 0- 
dealkylation of ethoxy-, pentoxy-, and benzyloxyphenoxazone, 
whereas £. drummondii treatment caused no induction of these 
activities. This finding contradicted the preliminary finding 
that g. drummondii markedly induced ethoxyresorufin 0- 
dealkylation. The reason for this discrepancy between our two 
studies is not known. The two studies were different in the 
year the S . drummondii crop was harvested, the methods of the 
assay, and in the laboratory and personnel where the assay was 
performed.
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Phenobarbital and £. fl-rummondii treatments in the chicken 
shared a similar pattern of metabolism of pentoxyphenoxazone 
suggesting induction of cytochrome P-450IIB1 by the extract. 
However this data must be interpreted with caution in the 
chicken because both treatments significantly decreased the 
pentoxyphenoxazone O-dealkylase specific activity in contrast 
to the marked increase in this activity observed with 
phenobarbital treatment in the rat.
In summary, the catalytic properties of hepatic microsomes 
from Sesbania drummondii-treated animals showed some 
similarities with phenobarbital treatment in the chicken but 
also differences with phenobarbital and fi-naphthoflavone 
treatments in both species.
Sesbania drummondii induced mostly opposite effects on the 
total specific content of hepatic microsomal cytochrome P-450 
in chickens versus rats. Total cytochrome P-450 specific 
content i.e.,a measure of all the cytochrome P-450 forms, was 
increased 2-fold in chickens but decreased 2-fold in rats with 
jj>. drummondii treatment. The magnitude of the increase 
induced in treated chickens was similar to that of 
phenobarbital-induced chickens. The absorbance maximum (Soret 
maximum) of the carbon monoxide-reduced difference spectrum 
was the only measure of the cytochrome P-450 enzyme component 
that was similarly not affected in both the chicken and rat by
£• drummondii treatment. Neither species expressed shifts in 
their absorbance maximum away from the uninduced levels. This 
was a distinct difference from B-naphthoflavone treatment in 
which a characteristic blue shift in the peak absorption to 
448 nm, occurred in both chickens and rats. Induction in the 
chicken and depression in the rat hepatic microsomal proteins 
with Sesbania drummondii treatment were confirmed using SDS- 
gel electrophoresis. This was evident by increased protein 
band staining intensity in the chicken microsomal proteins and 
decreased protein band staining intensity in the rat 
microsomal proteins. The protein profile as measured by the 
molecular weight of the protein bands appeared to be unique 
with £. drummondii treatment of chickens because it did not 
closely parallel phenobarbital- or B-naphthoflavone-treated 
chicken microsomal protein profiles. In contrast, the S. 
drummondii-treated rat microsomal protein profile was very 
similar to that of control rat microsomal protein but of lower 
protein band staining intensity. Again, there was no 
resemblance of the S, drummondii-treated rat with either 
phenobarbital or B-naphthoflavone. The strongest evidence of 
species differences in the response of the hepatic cytochrome 
P-450 monooxygenase system to Sesbania drummondii treatment 
was from immunochemical studies. Immunoblotting techniques 
(western blots) are best able to discriminate among the 
cytochrome P-450 forms. Sesbania drummondii treatment of 
chickens induced two microsomal proteins that were detected
with antibody against rat cytochrome P-450IA1, the major 
isozyme induced by 3-methylcholanthrene. One of these two 
proteins corresponded with the protein of B-naphthoflavone- 
treated chickens which was also detected with this antibody. 
This indicated that g. drummondii treatment induces an 
orthologue of rat cytochrome P-450IA1 in the chicken. 
However, the second protein band in the Sesbania drummondii- 
treated chicken, which was of a lower molecular weight, 
appeared to be unique to this treatment. This second 
microsomal protein may be a novel chicken cytochrome P-450 
isozyme induced with g. drummondii treatment that shares an 
epitope to the rat cytochrome P-450IA1 form. However, these 
two Sesbania drummondii-induced cytochrome P-450 isoforms did 
not exhibit the characteristic substrate specificities of 
cytochrome P-450IA1 isozymes in chickens or rats. Most 
notable was the lack of induction of the O-dealkylation of 
ethoxyphenoxazone in the g drummondii-treated chickens versus 
the marked inductions observed with B-naphthof lavone. Neither 
of these microsomal proteins seen in the chicken were detected 
by this antibody in the g. drummondii-treated rat. An 
antibody directed against the major phenobarbital-inducible 
rat P-450 isozyme, P-450IIB1, was shown to weakly cross-react 
with chicken g. drummondii-treated microsomes. However, this 
cross-reactivity appeared to be non-specific as both control 
and all treated chickens weakly cross-reacted with this 
antibody.
NADPH-cytochrome P-450 reductase was also differently affected 
by Sesbania druminondii-treatment in chickens versus rats. 
Sesbania drummondii treatment induced a 2-fold increase in 
NADPH-cytochrome c reductase activity in chickens and no 
change in this activity in rats. This suggested that the rate 
of electron transfer from NADPH-cytochrome P-450 reductase to 
the cytochrome P-4 50-substrate complex in the chicken might be 
altered as a result of S. drummondii treatment. In that 
regard, the reduction of cytochrome P-450-substrate complex is 
considered by many as the rate-limiting step in cytochrome P- 
450-dependent monooxygenase activity (White and Coon, 1980). 
Therefore, alterations of this enzyme, either quantitative or 
qualitative, may be envisaged to alter cytochrome P-450- 
dependent activity. The effect of induction of NADPH- 
cytochrome P-450 reductase by drummondii to the overall 
metabolic function of cytochrome P-450-dependent monooxygenase 
activity was evaluated by measuring the peroxygenase activity 
of cytochrome P-450 which proceeds independently of the 
contribution of the reductase by forming directly the 
divalently-reduced peroxy P-450-substrate complex (Kadlubar e£ 
aJL., 1973; Rahimluta and O'Brien, 1974). This was 
accomplished by comparing the cytochrome P-450-mediated 
metabolism of aminopyrine and aldrin catalyzed by the 
classical NADPH-dependent cytochrome P-450 reductase i.e., the 
oxygenase activity of cytochrome P-450 to that catalyzed by 
the organic hydroperoxide-dependent peroxygenase activity of
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cytochrome P-450 (NADPH-Independent system). This report is 
the first evaluation of the organic hydroperoxide-mediated 
metabolism of aminopyrine in the chicken and perhaps more 
importantly, of an organic hydroperoxide-mediated aldrin 
epoxidation in the chicken and the rat. This may have 
important mechanistic implications in that highly 
electrophilic epoxides are now shown to be generated via a 
peroxidaic mechanism from a chlorinated hydrocarbon 
insecticide.
Differences in the metabolism of aminopyrine were observed in 
hepatic microsomes from chickens treated with S. drummondii as 
a function of the NADPH- versus cumene hydroperoxide-dependent 
reactions. This suggests that in the chicken, £. drummondi i- 
induced changes in the NADPH-cytochrome P-450 reductase 
component does contribute to the increased aminopyrine N- 
demethylase activity. In contrast, the metabolism of aldrin 
was affected similarly with both NADPH or cumene hydroperoxide 
components in the £. drummondii-treated chicken. This implied 
that induction of microsomal mixed-function oxidase activity 
by Sesbania drummondii includes induction of an isozyme or 
family of isozymes in the chicken that are involved in the 
metabolism of aldrin and that the induction of the reductase 
component was not critical to this metabolism.
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In the Sesbania drununondii-treated rat, there were similar 
decreases in aldrin epoxidation and aminopyrine N- 
demethylation regardless of whether the NADPH- or cumene 
hydroperoxide-dependent reactions were employed. Thus it 
would not appear that the decreases in metabolism by rat liver 
microsomes were due to less effective electron transfer from 
the reductase. One possible explanation for this is that s. 
drummondii actually altered the cytochrome P-450 isozyme 
population such that it less effectively metabolizes these 
substrates. Indeed our observation of less cytochrome P-450 
protein band staining intensity in S. drummondii-treated rats 
using SDS-PAGE supports this contention.
Comparison of NADPH- versus cumene hydroperoxide-dependent 
aldrin metabolism yielded unexpected results with the 
phenobarbital-treated rat. Although a marked increase in the 
NADPH-dependent epoxidation of aldrin was noted with the 
phenobarbital-treated rat (5-fold), such an increase was not 
evident with the cumene hydroperoxide-dependent system. 
Cumene hydroperoxide has been shown to bind the hydrophobic 
domain of cytochrome P-450 which in some cases effectively 
interferes with the binding of certain substrates (Rahimtula 
and O'Brien, 1975; O'Brien and Rahimtula, 1980). Therefore, 
additional studies utilizing t-butyl hydroperoxide, a smaller 
less bulky organic hydroperoxide, that unlike cumene 
hydroperoxide, does not interact strongly with the cytochrome
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P-450 binding domain were undertaken. When t-butyl 
hydroperoxide was utilized with the phenobarbital-treated rat 
microsome, the increase in aldrin activity was again apparent 
suggesting that the apparent induction of aldrin epoxidase 
activity was not expressed with cumene hydroperoxide owing to 
non-specific interactions with the hydrophobic binding domain. 
No differences were detected between the two organic 
hydroperoxides on the S. drummondii-induced treatment effects 
on the metabolism of aminopyrine or aldrin in either chickens 
or rats.
In conclusion, it appears Sesbania drummondii treatment 
induces both the cytochrome P-450 and NADPH-cytochrome P-450 
reductase enzyme components of the hepatic microsomal 
cytochrome P-450 system of chickens. In contrast, only the 
cytochrome P-450 component is depressed in the rat with 
drummondii treatment. A number of chemically diverse 
compounds have also been reported to inhibit cytochrome P-450- 
dependent activity in rats. These compounds include an 
essential element, manganese (Deimling and Schnell, 1984); a 
hepatotoxicant, carbon tetrachloride (Sesardic et al. . 1989); 
as well as the therapeutically useful antifungal agents, 
ketaconazole, miconazole, and clotrimazole (Rodrigues al*, 
1987) and the antibacterial agent, chlorarophenical (Halpert et 
al-, 1988).
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Moreover, studies on the peroxygenase activity of cytochrome 
P-450 support the idea that increase in MFO activity following 
Sesbania drummondii treatment in chickens were due to 
alterations in the content and isozyme profiles of cytochrome 
P-450 and not due to alterations in electron-transfer 
efficiency. This was borne out by the immunological studies 
which indicated the presence of new immunoreactive proteins in 
the molecular weight range of cytochrome P-450.
The Sesbania drummondii extract in chickens appears to induce 
at least two cytochrome P-450 isozymes. An immunochemical 
study revealed that these two proteins cross-react with the 
antibody against rat cytochrome P-450IA1. One of these 
proteins may be a 3-methylcholanthrene-inducible P-450 form of 
the I cytochrome P-450 gene family. The other may be a novel 
cytochrome P-450 form induced by Sesbania drummondii. 
Interestingly, these two proteins did not show typical 3- 
methylcholanthrene-type catalytic activities. In fact, their 
catalytic activities were more like that of phenobarbital. 
Only specific isolation and gene sequencing will permit 
definitive identification and classification of the £. 
drummondii-induced chicken cytochrome P-450 isozymes.
In contrast to the chicken, the rat hepatic cytochrome P-450 
monooxygenase system was decreased with the Sesbania 
drummondii extract. This appears to be the result of a
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general depression of the constitutive cytochrome P-450 
isozymes rather than effects on specific cytochrome P-450 
isozymes as gel electrophoresis indicated that all proteins 
that had molecular weights similar to the cytochrome P-450's 
were less intense. Neither NADPH-cytochrome P-450 reductase 
nor the integrity of the endoplasmic reticulum appears to be 
altered in the rat. Two likely mechanisms for the S. 
drummond i i-induced effect in the rat are 1) Sesbania 
drummondii depresses the synthesis of new cytochrome P-450 
protein, i.e., down-regulation; or 2) Sesbania drummondii 
enhances the post-transcriptional and/or post-translational 
catabolism of cytochrome P-450 in a manner reminiscent of the 
ethanol inducible cytochrome P-450 discussed in the 
introduction to this thesis.
The Sesbania drummondii treatment used in this study was a 
crude plant extract which is composed of a number of different 
chemical compounds. Undoubtedly a number of the different 
chemical components contained in the extract are involved in 
the differences observed in the chicken versus rat hepatic 
microsomal cytochrome P-450 systems. This is not surprising 
owing to the extreme pharmacological response differences to 
a variety of chemical agents contained in plants. Another 
plant that induces different toxicosis depending on the animal 
species is Bracken fern fPteridium aauilinum) (Cheeke and 
Shull, 1985). Nonruminants (horses, pigs) may develop a
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thiamine deficiency, while cattle and sheep may exhibit signs 
of a fatal hemorrhagic syndrome. Bracken also contains a 
carcinogen which may affect all species, including humans. 
Natural toxicants in poisonous plants have had significant 
effects on livestock production in North America. Many of 
these natural toxicoses, such as fescue foot, summer fescue 
toxicosis, bracken poisoning, and vetch poisoning of cattle, 
still have not conclusively had their toxic agents defined 
(Cheeke and Shull, 1985). However, their pathophysiological 
effects have been vigorously pursued even in the absence of 
the knowledge of the specific toxic agent using crude extracts 
of these plants. Many of these studies have resulted in the 
discovery of useful preventive and treatment measures. 
Therefore, regafdless of the specific chemical(s) in the 
extract and the specific isozyme(s) of cytochrome P-450 
affected, it is clear that Sesbania drummondii can alter the 
hepatic microsomal cytochrome P-450 monooxygenase system of 
mammals and birds with important expected consequences on 
xenobiotic and endobiotic metabolism.
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Appendix 9. Phosphate concentration vs. protein 
concentration and incubation time in the chicken hepatic 
microsomal glucose-6-phosphatase assay.
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Appendix 10. Phosphate conc. vs. protein conc. and 
incubation time in the rat hepatic microsomal glucose-6- 
phosphatase assay.
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Appendix 11. Formaldehyde formation vs. protein 
concentration, incubation time, and aminopyrine 
concentration for the chicken hepatic microsomal 
aminopyrine N-demethylase assay.
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Appendix 12. Formaldehyde formation vs. protein 
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concentration for the rat hepatic microsomal 
aminopyrine N-demethylase assay.
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Appendix 13. Dieldrin production vs. protein concentration, 
incubation time, and aldrin concentration for the chicken 
microsomal aldrin epoxidase assay.
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incubation time, and aldrin concentration for the rat 
hepatic microsomal aldrin epoxidase assay.
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Appendix 15. Resorufin production vs. incubation time
at two protein levels in the chicken hepatic microsomal
methoxyphenoxazone O -dealkylase  assay .
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Appendix 16. Resorufin production vs. incubation time
at two protein levels in the rat hepatic microsomal
methoxyphenoxazone O -dealkylase  assay .
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Appendix 17. Resorufin production vs. incubation time
at two protein levels in the chicken hepatic microsomal
ethoxyphenoxazone O -dealkylase assay .
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Appendix 18. Resorufin production vs. incubation time
at two protein levels in the rat hepatic microsomal
ethoxyphenoxazone O -dealkylase  assay .
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Appendix 19. Resorufin production vs. incubation time
at two protein levels in the chicken hepatic microsomal
pentoxyphenoxazone O -dealkylase  assay .
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Appendix 20. Resorufin production vs. incubation time
at two protein levels in the rat hepatic microsomal
pentoxyphenoxazone O -dealky lase  assay .
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Appendix 21. Resorufin production vs. incubation time
at two protein levels in the chicken hepatic microsomal
benzyloxyphenoxazone O -dealkylase  assay .
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Appendix 22. Resorufin production vs. incubation time
at two protein levels in the rat hepatic microsomal
benzyloxyphenoxazone O -dealkylase  assay.
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Appendix 23. Formaldehyde formation vs. protein conc., 
incubation time, and aminopyrine conc. for the chicken 
hepatic microsomal cumene hydroperoxide-mediated 
aminopyrine N-demethylase assay
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Appendix 24. Formaldehyde formation vs. protein conc., 
incubation time, and aminopyrine conc. for the rat 
hepatic microsomal cumene hydroperoxide-mediated 
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Appendix 25. Formaldehyde formation vs. protein conc., 
and incubation time for the chicken hepatic microsomal 
t-butyl hydroperoxide-mediated 
aminopyrine N-demethylase assay
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Appendix 26. Formaldehyde formation vs. protein conc., 
and incubation time for the rat hepatic microsomal 
t-butyl hydroperoxide-mediated 
aminopyrine N-demethylase assay
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Appendix 27. Dieldrin production vs. protein conc., 
and incubation time, and aldrin conc. for the chicken 
hepatic microsomal cumene hydroperoxide-mediated 
aldrin epoxidase assay.
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Appendix 28. Dieldrin production vs. protein conc., 
and incubation time, and aldrin conc. for the rat 
hepatic microsomal cumene hydroperoxide-mediated 
aldrin epoxidase assay.
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Appendix 29. Dieldrin formation vs. protein conc., 
and incubation time for the chicken hepatic microsomal 
t-butyl hydroperoxide-mediated aldrin epoxidase assay.
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Comparison of the effects of Sesbania drummondii 
on the hepatic microsomal monooxygenase systems 
of chickens and rats
Marcy I. Banton, DVM; Wayru Flory, PhD; PtUr L. H. Jow tti, PhD; Gary W. Winston, PhD
SUMMARY
Sotbanio drummondii, ■ bade leguminous shrub found 
throughout the southeastern United States, induces dif­
ferent responses is  chicken v» rat hepatic microsomal 
monooxygenaae systems. G rape of 4- to ft-week-old Spra- 
gue-Dawiey rati and White Leghorn chickens were given 
extracts of 5  drummondii h f gevage for 3 day*. Doaei, 
which were 0.4 and 0.8% of daily body weight*, rerpac- 
tively, for the rata and chiefcaa, were adjusted to induce 
eimiier clinical iesionj In the 3  ^edae . The hepatic mi- 
croeomal monooxygensss Q k B i  of control and treated 
.T'iw.aU ew e compared, u*ing«jtuchrome f-4S0 content, 
cytochrome 6, contest, nadb- and NADra-cytodoeme e- 
reduetaae activity, and 6 cytodmxne P-450 madiatad an- 
lyme activities. Increases oftmrioidin the cytochrome P- 
450 content, NADPH-cytochrome c-reductase, aminopy- 
rine-Af-demathylase, aniline bydmxylaaa, ethoxycou- 
marin-O-daethylaw, and aryl hydrocarbon hyttrmjlaai 
activities; fourfold in the aldrin eporidaae activity; and 
15-fold in the ethoxyreeorufin-O-deatbylaae activity v e t  
obaervad in the S drummondii-treated rhich»n« Is  con­
trast, the tiaated rati bad nearly twofold den ia lua in 
th an  values, suggesting a epedas-epacific effect of 5  
drummondii on microsomal xnonooiygenaie systems, ia, 
induced with S drummondii.
Sesbania drummondii is a perennial herbaceous shrub 
or small tree inhabiting the sandy soils and marshes 
throughout southeastern United States. This poisonous 
plant, also called nttlabruah, coffaabean, or rettiebox, is 
sporadically ingested by livestock and usually results in
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and goats, usually in tbs fall or winter after other forage 
has become scarc*.u  The toxic principle of 5  drummondii 
has not yet been identified, but appears to be concen­
trated in the mature seed containing pods.4
Chickens and rats have been proven ■vprimawtally to 
be highly sensitive to extracts or 5  drummondii seeds and 
are, therefore, useful avian and mammalian experimen­
tal models for studying the toxic effects of the plant.* 
Cliidral signs, blood chemistry values, and tissue lesions 
haws been previously daaqrihad in poisoned chickens.* 
Typically, the clinical signs melude was Imam, depres­
sion, miorexia, diarrhea, ruffled /aethers, cold feet, and 
rapid lea* of body weight. An intamating climrel feature 
in chickens has bean a  severe d isease  in the concentra­
tion of total plasma proteins.* At nesopey, gross changes 
are ending in body tit, muscle mans liver, kidneys, spleen, 
crop, H l**^inai. and th e  h e a rt Similar r lin im l sod patho­
logic changes are observed in rats.*
Same of the changes ia poisoned birds, as well as in 
rats, can be explained by inhibition of smooth muscle 
function.* However, other changes in both spades may be 
caused by toxic effects of 5  drummondii on the liver. Ear­
lier studies have focused on the liver to determine the 
cause of depleted circulating serum protein concentre- 
- tions.* These results indicated that 5  drummondii inhib­
its protain synthesis and export protein release from the 
liver.* Further investigation revealed that S drummondii 
also alters a number of liver enzymes, including micro­
somal glutathione-S-transferase isosymee.*
The purpose of the study reported here were to char­
acterise and compare the effects of 3 drummondii on the 
major biotransformation system, the hepatic microsomal 
monooxygenase system, in susceptible avian and mam­
malian species, namely chickens and rats.
Materials and Methods
Animal»-~Twenty-four null sad bauds 300- to 500-g Whits 
Leghorn chickens* were group-housed in commercial brooden. 
figtitasn mall Spragus-Dswlsy 200- to SOO-g rets were main­
tained 3/aage on a 12-bour light/dark cycle in s  tern per* cun- 
and humidity-con trolled environment. Chickens and rats were 
given bad (standard commsraal discs) and water ad libitum. 
Both aperies were »—n f o r  1 week. Experiments using
T.IH.Aa 
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chickens wire performed with 3 groups of 8  »nim»l. 4  m aud 
and 4 control, in aach group. Experiment* uaing rata wan per­
formed with 3 group* of 6  animal*, 3 treated and 3 oontrol, in 
aach group.
Treatment*—Extract! of 5  drummcudii war* proparod bom 
dry ground aaada and poda gathered locally. Ground aaada and 
pods have virtually the aama tmoctty aa who la ground aaada.* 
The ground aaada and poda wara seabed overnight ia a 25 mAf 
(odium bicarbonata buffar (pH T.4I containing 0.02% aodiura 
axida in a ratio of 1 part ground aaada to 8  part* buffar. Sodium 
aaida wax added to inhibit bacterial growth in tha extract. Tha 
estreat waa recovered by vacuum filtration through 6 layer* of 
cbaaea cloth. The concentration of the extract waa rtetanninari 
bom the volume of filtrate par gram of aaada and poda. Animal* 
wore weighed daily for 3 day* and than aithar wan given troahiy 
prepared extract of 5 dmmmandit by gavaga or received no 
treatment. Control —■<— !« wore not given the extracts. Differ* 
aneaa in the growth, health, miaoaomal content or activities of 
control chicken* and rat* treated with the bicarbonate'erid* 
buffer V* thoaa not given tha buffa have net bean 0 bear* ad in 
pravioua axparimanu in our laboratory. The volume of extract 
given waa eaieniatad by multiplyiag tha body weight of the 
animal the doe* aa penantaga of body weight, and tha cancan- 
tration of extract. Traatod chicken* received daily doeaa equal 
to 0.8% of bod>- weight, and rate received 0.4% of body weight. 
The** data* have bean found to induce similar »<*«£»> aigna 
and neeropay laaiona in the 2 aparimana over a 3-day period.'
Prtporatien of microsomal—On lb* fourth day, tba «"<"»»)« 
were weighed, killed by guillotine, and examined for groaa le- 
ilona. Liven war* axeftilly removed, weighed, and plaead on 
ica. Miooaomaa were prepared from tha pooled liven of tba 
group, tree tad or control Tbv liven ware minced, rineed, and 
bomogenixed in 4 volumaa of ioa-cold buffar aolution (10 mAf 
trio, pH 7.4; OffSAf auaoaa; and 1.0 mlf diaodium XtiTA). A 
mieroaomal pallet waa prepared by xtapwiaa differential eantri- 
ftigation of tha homogaoAte’ at 600 x g, 8,000 x g, and 14,500 
x g, and subsequent centiifiigatioo of the aupernatant at 106,000 
x g. Tha rcculting pallet waa walked once with 0.12Slf EC1 
and reoantrifugod at 106,000 x g for I hour. Tha final miao­
aomal pellti waa rasuspendad is 0.126Af KC1 in 20% glycerel 
and frosan I -  70 C) until uaad. bfiauaomaa wen uaod within 2 
week* of iaolation. The concentration of mieroaomal proutna 
waa determined. uaing bovin* aerum albumin aa a reference 
aUndftnL*
DtUmunatum ofcytochrom* content end rtductatt aetwOitt— 
Cytochrnma P-4B0 content of tha microaomaa waa detenninad 
by the method cf Omura and Sato,' uaing tha difference spec- 
sum of tha carbon monoxide complex of dithionite-reduced cy- 
toehroma P-460 minui tha spectral contribution of reduced 
eytochromtT^SO. The change in absorbance at 480 am ralati** 
to 4 9 0  nm waa then convened to the specific content of cyto­
chrome F-450, uaing an extinction coefficient of 91 o r 'a t l f* 1. 
The concentration of cytochrome 6, in the miaoaomal suapen- 
auna waa determined from tha NADH-reduoad diffaranc* apec- 
trum by using tha — mefflriant of 186 tor
the abaorbanc* change at 426 miaua 409 nm.*
The naDH and N ADPH-cytoehrocn* c-reducteae activitiaa ware 
amayari by uaa of tha method of Phillip* and Langdon,1* aa mod­
ified by Yaeukochi and Ma*tar*,u in which the rata of cyto­
chrome c reduction waa followed spectrophocomatrieelly at 660 
nm. The reduetae* activitiaa ware quantified, uaing an extinc­
tion eoefHriani of 19.6 nm*1 cm*1 for the reduced minua tha 
forma.
itm urtm m t of cuyma aounticr—'Hi* ntiacecnial-inedietad 
. . . t . t—n.m of aminopyrine war maeeured by analyaia of the 
formation of formaldehyde. The reaction mixture rnnaiatari of
0.4 mg of mieroaomal protain, O.SmAf nadp +, 10 mAf gtucoae-
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6-phoaphata, 7 U of giucose-6-phosphate dehydrogenase, 10 mAf 
MgCl,, 100 mAf potaaaium phoaphata buffar (pH 7.4), and 10 
mAf aminopyrine in a final volume of 3.0 ml. Tha reaction wax 
ctarted by the addition of tha naDPh gaaerating ryetctn. incu­
bated at 37 C for 15 minute*, and atopped by tha addition of 1 
ml of 70% trichloroacetic acid. Aminopyrina-Af-damathylaat 
Iatnd) era* quantitated by maturing the amount of formal­
dehyde formed according to the method of Naah,u compared 
with a atandard curva prepared in tha reaction matrix.
Aniline hydroeyla*# activity (anni aval maaaurad by follow­
ing the formation of p-aminophanol from aniline according to 
tha method of Lake,' with modification*. Tha 2-ml reaction mix­
ture contained 1 mg of miaoaomal protein, 50 mAf tria-HCl 
buffar I pH 7.81, 5 mAf MgSO„ 0.6 mAf nadp +, 5  mAf giucoat- 
6-phoaphace. 1.5 U of giiimaa g phoaphata dahydroganaaa, and 
6 mAf aniline-HCL The reaction waa atartad by the addition of 
tba nadph generating ayetam and waa incubated in a 37-C water 
bath for 10 misutaa The reaction waa terminated by adding 2 
ml of 10% trichloroacetic add. Alter osntriAigatioa, a 2-ml ali­
quot of the aupernatant waa added to 1 ml of 10% N*,C0, fol­
lowed by tba addition of 2 ml of 1% phenol in 0.1AI NaOH. Tba 
moulting optical denxity wea meaaurod at 820 nm altar 30 min­
ute* and compared with a p-aminophanol atandard.
Aldrin apmbdaaa activity (Ah) we* determined from the amount 
at  dialdnn produced, a* da* crib ad by Riviar* at alu with mod­
ification*. The Incubation cyatam contained 60 mAf potaaaium 
phcephatc buffar (pH 6.8). 0 .26 mAf nadp +, 2.5 mAf ghicoaa 6- 
phaaphaia, 1 U of ghirca* (i phoaphata dabydrogasaaa, 0.2 mg 
of microeomal protein, and 80 (J f  aldrin* in a final volume of
1.0 m l Incubation waa performed aerobically in a conatant tem­
perature ahakar at 87 C for IS minute*. The reaction waa ini­
tiated by the addition ef aldrin and cloppad by tba addition of 
Off ml of aeeton*. Hexane (8 ml) waa added, and tha tuba* war* 
mpped and vortaxad for 45 aaconda. Dialdnn* era* aaaayad by 
uaa of a gaa chromatograph' equipped with an alectron-captur* 
datactor (**Ni) and a capillary column* (15 m long. 0.53 mm is, 
phaaa 007-17). The column, datactor, and iqjactor temperaturat 
were 220 to 240 C (10 Cfmin), 300 C, and 180 C, raepactivaly 
The injection of *ampla* waa mad* ia the *plitter* made, uaing 
a direct fleet injection liner. The carrier gaa waa 8% methane 
in argon at a How rata of 11 Carrier gaa waa *in uaed
for datactor make-up to a total flow of approximately 30 ml/min. 
Tba amount of di aldrin in lb* extract waa quantified by peak 
height from a atandard curve.
The O-daalkyiation of 7-athoxynoumarin and 7-athoxyreao- 
rufin' waa maaaurad fluoromatrically uaing a apactropbotofluo- 
rometer,* by tba method of Lake.' The 7-ethoxycoumarin-O- 
deethylaaa (sconl aaaay waa run at 37 C for 10 misutaa and 
contained a atandard reaction mixture of 60 mAf tria HC1 buffer 
(pH 7.6), 5 mAf MgSOv 0.5 mAf WABP-r, 5 mAf gtuooaa g phoa- 
phata, 3 U of ghinn** 6 phoaphata dabydrogenaa*. 0.6 mAf 7- 
ethoxyeoumarin, and 1 mg of miaoaooul protein in a final vel­
um* of 2 mL Tba 7-athcxyreanrufin-O deethylaaa (kaoni aaaay 
waa alao pacformad at 37 C for 10 minute* and contained tha 
aforementioned componesu ia the reart inn mixture, with tha 
exception that 6 uAf 7-athaxyreeanifia area uaad for tba aub- 
a t t u  and that the microsomal protein concentration n a  0.1 
mgfrnL The buffar uaed waa 50 mAf bria HC1 (pH 6.41, iaataad 
of the tria HC1 (pH 7.8). lb* reaction* were atartad with the 
addition of aufaetrato and taraunatad by tba addition of 1 ml of 
xinc sulfate aolution, followed by 1 ml of saturated barium hy­
droxide aolution to all tuba*. Alter cantrifiagation. 1.5 ml of 
aupernatant waa removed and added to 3 mi of O.&Af gtytina- 
andiiun hydroxid* buffar (pH 10.6 for lCOD. pH 8.5 for caoDi. 
Tha ecod aaaay uaad 380-nm avritatinn and 462-nm emiaaion
• IT A. gwwwt Trwem* fork. NC
• BerieaM etliao A W w anl.H eriaaM ur*. Au.tili N 
'  4aa*m Cam-Hea Haww Ct
• me, rtwwi c*. at ieu*.
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wavelengths and * u  compared with an umhelliferop* (7-hy- 
drmtyeoumsnnj standard. Tbs caet) activity was nMacund. using 
5 35  up natation and 582-tun emission wevalengths and waa 
quantitated with 7-bydrexyraaenifis aa a atandard.
Tba aryl hydrocarbon hydroxylase activity taXHl waa mu- 
aurad by the method described fay Gueogeriit. “ Tba compo­
nents of a 1 ml reaction mixture included BO mM potaaaium 
phoaphata buffer (pH 7.4). 5 mM MfCV 1 mM nabp +, JO mM 
giucose-S-phoephase. 3 U of glumes fi phoaphata dehydroge- 
naaa, BO iM  beasoMpvrsne,' and 0.1 mf of micnaonaal protain. 
Tha reaction waa atartad with tba naBPH generating system. 
Incubations wara performed at 37 C (or 10 minutes and war* 
tarminatad with 1 oil of oold acstoo* (4 C). Tha product! wara 
extracted with 3.25 ml ofhexane followed by tba addition of IN 
NaOH. Fluorescence of tha aquaoua layar wat raad with tba 
aadtatioo at 395 am and tha ormesuin at 522 nm. Tha aryl 
hydrocarbon hydroxylase activity n i  quantitatad. uaing a 3- 
OH bamoiatpyraoa standard.
Siantnro.1 mvoiyau —Tba significance of difference batwaan 
nontraatad controls and treated group* was determined, uaing 
tha Student i tart Tha P values > 0.05 wart not conaidarad 
Kitiiciolly
Results
Body u/tighis and tiotr tucghte—Decreases in body 
weights is cbidtrni ware detected is  tba S drummondii- 
treated groups, compared with controls. Weight losses de­
veloped. despite detection of large quantities of food ma­
terial is the crop* of traated chickens at necropsy The 
treated rats bad slight, but not significant, decreases in 
gains in body weight relative to tha controls, liver weight 
changes paralleled those of body weight in tba treated 
animals, resulting in liver to body weight percentages 
similar to those of the control animals (Table 1).
Hepatic microsomal cytochromes and reductases — 
Striking differences in the specific content of miaoaomal 
cytochrome P-450 of S tfrummondii-tiaated vs control an­
imals were detected (Table 21. An approximate twofold 
increase in rW irni* (p < 0.011 and a twofold decrease 
in rats1 IP < 0.05) cytochrome P-450 were consistently 
observed for the treated group*. Significant differences 
were not observed in the cytochrome 6* content of micro­
tomes from 5  drummondii-tnatod chickens or rats.
The effect of S drummondii treatment on naDPH- and 
NAfiH-cytochrome c-reductaae activities followed a pat­
tern n ^ 'ia r to that described hr the cytochromes. Merited 
increases in the chickens IP < 0.01) and slight, but not 
significant, decreases in the rats were observed for na&ph-
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cytochrome c-reductase activity Significant differences 
were not observed for NADH -cytochrome c-reductase ac­
tivity in both species treated with S drummondii.
Btpanc microsomal manooKygtnost actiniae*—The ef­
fects of S drummondii treatment on 6 selected hepatic 
miaoaomal mnnooxygenaae enzyme activities are com­
pered in terms of milligrams of miaoaomal protain (spe­
cific activity) and "**»«»»)»« of cytochrome P-460 (molar 
activity or turnover; Table 3).
When expressed as per milligram of microsomal pro­
tein, increases in all 6 activities were evident with the 
treated chickens. Twofold increases were detactad for aPHD 
IP < 0.05), ANH IP < 0.05), XCOD <P < 0.01), and ahh  CP
< 0.01) activities. Tba AX activity increased fourfold in 
treated birds <P < 0.01). The most pronounced increase 
eras in  IXOD, with e  15-fold increase in activity in traated 
birds, compared with controls CP < 0.01).
Significant decreases in 3 activities, expressed as per 
milligram of mieroaomal protain, were observed in the 
treated tats. A 40% reduction in apvd IP < 0.01), anh  IP
< 0.01), and *COD CP < 0.01) activities developed in the 
treated rats. Decreases ia ax, aKH, and h o d  were ob­
served in treated rats, but these differences were not sig­
nificant.
More specific changes in enzyme activities were evident 
for activities expressed as the turnover number for the 
cytochjome(s) P-450 (unitMnanomole of F-460). Only 
ahh, ae, and xnoD activities were increased in the treated 
chickens at approximately L2-fold, twofold, and seven­
fold, respectively. In rats, significant decreases in enzyme 
activities were not detected.
Discussion
Results of this study indicated that extracts of 5  drum­
mondii grsatiy affect the hepatic mioosoma) monooxy- 
gsnaae systems of chickens and rats. In White Leghorn 
chickens, S  drummondii treatment results in induction 
of the hepatic mioosomal monooxygenase system. This 
finding was shown fay the increases in cytochrome P-450 
content, NADPH-cytodtrome c-reductase activity, and the
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activities of 6 cytochrome / ’-450-mediated cnryme activ­
ities.
The induction of the monooxygenase system in birds is 
generally similar to that in mammals, ia, chickens re­
spond to’the 3>metbyleholanthrene (3-mc), phenobarbitol 
(PB). and the mixed type of claaairal mammalian induc- 
eis.1'
3-Methylcholantbrene, fi-napthaflavune and tatracho-. 
rodibemo-p-dioxm (3 m.mmeliew 3-siC type of inducers) 
have been examined in the White Leghorn chicken. Re­
ported Endings have included slight (twofold) increases 
in ethylmorphine-Af-demethylaee and anh,1* moderate 
increases in cytochrome P-450 content,1'  and large in­
creases in AKH (7 to 20-fold) and UOD (40-fold) activi­
ties. l , ' li Induction of NADPH-cytochrome c-reductase
i . : . . 1.. Ir. ) ■'"* '•as not been reported with 3-llc in­
ducers.1*
A number of studies have examined the effects of ra  
on the induction of monooxyginoses in chickens. In- 
oeoser in cytochrome P-460 content (three- to fourfold) 
and increases in apnb and ANH ectrvitiss have been re­
ported.UJ1 To the best of our knowledge, the effects of PB 
on the NAPPH-cytnchrome c-reductase activity have
-.•'t be-?o 'sported; however, in mswimsls an induction of 
rhic reductase develops with PB.“
Of the mixed-type inducers, a literature eearcb indi­
cated that only polychlorinated biphenyls have been stud­
ied in chickens. Arochlor 1254 and 1268 treatments result 
in increases in cytochrome P-46Q and in the monoaxy- 
genose activities of ax, aPNd, and an h ." -*1 A change in 
NADPH-cytochrom# c-reductase activity was not observed 
in chickens treated with Arochlor 1254."
Additionally, a number of other compounds hove been 
determined to have inductive effects on the monooxygen- 
are svstvm in chickens and other birds. Ons such com­
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pound, prachlons, was studied by Riviere et alu in several 
avian species, including chickens. A fourfold increase in 
cytochrome P-450 with increases in EKOD (threefold). a£ 
(2.5-fold), and ANH (threefold) were observed. Govindwar 
et alu  examined the effects of caffeine on So noli Pearl 
chicks and found slight increases in cytochrome P-450, 
cytochrome 6,, and NADPH-cytochrome c-reductase activ­
ities.
Tbs response profile of the hepatic monooxygenase sys­
tem of White Leghorn chickens to S dmmmondii is some­
what different than that described above for the elassicisl 
inducers. We observed essentially twofold increases in cy­
tochrome JM50 content, APND, ANH. aHH, ECOD, and 
NADPH-cytochrome c-reductase activities; a sixfold in- 
aaose in AC, and a fiftsenfold increase in erod activity. 
Ssstoruo drummpndii is a complex mixture of com­
pounds, and in the chicken, may be s mixed type of in­
ducer, however, fiirthar studies will be necessary to confirmAil
Usually compounds that are inducers of the microsomal 
monoaxyganase systems in avian species art also induc­
ers of the monooxygenast systems in memm.l. However, 
this was not the cose with 5  drummondii. A depression, 
rather than induction, of all the activities of the hepatic 
monooxygenase system was observed in microtomes from 
the 5  dnurujuvufu-treaced rats.
Although the specific activities (nanomole of product/ 
minute/milligram of mioosomal prowin) for all the sub- 
stratei catalysed by microtomes from 5  drummondu 
boated chickens were higher than those for controls, the 
turnover numbers (nanomole of product/minute/nanom­
ole of P-480) were essentially the same except in the cose 
of az  and UOD, which were three- and sevenfold higher, 
respectively, with miansomes from the 5  drummondii- 
treated chicks as. compared with microtomes from control
Am J Vel Res, Vol 50, No. 10. October 1989
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ehicksos The** data suggest induction of at least 1 now 
isozyme in conjunction with induction of aovtral consti­
tutive forms in the ehiekan livar. In rats, S drummondii 
appeared to auppias* the constitutive isotytnes and, in 
the case of MOD. poaaibiy indunad a novel iaoryme with 
lower u o o  activity. More riforous proof Temnins to be 
established. At the present time it is not known whether 
the same component in S drummondii products the ef­
fects seen in chickens and rats. The mechanisms for mon- 
oxygenase induction in chickens and depression in rats 
I -■ S Jrui-.mondii are not presently known. Whether eim-- 
ilar responses will occur in other avian and mammalian 
spades will require further study.
The passible implication of altering a major drug me­
tabolising system by consumption of S drummondii could 
be important in any spades sepnsiH to this tome plant. 
The alteration of the cytochrome P-450 system could cause 
lass tmdc agents to become more toxic, so as to produce 
acute intoxication on exposure. The alteration of this sys­
tem will also change the pharmacokinetics of many ther­
apeutic agents given at the time of S drummondii exposure. 
The known toxic affects of S drummondii in cattle pres­
ently are limited to acute tom wees from ingestion of large 
quantities of a*.*d pods. However, the potential exists for 
low-leval chronic exposures to the plant in contaminated 
feed. Sttbania drummondii is a  major wead problem in 
southern soybean fields. If the hepatic monooxygenase 
system of cattle is induced or depressed from 5 dntm- 
mendii, then perhaps these changes in xanobiotic metab­
olism will result in ineffective or toxic drug therapies.
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appendix of  my Ph.D. d i s s e r t a t i o n  a t  Louisiana S t a t e  U ni ve rs i ty .  The r e p r i n t  
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AJKirj
291
U niversity of Texas Press POST OFFICE BOX 7319 AUSTIN, TEXAS 73713-7319
TELEPHONE |5 I l |  471-7133 TELEX 7 7 6 4 5 3  UTEXPRES AU5 FAX |>I2|  320-0668
21 February 1990
Marcy I. Banton, DVM 
School of Veterinary Medicine
Veterinary Physiology, Pharmacology & Toxicology 
Louisiana State University 
Baton Rouge, LA 70803
Dear Marcy I. Banton:
Thank you for your letter 19 February 1990. We are pleased to grant 
you permission to reproduce the line drawing of Sesbania drummodii 
(Rydb.) Cory published on page 545 of our book TREES, SHRUBS, AND 
WOODY VINES OF THE SOUTHWEST by Robert Vines in your dissertation at 
Lousiana State University.
This permission is granted only for the use of the drawing in your 
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